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CHAPTER 1 
INTRODUCTION 
 
1.1.  Pulmonary drug delivery 
Pulmonary drug has been long accepted as the preferred route for the local delivery of therapeutics 
to the lungs for the treatment of a range of prevailing lungs ailments including chronic obstructive 
pulmonary disease (COPD), asthma and cystic fibrosis [1, 2].  More recently, however, the lungs 
have been also recognized as a viable route for the systemic administration of therapeutics through 
the lungs [3].  The interest in using the lungs as an alternative pathway for the delivery of drugs to 
the blood stream is due in part to the reduced enzymatic activity in the lung tissue, avoidance of 
first pass metabolism, and the lungs large surface area [4, 5], characteristics that enhance drug 
bioavailability and pharmacokinetics [6, 7]. 
There are three main devices that are used for the delivery of therapeutics to the lungs: nebulizers, 
dry powder inhalers (DPIs) and pressurized metered-dose inhalers (pMDIs) [8, 9].  pMDIs are of 
great relevance in the context of pulmonary drug delivery as they are the least expensive and most 
widely used aerosol devices.  pMDIs are portable, have long shelf life, and are highly compliant 
[10, 11].  pMDIs self-propelling mechanism also helps to improve lung deposition efficiency in 
patients with compromised lung airflow, such as those suffering from COPD and other lung 
disorders [12]. 
It may be surprising at first to note, therefore, that there is no pMDIs formulation in the US that 
has been approved for the delivery of therapeutics to the systemic circulation.  Moreover, there are 
no OI formulations available for treatment or to aid in the treatment of many prevailing lung 
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diseases such as lung cancer and pulmonary tuberculosis, even when conventional delivery routes 
are known to be associated with high toxicity and poor patient compliance.  Currently available 
pMDI formulations consist mostly of a small class of therapeutics (steroids and beta-agonist) [7, 
13, 14]. 
However, a closer look into the literature reveals that our ability to develop pMDI-based OI 
formulations for local or systemic delivery of drugs to and through the lungs remains basic at best.  
Moreover, the breakthroughs seen in conventional delivery routes as nanotechnology is applied to 
the controlled and targeted delivery of therapeutics, have not been explored nor materialized to the 
same extent to the pulmonary routeA closer look into the literature reveals that our ability to 
develop pMDI-based OI formulations for local or systemic delivery of drugs to and through the 
lungs remains basic at best.  Moreover, the breakthroughs seen in conventional delivery routes as 
nanotechnology is applied to the controlled and targeted delivery of therapeutics have not been 
explored nor materialized to the same extent to the pulmonary route. 
It is our main goal in this work to address some key but focused issues on both fronts, in terms 
of nanocarrier design for pulmonary delivery, with a focus on dendrimers as nanocarriers, and to 
the formulation of such nanocarriers in pMDI formulations, with a focus on searching for 
pharmaceutically acceptable moieties to enhance stabilities of HFA/HFO suspension. 
1.2. Challenges in the development of aerosol formulations for the delivery of 
therapeutics to and through the lungs. 
In order to efficiently deliver therapeutics to the lung tissue, there are several important 
considerations.  Because the propellants used in pMDIs are halocarbons that possess a dual 
hydrophobic and lipophobic character [15, 16], most therapeutics of interest, including small polar 
and hydrophobic drugs and biomacromolecules, have very limited solubility in these propellants.  
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Drugs are thus usually formulated in pMDIs in the form of suspensions – solutions can be formed, 
but with the help of co-solvents that negatively impact the chemical and physical stability of the 
formulation and their aerosol performance[17].  Another important consideration is that the 
optimum aerosol size for deep lung deposition is between 0.5 and 5.0 µm [18].  Particles smaller 
than 0.5 µm may be exhaled back – which brings the issue of the formulation of our nanocarriers, 
which are of the order of a few nm.  This can be addressed by engineering particles of micron-size 
range containing such nanocarriers (core-shell particles).  On the other hand, particles larger than 
5.0 µm will be retained in mouth and throat and will end up in the digestive track, which suggests 
that the micron-sized engineered particles containing the nanocarriers need to be stabilized in the 
propellant so as to prevent coagulation that would in turn lead to large aerosol sizes of poor lung 
deposition [17, 19, 20].  Steric stabilization in low dielectric propellants is thus a key issue and 
will be addressed in this work at a fundamental level, combining ab initio calculations, molecular 
dynamics (MD) simulations and high pressure tensiometry. 
In addressing formulation issues, another key consideration is the investment in and further 
development of new propellant-based formulations.  Although HFA propellants are currently 
approved by the FDA for use in medical aerosols, and are non-ozone depleting, they are 
greenhouse gases with high global warming potential (GWP) [21].  Following similar trends that 
led to the replacement of chlorofluorocarbons with HFAs, the HFAs are also expected to be phased 
out once such medical aerosols can be formulated with more environmentally acceptable 
propellants.  Hydrofluoro-olefins have emerged as the non-ozone depleting and low GWP 
alternatives to HFAs.  With GWP < 150, HFOs satisfy (and have been approved by) European 
regulatory agencies mandating that all new model vehicles should use refrigerants with such GWP 
starting 2011 [22].  This criteria makes HFA’s phase out in the automobile refrigerant market a 
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must.  Based on historic grounds, such transition will also condition the transition in propellants 
used in other applications including medical aerosols, and HFO are the natural choice  [23, 24]. 
We thus focus our ab initio and MD results and tensiometry studies on these novel propellants.  
We also employ molecular dynamics (MD) simulations as a tool for the design of surfactants for 
the stabilization of aqueous dispersions in HFOs in the form of microemulsions, which represents 
a potential strategy for the formulation of dendrimers in pMDIs. 
1.3. Challenges in designing nanocarriers for the delivery of therapeutics to and 
through the lungs.   
Once the therapeutic has reached the lung tissue; i.e., issues related to drug formulation have 
been addressed, there are several barriers it needs to overcome before reaching its site of action.  
For therapeutics that are aimed at the lung tissue (local delivery), enzymatic degradation, the 
presence of the mucus layer and mucociliary clearance in the airways, and macrophages and lung 
surfactants in the alveolar tissue represent important extracellular barriers.  Meanwhile, the cellular 
membrane and endocytic vesicles are some of the potential intracellular barriers [25, 26].  For 
systemic delivery of drugs through the lungs, the lung epithelium will also represent significant 
barrier for the transport into the systemic circulation.  Once in the systemic circulation, the ability 
to reach the target tissue, cell population within that tissue, and desired intracellular organelle 
represent other major challenges – which are similar to those seen for therapeutics delivered via 
oral delivery (once in systemic circulation) and i.v. [27]. 
There are many therapeutics of relevance for local or systemic pulmonary delivery.  These 
include small molecules, peptides, proteins, and nucleotides [27-29].  There are many ongoing 
clinical trials studying the formulation of therapeutics in OI formulation for systemic delivery, 
suggesting the promise of this non-invasive route [30].  Silencing RNA (siRNA) has emerged as 
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a therapeutic with great promise in the treatment of a number of diseases, including cancer, COPD, 
asthma and others [31, 32].  Because siRNA can be easily degraded extracellularly (and 
intracellularly as well) [33], and has poor cellular internalization as it is large and negatively 
charged [34, 35], siRNA delivery agents can represent a strategy for improving its delivery and 
action [36].  An ideal delivery agent should protect siRNA from enzymatic degradation, facilitate 
cellular uptake and promote endosomal escape inside the cells, while possessing low toxicity.  
Polymeric nanocarriers (PNCs) have great potential to improve pulmonary delivery of nucleic 
acids.  PNCs can be used to condensate, encapsulate, or conjugate nucleic acids into nano-sized 
particles that can be efficiently internalized by cells [37, 38].  PNCs can function to protect nucleic 
acids from degradation, promote sustainable release, help overcome extra- and intra-cellular 
barriers and offer versatility in terms of cellular internalization and targeting through conjugation 
of various ligands in order to improve delivery efficiency of therapeutics to and through the lungs 
[37, 39-41].  
Dendrimers are particularly relevant nanocarriers.  They are branched 3D structures, highly 
monodispersed, and contain a large number of functional end groups [42, 43] that can be used to 
conjugate with ligands to promote extracellular transport, to provide sustained release and also 
extra- and intracellular targeting capabilities.  Poly(amido amine) (PAMAM) dendrimers are one 
of the most studied dendrimer nanocarriers (DNCs) [44-46].  PAMAM DNCs with NH2 terminal 
groups are cationic polymers that can be used to complex siRNA, and have been shown to enhance 
gene knockdown of target tissues upon i.v. administration [45, 47-49]. 
In this work we first studied the microstructures of functionalized PEGylated NH2-terminated 
PAMAM DNCs, and their ability to condense and controllably release siRNA to lung epithelial 
cells.  We use atomistic MD simulations to determine the microstructure of the ligand-modified 
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nanocarrier and their complexation to siRNA.  Following the observation that PEG can interact 
quite favorably with NH2-terminated PAMAM dendrimer, we expand the study further to see the 
interaction between PEG and PAMAM dendrimers with different terminal functional group.   
 
1.4.  Goals and approaches.  
The strategy proposed to achieve our goals is schematically represented in Figure 1, and 
discussed in the following two goals:  
 
Figure 1 Schematic diagram of our goals for the design of nanocarriers and formulations for 
pulmonary drug delivery. 
Goal #1: Design Biocompatible Moieties for the Steric Stabilization of Suspension 
Formulations in HFO-based Propellants.   
HFA/HFO-philic moieties are required in order to impart stability to dispersions in HFO 
propellants [50], and are thus central to the development of novel HFA/HFO-based pMDI 
formulations for the delivery of drugs in general and nanocarriers – of particular interest in this 
work.  In order to systematically address the issue of HFA/HFO philicity, we took a combined 
experimental and computational approach.  Our strategy can be divided in three steps.  i) search 
for tail chemistries that can be well solvated by HFA/HFO.  Here we use ab initio calculations to 
investigate the interaction between HFA/HFO and three tail chemistries: alkane, ether and ester.  
The HFO-philicity scale was determined.  The HFO propellant of choice was HFO-1234ze; ii) 
Developing Functional 
nanocarriers and their 
pMDIs formulations 
HFO-philicity scale  ab 
inito, MD， Tensiometry
Dendrimer Microstructure 
and Functionalization
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with an HFO-philicity scale at hand, we studied the interface between HFO|H2O in the presence 
of various non-ionic surfactants containing those HFO-philic tails groups.  iii) The surfactant 
balance (minimum tension) was optimized.  With the surfactant of choice – EO-PO, we altered the 
head to tail ratio and studied its effect on interfacial tension of HFO|H2O interface, and the results 
from MD and high pressure tensiometry were compared to validate.  This is the first step in the 
development of a feasible dispersion-based system for the delivery of water-soluble or water-
dispersible therapeutics, as for example dendrimer-conjugated drugs, using HFO-based pMDIs.   
Goal #2: Design PAMAM Functional Dendrimer Nanocarriers for the Delivery of 
Therapeutics to and through the Lungs.   
Polymeric nanocarriers such as PAMAM DNCs can be employed to overcome the extra- and 
intracellular barriers discussed earlier for the delivery of therapeutics locally to the lungs or 
systemically through the lungs.  Understanding the microstructure of such nanocarriers is the key 
for their design in drug delivery applications.  The microstructure has an impact starting at the first 
design steps which is related to the ability to chemically functionalize the polymer with 
therapeutics, imaging agents and ligands; i.e., the chemistry with the DNCs will depend on the 
localization / availability of the functional end groups – are the end groups exposed to solvent 
environment or buried (hard to modify).  The microstructure of the ligand-modified nanocarrier is 
also of great relevance, as the conformation of theses ligands, which will depend on the interaction 
with the aqueous environment and the dendrimer itself, will dictate its interaction with the 
physiological environment, and thus its extra-cellular transport, its tissue and cellular targeting 
ability, release rate, etc.  It can also impact the degree of complexation with siRNA, and thus its 
ability to improve gene knock down efficiency.  Our approach to design DNCs for drug delivery 
applications to the lungs can be divided into 2 steps:  i) Atomistic MD simulation studies of the 
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microstructure of ligand-modified PAMAM dendrimers.  We studied the effect of the dendrimer 
size or generation (G), and of poly(ethylene glycol) (PEG) grafts – size and density, on their 
microstructure.  These studies are relevant to a variety of drug delivery applications to the lungs, 
as PEG can be used to enhance transport across the mucus barrier, protect therapeutic cargo, as 
linkers to functional targeting groups (at the end of PEG) and others.  The focus of this work is on 
how PEG can affect the complexation with siRNA.  ii) Following the observation that O from PEG 
interact strongly with NH2 terminal group of PAMAM, we expand the study further to see how 
PEG interact with PAMAM dendrimers with different terminal groups, and how the different 
interactions will affect the conformation of PEG and microstructures of PAMAM dendrimer.  The 
interactions between PEG and different charged functional groups will have broad implication in 
different drug delivery systems as PEG is such a widely used ligand in drug nanocarriers. 
1.5.  Background relevance to this study 
1.5.1. Lung Diseases 
Lung Diseases, not including lung cancer, cause an estimated 225,000 deaths in the US yearly 
[51].  Lung cancer is a leading cause of cancer death in both man and women, with 226,000 new 
cases in 2012 [52].  COPD, a term used to describe chronic lung diseases that cause limitation in 
airflow, is the fourth cause of death in the US, and is estimated to become the third cause of death 
worldwide by 2030 [53].  The development of new technologies for the efficient delivery of 
therapeutics to treat lung diseases is, therefore, of great relevance today, and even greater 
significance in the future, as risk factors associated with many lung diseases, such as air pollution 
[54], represent an ever increasing health challenge in both developed economies and in the 
developing world alike.   
1.5.2. Pressurized Metered-dose Inhalers (pMDIs) 
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Pressurized Metered-dose Inhalers (pMDIs) consist of a canister (pressure vessel) lodged 
upside down in a support, a metering valve, and an actuator, as schematically depicted in Figure 
2. 
 
Figure 2. Schematic diagram of main components of pMDI. 
pMDIs contain a drug in solution or in suspension in compressed liquid propellant, which is in 
equilibrium with its vapor.  Because most drugs of interest, including small molecular weight or 
biomacromolecules, polar or hydrophobic, all have extremely low solubility in the semifluorinated 
propellants used in medical aerosols [55],  solution formulations will require the use of large 
quantities of a co-solvent (ethanol), which negatively impacts both the chemical stability of the 
formulation and the quality of the resulting aerosol [55-59].  Dispersions (suspensions) are thus 
common for pMDIs formulation.  
1.5.3. Challenges of Formulating Active Ingredients in pMDIs. 
Challenges of Formulating Active Ingredients in pMDIs.  While solution formulations in 
pMDIs can in general only be prepared with the help of co-solvents, the alternative strategy, which 
involves the dispersions of drug crystals, is also a challenge due to strong cohesive forces between 
the drug particles that lead to the agglomeration / coagulation, and thus decrease in aerosol quality 
[60, 61].  A natural strategy to overcome instability in low dielectric solvents such as halocarbon 
Figure 2. Schematic
diagram of main
components of pMDI.
Vapor
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Figure X: Schematic
diagram of the main
components of a pMDI.
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propellants is to stabilize the dispersions with the help of amphiphilic species via steric barriers.  
However, surfactants approved by the FDA for use as dispersing agents in pMDIs today were 
developed during the time that CFCs was in use, which has a significantly lower µ and Ɛ than 
halocarbons – Table1, and thus are no good stabilizers for existing pMDIs.  Consequently, a 
systematic study leading to the design of moieties that are well solvated by the propellants is of 
great relevance in the formulation of dispersions in pMDIs. 
1.5.4. Semi-fluorinated alkanes (HFAs) and olefins (HFOs)  
Semi-fluorinated alkanes (HFAs) and olefins (HFOs) are employed in a variety of industrial 
applications, including as energy efficient refrigerants for heating, in ventilation and air 
conditioning (HVAC) systems [24, 62-64], in mobile air-conditioning systems [63-65], as blowing 
agents [64, 66, 67], in fire extinguishers [67, 68], as solvents [64, 69], foam forming agents [64, 
70], and in medical aerosols [71], including topical[72, 73] and nasal sprays[74, 75], and pMDIs 
[55, 76, 77].  The design of chemistries highly compatible with the low dielectric (Table 1) 
semifluorinated propellants used in these industries is key to enable traditional and advanced 
propellant-based technologies.  For example, in order to achieve high efficiency in HVAC systems, 
deposits of lubricants on the walls of heat exchange coils need to be prevented.  This can only be 
achieved by either using highly soluble oils or dispersing such oils in the refrigerants/propellants.  
In the case of medical sprays, the formulation of active ingredients may require either aqueous or 
solid dispersions in the propellants.[55, 76]  Dispersing agents with moieties that strongly interact 
with the propellant can be employed in the development of these and other suspensions of 
commercial/industrial interest. 
1.5.5. HFOs  
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HFOs represent the fourth generation propellants/refrigerants [78, 79].  Different from CFCs, 
they have zero ozone depleting potential (ODP) - Table 1.  Because of the presence of a chemically 
active double bond, which reacts with hydroxyl radicals in the atmosphere, HFOs have reduced 
lifetime and low GWP – Table 1.  They represent, therefore, a significant advancement compared 
to HFAs.  There are two major HFO propellants being produced in large scale: 1,3,3,3,-
tetrafluoropropene (HFO-1234ze) and 2,3,3,3-tetrafluoropropene (HFO-1234yf) [80, 81].  HFOs 
are classified as non-polar (hydrophobic), but they have a significant dipole moment (µ) and 
dielectric constant (Ɛ).  At the same time, the presence of the larger F atoms in the molecule 
decreases dispersive interactions with hydrophobic compounds (lipophobic).  These molecules 
have, therefore, a simultaneous dual hydrophobic and lipophobic character, which causes 
significant challenges in the development of pharmaceutical formulations as discussed earlier.  It 
is also important to note that a comparison between HFO-1234ze and HFA-134a – one of the 
propellants currently approved by the FDA for use in medical sprays, it has been shown that HFOs 
have similar toxicity profiles compared to HFAs [66, 82], thus paving the way for the consideration 
of HFOs in medical propellants [83].  
 
 
 
Table 1 Physical properties of semi-fluorinated alkanes (HFAs) and olefins (HFOs), and of 
chlorofluorocarbons (CFCs) 
 Psat*(bar) ρ1*(g•ml
-1) µ(D) ε ODP GWP 
CFC 11 (CCl3F) [84-89] 0.87 1.49 0.46 2.3 HIGH HIGH 
CFC 12 (CF2Cl2) [84-89] 5.60 1.33 0.51 2.1 HIGH 8100 
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CFC 114 (CF2Cl2) [84-89] 1.81 1.47 0.50 2.3 HIGH HIGH 
HFA 134a (CF3CH2F)[90] 5.72 1.23 2.06 9.5 None 1430 
HFA 227 (CF3CFHCF3)[91] 3.90 1.42 0.93 4.1 None 3200 
HFO-1234ze (CH(F)=CHCF3)[92, 93] 4.81
@ 1.12 1.44 / None 6 
HFO-1234yf (CH2=CFCF3)[93, 94] 5.96
& 1.09 2.54 / None 4 
ρ = density; µ = dipole moment; ε = dielectric constant; ODP = ozone depleting potential; 
GWP = global warming potential, relative to that of CO2. * at 20̊C; @ at 25oC; &  at 21.1°C 
1.5.6. Potential of functional nanocarriers for pulmonary drug delivery 
There are many barriers for the therapeutic molecules to reach their site of action.  In OI 
formulations, the first challenge is to reach the lung tissue.  The optimum aerodynamic diameter 
of the aerosol particles for deep lung deposition is between 0.5-5.0µm.  Once drug particles are 
successfully deposited into lungs, they face extracellular barriers that may be a healthy or diseased 
mucus (in case the target is the airways) or macrophages and lung surfactants (in case the target is 
the alveolar cells) – note that macrophages may be the target themselves [95].  The therapeutic 
molecules will also have to transverse the plasma membrane.  Once inside the cell, the drug has to 
be carried across several other barriers in order to reach desired target and exert their therapeutic 
effect.  For siRNA, its site of action is in the cytosol.  Therefore, after internalized, they need to 
escape the endolysosomal compartments.  If the therapeutic is intended for systemic delivery, it 
also has the lung epithelium as extracellular barrier even before it reaches the systemic circulation.  
Functional nanocarriers may serve in all steps of the way to improve delivery efficiency.  In the 
case of siRNA as the therapeutic molecule, PEGylation of NH2 terminated PAMAM DNCs may 
help decrease the interaction with the mucus layer and/or macrophage uptake [96].  It can also 
decrease interaction between nanoparticles that may lead to aggregation.  PEGylation may also 
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help to modulate the interactions between siRNA and the dendrimers, and thus to modulate the 
rate of release, and how pH (such as the low pH in endolysosomes) affect the release. 
1.5.7. Nanocarriers for siRNA Delivery to the Lungs  
Nanocarriers for siRNA Delivery to the Lungs.  Gene therapy is a broad term that involves any 
approach to treat diseases using intracellular transfer of nucleic acids (DNA or RNA) to modulate 
cellular functions by activation or inhibiting induction of specific genes [97-99].  Gene down-
regulation is a critical research area in life science, and it can be achieved either at transcriptional 
level or at the post-transcriptional level [100-103].  Small interfering RNA (siRNA) and antisense 
oligodeoxynucleotides (ODN) are two effectors acting on the post-transcriptional level small 
nucleic acids [104, 105].  Cancers are very good candidates for siRNA based treatment for several 
reasons.  Abnormal gene pattern is usually observed in cancer cells, thus gene down-regulation 
strategy can be either used to mute gene expression of mutated genes or to down-regulate genes 
that controls proliferation [106-109].  There are many nanocarriers for delivery of siRNA being 
evaluated for their efficiency and toxicity [110-114].  Different poly-cations can electrostatically 
complex with siRNA (negatively charged), including chitosan, PEI, PLL, PAMAM and others [39, 
40, 115-117].  Block copolymers can be used to prepare micelles as siRNA nanocarriers [118].  
siRNA can also be conjugated directly to PEG and other polymers via chemical bonds [119].  
Nanoparticles made of biocompatible polymers like chitosan or PLGA can be used to incorporate 
siRNA [110, 120].  The ability to evaluate the capabilities of such nanocarriers with respect to 
their protection against siRNA degradation, delivery efficiency, functions in specific targeting or 
controlled release and toxicity are relevant to the design of the nanocarrier, and will be carried out 
in this work. 
1.5.8. PAMAM Dendrimer Nanocarriers (DNCs)  
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PAMAM Dendrimer Nanocarriers (DNCs) are very promising in a wide range of biomedical 
applications including gene and drug delivery and as imaging agents due to their unique structure, 
which is characterized by high size uniformity, low polydispersity and a large number of 
modifiable surface functional groups.  There are several strategies for drugs to be loaded onto 
PAMAM dendrimers, including complexation, which is driven by electrostatic interactions, 
conjugation through the formation of covalent bonds, and encapsulation, which is driven by 
hydrophobic forces.  The cationic nature of NH2-terminated PAMAM dendrimers enables their 
complexation with siRNA.  The multivalent surface functional groups in DNCs can be engineered 
to covalently conjugate drugs and/or ligands to the carriers as well. 
1.5.9. PEG as Ligand for PAMAM dendrimers 
PEG as Ligand for PAMAM dendrimers.  Drug-dendrimer conjugates/complexes are usually 
further modified by the conjugation of ligands in order to confer the carriers specific characteristics 
designed to enhance their efficacy as a drug delivery agents.  Among the many choices of ligands, 
PEG is widely used to modify the surface of PAMAM dendrimers.  PEG can be used to provide 
extra protection to the payload, to modulate the transport across extracellular barriers and reduce 
the cytotoxicity of cationic PAMAM dendrimers by neutralizing and/or shielding surface charges, 
and also to improve system circulation, and to provide a mechanism to controlled the release of 
the therapeutic cargo [121-126].  
1.5.10. Ab initio calculations  
Ab initio calculations (Figure 3) was employed to determine the HFO-philicity of candidate 
chemistries [127].  The pair interaction (binding) energy between the propellant and tail fragment 
(Eb
st) was computed using the supramolecular approach [128]:  
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Figure 3 Schematic diagram of the calculation of the non-bonded interaction energy Eb
st between 
HFO and tail fragment. 
𝐄𝐛
𝐬𝐭 = 𝐄𝐬𝐭 − 𝐄𝐬 − 𝐄𝐭          Equation 1 
where Eb
st is the binding energy between the propellant and tail fragment, Est is the total energy 
of the pair, Es and Et are the energies of isolated propellant and tail fragment, respectively.  The 
more negative Eb
st, the more favorable the interaction between the pair, and thus the better the 
solvation of that HFO-phile.  As the tail chemistry is varied, and HFO-philicity scale can be then 
constructed. 
1.5.11. MD of the HFO|Water Interface  
MD of the HFO|Water Interface.  MD can be used to gain microscopic insight into interfacial 
systems such as that of the HFO|Water (HFO|W) interface, and that of the surfactant-modified 
HFO|W interface.  It can also be used to quantitatively assess the tension reduction upon surfactant 
adsorption at the interface, and thus be used to guide the design of amphiphiles that can be 
employed to form stable water-in-HFO dispersions, which may be potentially employed in the 
formulation and delivery of dendrimer nanocarriers to the lung tissue. 
1.6. Innovation and relevance 
This work is relevant for the design of functional dendrimer nanocarriers and their pMDI 
formulation for the local and systemic delivery of therapeutics, including small drugs and nucleic 
Eb
st= - -
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acids to and through the lungs.  Given the advancement of nanocarrier technologies in drug 
delivery, there is great promise in using nanocarriers for pulmonary delivery.  The challenges come 
from 1) formulating nanocarriers in a form of high efficiency and efficacy, 2) designing 
nanocarriers that is tailored to overcome barriers / challenges encountered in pulmonary 
environment.  Thus we focus our efforts on 1) design biocompatible moieties for the steric 
stabilization of suspension pMDI formulations, and 2) design functional PAMAM dendrimer 
nanocarriers for the delivery of therapeutics to and through the lungs.   
1.6.1. Aim #1 
For Aim #1. In the design for suitable moieties for pMDI formulation, we started by 1) 
screening the fluorocarbon philicity of candidate tail chemistry, then 2) with the philicity scale at 
hand, we further our studied the propellant|H2O interface in the presence of various non-ionic 
surfactants containing those HFO-philic tail groups, and 3) the surfactant balance was optimized 
(minimum tension) with selected surfactants.   
This work is innovative as it represents the first study that the properties of the bare and 
surfactant modified HFO-1234ze|H2O interface has been reported – either experimental or 
computational results.  All prior studies published on HFOs were related to their thermophysical 
and toxicological properties [129, 130].  A basic understanding about interfacial/solvation 
behavior in HFOs is relevant as it will allow us to esxpand the applicability of medical aerosols 
for the delivery of therapeutics to and through the lungs.  These results will also be of relevance 
to many other industries that currently employ/are preparing for switch to HFO 
refrigerant/propellants. 
1.6.2. Aim# 2 
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For Aim# 2.  This work is innovative in many ways.  It represents the first work where the 
effect of PEG size and grafting density on the microstructures of solvated PAMAM DNCs is 
investigated with atomic resolution.  This systematic computational study of PEGylated NH2-
terminated PAMAM dendrimers is relevant as it will help us understand how conformational 
changes, charge shielding/neutralization, and solvation forces may impact the microstructure of 
the nanocarrier, and thus its function under conditions relevant to the physiological environment.  
Moreover, we extend our study to include PAMAM dendrimers of different terminal chemistry, 
and the effect of PAMAM dendrimer chemistry on microstructures of PEG chains that are 
conjugated to them.  The conclusions are not only meaningful for PAMAM dendrimers as 
nanocarriers, but also broadly applicable to other polymeric nanocarriers where PEGylation is used.  
This work is also innovative as there has been no systematic study on the effect of PEG length and 
graft density on the PAMAM dendrimer-siRNA complexation.  The methodology used here can 
be broadly applicable to other field of study where microscopic structures is of interest yet hard to 
approach from experimental tools.  
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CHAPTER 2 
UNDERSTANDING IN THE LOW GLOBAL WARMING 
HYDROFLUOROOLEFIN HFO-1234ZE PROPELLANT 
2.1. Introduction 
Halocarbons find applications as refrigerants, foam-forming agents, blowing agents, solvents 
and are also of great relevance in medical aerosols.[131-134] There are two major considerations 
in choosing a working fluid as refrigerant/propellant: (i) the physicochemical properties that 
determine their performance, and (ii) their environmental impact that can be quantified by 
attributes such as their ozone depleting effect (ODE) and global warming potential (GWP).  A 
major shift in propellant/refrigerant working fluids started in the late 80’s when a mandate was 
put in place requiring the replacement of chlorofluorocarbons (CFCs) by hydrofluoroalkanes 
(HFAs).[135, 136]  The switch was motivated by the highly negative environmental impact of 
CFCs, especially due to their high ODE.  HFAs were acceptable candidates because they are 
non-ozone depleting, and their physicochemical properties were somewhat compatible with 
those of CFCs.[137, 138] 
Past forward ca. 20 years, and there are still major challenges to be overcome in using HFAs 
as working fluids, especially in the pharmaceutical industry.  These challenges can be to a large 
extent attributed to the unique solvation properties of HFAs.[139, 140]  Another major working 
fluid switch is happening now, and is being largely driven by the EU regulations on fluorinated 
gases that were put forth in 2011.  The mandate by the European regulatory agencies dictates that 
all new model vehicles should use refrigerants with GWP < 150.[140]  This criterion makes HFAs’ 
phase out in the automobile refrigerant market a must, due to the HFAs large GWP  – relevant 
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properties of selected halocarbons are shown in Table 2.[141]  Since then, car companies in the 
USA and Japan have also announced the switch to low GWP working fluids.  Based on historic 
grounds, the shift in refrigerant is expected to drive the industry to seek for alternative 
propellants/solvents for the all the other major markets as well.[142, 143] 
Table 2 Some relevant physicochemical properties of the fourth generation propellant HFO-
1234ze compared to the hydrofluoroalkanes HFA-134a and HFA227. 
properties reported @ 20℃ and 1atm 
*Liquid properties measured at 
saturation pressure 
 
HFA-134a 
FF
FF  
HFA-227 
F
F
FF
F
F
F  
HFO-1234ze 
F
F
F
F  
Molecular weight (g/mol) 102 170 114 
Liquid density (g/mL)*bc 1.21 1.46 1.12 
Heat of vaporization (kJ/kg) @ NBP*a 217.0 131.4 197.4 
Surface tension (mN/m)*a 8.11 10.24 8.55 
Dipole moment (Debye)*bc 2.058 0.94 1.443 
Boiling point (℃)bc -26 -16 -19 
Global warming potential (GWP)bc 1430 3220 6 
Solubility of water in propellant (ppm)bc 1300 610 225 
Solubility of propellant in water (ppm)bc 193 58 373 
aHigashi et al. [144] 
b Solvay [145] 
cHoneywell [146] 
*NBP = normal boiling point 
Within this context, hydrofluoroolefins (HFOs) have emerged as the fourth generation 
propellants.  HFOs have no ODE and very low GWP.[147]  HFO-1234ze (1,1,1,3-
tetrafluoropropene), one of the HFO candidates, has been shown to be non-flammable,[148] to 
have low toxicity - similar to that of HFAs,[145, 149, 150] and to possess physicochemical 
properties similar to HFAs.  On one hand, these characteristics are expected to somewhat facilitate 
the transition process from HFAs to HFOs.  However, in spite of all the potential benefits of this 
new generation of environmentally acceptable working fluids (HFOs), the transition process is still 
expected to bring tremendous challenges to the industry, just as it has happened during the 
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transition from CFCs to HFAs, as the industry will have to adapt the various processes to these 
new working fluids.[151-153] 
One major issue to be expected is the solubility and solvation of additives that are used in all 
the above-mentioned industries.  For example, in order to achieve high efficiency in HVAC 
systems, deposits of lubricants on the walls of heat exchange coils need to be prevented.  This can 
be achieved by either using highly soluble oils or dispersing the oils in the refrigerants.[154]  In 
the case of medical sprays, the formulation of active ingredients may require either aqueous or 
solid dispersions in the propellants.[155, 156]  Dispersing agents with moieties that strongly 
interact with the propellant can be employed in the development of these and other suspensions of 
commercial/industrial interest.  A key aspect in transition to the new propellants is thus the 
development of a fundamental understanding on the solvation behavior in HFO propellants.  HFOs 
are interesting fluids as they have a dual hydrophobic and oleophobic character.  The presence of 
bulky F atoms is expected to decrease their interaction with hydrophobic moieties thus imparting 
their oleophobic character.  At the same time, they have non-negligible but small dipole moment.  
They can be thus also considered hydrophobic – refer to their very low mutual with water shown 
in Table 2.  While there has been several studies in the literature discussing the physicochemical 
properties of HFOs,[144, 157-160] there is currently no work on their solvation capacity. 
In light of the challenges and opportunities discussed above, our overall goal is to develop an 
understanding of the solvation forces in HFO propellants.  A more specific goal, and the objective 
of this work, was to develop a scale of solvation in a selected HFO - HFO-1234ze.  We investigate 
the solvation of relevant tail fragments that are (i) representative of the chemistries of the additives 
of interest to the various industries discussed above, and (ii) yet that have functionalities that are 
selected in a way to systematically probe the effect of both polarity and structure (degree of 
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branching) of the tail fragments on their solvation by HFOs.  We employ ab initio calculations to 
determine the pair interaction (binding) energy between the HFO-1234ze and the tail fragments, 
and use that information to develop the scale of solvation in HFOs.  We also determine the 
solvation of the same fragments in the HFA propellants most widely used in the industry (HFA-
134a and HFA-227) to compare and contrast with the next generation HFO propellant HFO-
1234ze. 
2.2. Computational details 
2.2.1.  Pair interaction (binding) energy of propellant-tail fragment (Ebst) 
Binding energies of the propellant-tail fragment (Eb
st) were computed using the supermolecule 
approach:[161]  
𝑬𝒃
𝒔𝒕 = 𝑬𝒔𝒕 − 𝑬𝒔 − 𝑬𝒕        Equation 2 
where Eb
st is the binding energy of propellant (solvent - s) and tail fragment (tail - t), Est is the 
total energy of the pair, and Es and Et are the energies of isolated propellant and tail fragments, 
respectively.  More negative (bigger in magnitude) Eb
st’s indicate more favorable pair interactions, 
and thus enhanced HFO-philicity of the tail fragment.[162]  Good solvation is a required attribute 
in the steric stabilization of colloidal dispersions in low dielectric solvents such as HFO 
propellants.[163]  Calculations were carried out using Gaussian 09.[164]  The structures were first 
optimized using second order Møller-Plesset perturbation theory (MP2) and 6-31g+(d,p) basis set.  
Single point energy calculations of the optimized structures were carried out at MP2 level of theory 
with the dunning basis set aug-cc-pVDZ.[165]  Basis set superposition error (BSSE) was corrected 
by the counterpoise method of Boys and Bernadi.[166, 167]  Partial charge distributions were 
calculated by fitting electrostatic potential using CHELPG subroutine of Gaussian 09.[168]  Gas 
phase dipole moments were calculated at MP2/aug-cc-pVDZ with structures optimized at MP2/6-
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31g+(d,p).  A group of optimizations (no less than 4) were done for each solvent-tail or tail-tail 
pairs starting from different configurations to improve the chances of reaching a global minimum.  
An error of ±0.42 kJ/mol is assumed based on the calculated difference in Eb’s for the CF4 dimer 
calculated with the aug-cc-pVDZ basis set and the basis set limit at MP2 level of theory.[169]  
2.2.2. Chemistry of propellants and tail fragments.   
Setting up ab intio computational studies relevant to the behavior of polymer/oligomer systems 
representative of moieties required for the stabilization of colloidal dispersions in low dielectrics 
inevitably requires some tradeoffs between the level of detail in the model (size of the fragments) 
and the computational power available.  Once we defined the chemistries of interest, we set the 
number of backbone atoms in the fragments to 5, which is the minimum number of atoms possible 
to accommodate all chemistries / represent all chemical features of interest, while the featuring 
functional group is represented once and only once.  Fixing the number of atoms in the backbone 
to a common number of atoms also facilitates the comparison among tail fragments.  It is worth 
mentioning, however, that by truncating the number of repeat units studied for each tail fragment, 
we are to some extent artificially (and inevitably) impacting the polarizability and dipole moment 
of the system, when compared to the full polymer chain,[170] and this is one of the necessary 
tradeoffs.  We study three distinct chemistries, namely: alkanes, ethers and esters.  Alkanes were 
chosen as negative control (we expect them not to interact well with the propellants).  Ethers are 
relevant as they find many applications in the industry in the form of non-ionic surfactants (head-
groups), and EO is present as an excipient in an FDA-approved portable inhalers (Symbicort HFA).  
Ester is a relevant chemistry given their biodegradable nature and wide use in medical and drug 
delivery applications.[171, 172]  For each chemistry of interest, we also investigate fragments that 
have one re more pendant methyl groups (branching) attached to the backbone, as a potential 
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strategy to impact the self (fragment-fragment) interaction.  Tail-tail self-interactions are also of 
great relevance in the stabilization of colloidal systems in low dielectric media such as the 
propellants discussed here – the lower the self tail-tail interaction, the more capable the tail is to 
help avoid colloidal aggregation.[173]  The chemistries investigated in this work were:  (i) alkanes: 
pentane (C5) - (CH3(CH2)3CH3) and isohexane (ISO) (CH3CH(CH3)CH2CH2CH3), (ii) ethers: 
ethylene oxide (EO) - (CH3CH2OCH2CH3) and propyleneoxide (PO) - (CH3CH(CH3)OCH2CH3), 
and (iii) esters: glycolide (GA) (CH3CH2C(O)OCH3), lactide (LA) (CH3CH(CH3)C(O)OCH3), and 
tetramethyl-glycolide (TMGA) (CH3C(CH3)2C(O)OCH3).  Note that ISO has a pendant CH3 group 
compared to C5, the same for PO (represent the hydrophobic group of many non-ionic surfactants) 
when compared to EO.  In the case of the esters, we were able to further study the effect of 
branching, with the addition of one pendant CH3 on going from GA to LA, and two CH3 pendant 
groups on going from GA to TMGA based on practical availability of these chemical entities. 
2.2.3. Enhancement Factor (Eenh) incorporates tail-tail self-interaction binding 
energies (Ebtt) 
Another important component in understanding the ability of tail chemistries to provide 
stability to colloidal dispersions in HFOs besides solvent-tail interactions accounted for in the Eb
ts, 
is the fragment-fragment self-interaction.[173]  It is important to maximize the solvent-fragment 
interaction, and at the same time minimize the tail-tail self-interactions.  In order to account for 
both factors in our screening of tail chemistries with potential in the stabilization of colloidal 
dispersions in HFOs, we define the Eenh, which is the ratio between the binding energy between 
propellant and tail fragment (Eb
st) to that of tail fragments’ self-interaction (Ebtt) [173]: 
𝑬𝒆𝒏𝒉 =  
𝑬𝒃
𝒔𝒕
𝑬𝒃
𝒕𝒕          Equation 3 
2.2.4. Cluster studies: (HFO-1234ze)n-Tail Fragment.   
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In order to gain more insight into the microscopic interactions between the propellant and 
fragment that will happen in a bulk-like environment, we also included in our investigations cluster 
studies in which one tail fragment is allowed to interact with multiple propellant molecules that 
closely resemble the first solvation shell of the fragment: (HFO-1234ze)n-tail fragment, where 
n=6.  However, because such cluster systems include a large number of heavy atoms, calculations 
needed to be conducted at a lower level of theory and basis set - HF-6-31g(d).  Because of the 
complexity of the energy surface in such systems and the relatively low level of theory and basis 
set, we limit our analysis to the cluster studies to understanding the accessibility of the local dipoles 
of the fragments by the propellant molecules.  We focus our study on three tail chemistries - EO, 
GA and TMGA to understand the effect of both fragment polarity and branching on their 
interactions with the new generation propellant HFO-1234ze, as it is central to our work. 
2.3. Results and Discussions 
In this work we systematically investigate the effect of the chemistry and structure of tail 
fragments on their solvation by the hydrofluoroolefin HFO-1234ze using ab initio calculations.  
We also perform calculations with the hydrofluoroalkanes HFA-134a and HFA-227, which are the 
most common propellants currently being used by the industry.  The binding energy (Eb
st), strong 
interaction sites of optimized pairs, and atomic charge distributions before and after interacting in 
a dimer system, together with other quantitative and qualitative results help us to quantify the 
philicity of fragment candidates of relevance to the various industries where such semi-fluorinated 
propellants are employed.  The comparison/contrast between solvation in HFOs and HFAs can 
also help us understand and anticipate the challenges and opportunities that lie ahead in the 
expected transition from HFAs to HFOs, the next generation working fluids. 
2.3.1. Tail chemistry and its effect on the binding energy (Ebst) 
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A summary of the Eb
st between all tail chemistries and the three propellants investigated in this 
work are presented in Table 3.  Dipole moments of the propellants and tail fragments are from ab 
initio calculations and are shown in parentheses, next to the corresponding molecules. 
Table 3 Summary of the binding energies (Eb) between the different propellants (solvent = s) and 
tail fragments (tail = t) - Eb
st (kJ/mol), calculated at the MP2/aug-cc-pVDZ//MP2/6-31g+(d,p) 
level of theory and basis set, with BSSE corrected by the counterpoise method.  The dipole 
moments (in Debye, D) for the propellants and tail fragments are shown in parenthesis.  Tail 
fragments are: pentane (C5), iso-pentane (ISO), ethylene oxide (EO), propylene oxide (PO), 
glycolic acid (GA), lactic acid (LA), and tetramethyl glycolic acid (TMGA).  The dipole moment 
was calculated in this work using partial charges from ab initio calculations.  The error in Eb
st is 
estimated to be ±0.42 kJ/mol. 
Tail fragment 
Ebst (kJ·mol-1) 
HFA-134a (2.12) HFA-227 (1.46) HFO-1234ze (1.14) 
C5 (0.09) -6.8 -10.3 -8.4 
ISO (0.15) -6.3* -10.0* -9.1 
EO (1.30) -18.8* -25.1* -19.5 
PO (1.23) -19.2* -26.4* -19.0 
GA (1.65) -20.0 -24.1 -19.2 
LA (1.69) -19.7 -24.2 -18.9 
TMGA (1.76) -20.5 -25.3 -20.3 
*Results by Pegiun et al. at the same basis set and level of theory.[31] 
2.3.2. Effect of Tail Polarity 
In order to isolate the effect of single parameters, the effect of the polarity of the tail fragments 
on Eb
st is investigated first.  The results for those selected fragments are summarized in Figure 4, 
for all propellants investigated. 
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Figure 4 Effect of tail polarity on the binding energy between the different propellants (solvent 
= s) and tail fragments (tail = t) - Eb
st (kJ/mol), calculated at the MP2/aug-cc-pVDZ//MP2/6-
31g+(d,p) level of theory and basis set, with BSSE corrected by the counterpoise method.  Tail 
fragments are: pentane (C5), ethylene oxide (EO) and glycolic acid (GA), which are 
representatives of the alkane, ether and ester chemistries, respectively.  The dipole moments (in 
Debye, D) for the tail fragments are shown in parenthesis.  The dipole moment was calculated in 
this work using partial charges from ab initio calculations. 
These three fragments, C5, EO and GA, are linear (do not have pendant methyl groups), and 
are representative of alkanes, ethers and esters, respectively.  From Figure 4, it can be observed 
that the magnitude of the binding energy for all propellants dramatically increases as the fragment 
polarity increases on going from C5 (0.09D) to EO (1.30D).  This is in agreement with solubility 
data measurements in HFAs.[174]  Dispersibility studies have also shown that alkane-based 
surfactant tail groups are poor stabilizers, whereas EO-moieties can be successfully employed to 
stabilize particle dispersions in propellant HFAs.[174, 175]  
However, upon further increasing the polarity of the fragment upon the addition of a carbonyl 
oxygen besides the ether oxygen (compare EO with 1.30D and GA with 1.65D), no large gain in 
solvation is achieved, or the binding energy can even decrease in magnitude, as is the case for 
HFA-227.  This can be attributed to the fact that the overall Eb
st is also impacted by two other 
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contributions, one being the polarity of the propellant and the other the overall dispersive 
interactions of the pair.  HFA-227 shows the strongest solvation (Eb
st) of all propellants, even 
though its dipole moment is much smaller than that of HFA-134a, clearly demonstrating the impact 
of the dispersive energy of the system.  HFA-227 has more heavy atoms (10 heavy atoms) than 
HFA-134a (6 heavy atoms) and HFO-1234ze (7 heavy atoms).  These results are in agreement 
with our experimental observations that show that microparticles in general can be better dispersed 
in HFA-227 compared to HFA134a. 
We can also observe from Figure 4 that the magnitude of Eb
st for HFO-1234ze is similar to 
that of HFA-134a for the more polar fragments.  This happens in spite of the lower dipole moment 
of HFO-1234ze (1.14D) compared to HFA-134a (2.12D).  This behavior is attributed to a 
balancing/stronger dispersive interaction between HFO-1234ze and the fragments compared to 
those of HFA-134a, due to the greater number of heavy atoms in HFO-1234ze.  This observation 
is supported by the larger Eb
st between HFO-1234ze and the non-polar fragment C5, when 
compared to that between HFA-134a and C5.  The similar solvating behavior of HFO-1234ze and 
HFA134a propellants can be seen as a good indicator for the industry that depends on that solvent 
strength, such as in foam forming and topical foams.  It suggests that HFO-1234ze may be a good 
alternative propellant in technologies that currently employ HFA-134a. 
It is also worth noting that while differences in interaction energies (Eb
st) between two 
propellants towards a fragment may be small in term of KJ/mol – e.g. the difference in interaction 
energy between HFA-134a and HFA-1234ze towards GA is only 0.8 KJ/mol, these differences are 
expected to be amplified in experimental systems dealing with polymers made of many fragments, 
and many solvent-fragment interactions. 
2.3.3. Optimized structure and strong interactions 
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As observed above, a general trend in solvation of the tail fragments by the propellants does 
not emerge based simply on the polarity of the tail fragments.  To fully understand the nature of 
the propellant-tail fragment interactions it is necessary to look in more detail into the optimized 
geometries of these pairs to find microscopic evidence behind their Eb
st.  Besides the dispersive 
interactions expected in these “non-polar” solvents/propellants, we do expect dipole interactions 
to arise due to the small but non-negligible dipole of the propellant molecules, and likely further 
polarization of the propellant upon interaction with the polar fragments.  Here we single out those 
fluorine··hydrogen (F··H) and oxygen··hydrogen (O··H) non-bonded interactions with separation 
distance 3 Å or shorter, as they are expected to be the dominating contributors to Eb
st.[156, 175]  
Optimized structures of the HFO-1234ze-, HFA-134a-, and HFA-227-tail fragments pairs are 
shown in Figure 5, 6, and 7, respectively.  Strong interaction sites that have an O‥H or F‥H 
distance within 3Å are labeled with dashed lines in the optimized structures.  These strong 
interaction sites are summarized in Table 4.  As our control, pentane (C5) and ISO have no O‥H 
strong interaction bonds, and the influence of this effect is clearly shown by the magnitude of their 
binding energies with propellants (see Table 3). 
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Figure 5 Structure of optimized HFA-134a and the ester-based pairs: (a) HFA-134a-GA; (b) HFA-
134a-LA; and (c) HFA-134a-TMGA.  Tail fragments are: glycolic acid (GA), lactic acid (LA), and 
tetramethyl glycolic acid (TMGA).  All geometries shown were optimized at the MP2/6-31g+(d,p) 
level of theory and basis set.  “Strong interactions” are labeled if O··H or F··H distances are within 
3 Å.  Distances are labeled next to each strong interaction, in Å.   
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Figure 6 Structure of optimized HFA-227 and the ester-based pairs: (a) HFA-227-GA; (b) HFA-
227-LA; and (c) HFA-227-TMGA.  Tail fragments are: glycolic acid (GA), lactic acid (LA), and 
tetramethyl glycolic acid (TMGA).  All geometries shown were optimized at the MP2/6-31g+(d,p) 
level of theory and basis set.  “Strong interactions” are labeled if O··H or F··H distances are within 
3 Å.  Distances are labeled next to each strong interaction, in Å. 
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Figure 7 Structure of optimized pairs of (a) HFO-1234ze–C5, (b) HFO-1234ze-ISO, (c) HFO-
1234ze -EO, (d) HFO-1234ze-PO, (e) HFO-1234ze-GA, (f) HFO-1234ze-LA, (g) HFO-1234ze-
TMGA.  Tail fragments are: pentane (C5), iso-hexane (ISO), ethylene oxide (EO), propylene oxide 
(PO), (glycolic acid (GA), lactic acid (LA), and tetramethyl glycolic acid (TMGA).  All geometries 
shown were optimized at the MP2/6-31g+(d,p) level of theory and basis set.  “Strong interaction” 
is defined as those between O··H, and with a separation distance < 3Å.[31]  Distances are labeled 
next to each strong interactions, in Å. 
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Table 4 Summary of “strong interactions” between the propellants and the different tail fragments 
- pentane (C5), iso-pentane (ISO), ethylene oxide (EO), propylene oxide (PO), glycolic acid (GA), 
lactic acid (LA), and tetramethyl glycolic acid (TMGA).  Refer to Figure 5, 6, and 7 for atom 
number identification.  “Strong interaction” is defined as those between O··H or F··H, and with a 
separation distance < 3Å.[31]  Partial charge of H1 (hydrogen atom involved in strong O··H 
interactions) are shown in brackets. 
HFA-134a “Bond” length (Å)  
Bonds C5 ISO* EO* PO* GA LA TMGA  
C-H1‥O 
 
  
2.21 
(+0.046e) 
2.21 
(+0.055e) 
2.26 
(+0.103e) 
2.23 
(+0.089e) 
2.25 
(+0.095e) 
 
C-H‥F5 2.96 2.70 2.72  2.76 2.73 2.68  
 
2.83 
 
2.87 
2.92 
   2.98   
C-H‥F7 2.78 2.71  2.68 2.95 2.66 2.66  
 2.90   2.82 2.91 2.77 2.72  
C-H‥F6  2.72 2.74 2.75 2.73  2.94  
HFA-227 “Bond” length (Å)  
Bonds C5 ISO* EO* PO* GA LA TMGA  
C-H1‥O 
 
  
2.04 
(+0.118e) 
2.06 
(+0.130e) 
2.13 
(+0.180e) 
2.13 
(+0.160e) 
2.12 
(+0.176e) 
 
C-H‥F11 2.86  2.82 2.86 2.85    
 2.93   2.87 2.98    
C-H‥F10    2.84 2.75 2.65 2.65  
C-H‥F5  2.89 2.82 2.81  2.8 2.72  
C-H‥F4 2.94     2.89 2.70  
 2.86     2.74 2.83  
C-H‥F8    2.81 2.8    
HFO-1234ze “Bond” length (Å) 
Bonds C5 ISO EO PO GA LA TMGA  
C-H1‥O 
 
  
2.25 
(+0.188e) 
2.11 
(+0.279e) 
2.28 
(+0.213e) 
2.25 
(+0.222e) 
2.26 
(+0.230e) 
 
C-H‥F7 2.93 2.88 2.84 2.87 2.83 2.78 2.66  
   2.77  2.73    
C-H‥F8   2.84  2.61 2.67 2.65  
   2.77   2.89 2.89  
C-H‥F9 
 
2.87 
2.90 
2.83 
2.89 
 
2.98 
 
    
*Reported by Penguin et al.[31] 
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It is proposed that oxygen atoms are crucial because they can provide strong interaction (O··H) 
sites as they are solvated by the propellant molecules.[169, 173]  Here we confirm this observation 
and also note that oxygen atoms can form strong interactions with sites in the HFO-1234ze 
propellant, in a similar fashion as to HFAs.  We can also see from Figure 5, 6, and 7 (and summary 
in Table 4) that although ester group has two oxygen atoms, only one oxygen atom is capable of 
forming strong interactions with the propellants given the conformational restrictions.  Because 
ester and ether groups have the same number of strong interactions (involving oxygen atoms) with 
the propellants, the ester chemistry has no significant difference in Eb
st compared to the ether group, 
in spite of having more oxygen atoms and higher dipole. 
It is also interesting to observe that whenever the ester moiety is interacting with propellant 
molecules, they always form strong O‥H bond with carbonyl oxygen (C=O) instead of ether 
oxygen (C-O-C) (both within the ester functional group).  This preference in interaction comes in 
part from the fact that the carbonyl oxygen (C=O) is geometrically more favorably oriented to 
interact with hydrogen atoms of the propellants.  This is clearly shown in any one of the Figures 
5, 6 or 7.  The preference is also attributed to the more negative charge of the carbonyl oxygen 
compared to the ether oxygen, a fact that will be discussed below. 
2.3.4. Effect of Tail Branching 
The optimized structures of the tail-solvent fragments can also help us understand the effect of 
branching (methylation) on the solvation of the tail fragments.  Branching is a strategy that may 
be employed to reduce fragment-fragment interactions as will be discussed in more detail below, 
and as a consequence, to improve the ability of such fragments to provide steric stabilization to 
particles and other dispersions in low dielectric propellants.[174]  However, branching may also 
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adversely (negatively) affect the solvation of the fragments by the propellants, which would be 
undesirable, and is thus investigated here. 
We have selected the following groups for our study of the effect of tail branching: GA, LA, 
TMGA.  These fragments all contain ester-based groups, and differ only in the degree of branching.  
While GA has no pendant group, LA has one pendant CH3 group and TMGA has two pendant CH3 
groups.  Because these three chemicals all share the same functional group, we can isolate the 
effect of branching.  The summary of the Eb
st between the various propellants and those tail 
fragments is shown in Figure 8: 
 
Figure 8 Effect of the degree of branching (number of CH3 pendant groups) on the binding energy 
between the different propellants (solvent = s) and the ester-based tail fragments (tail = t) - Eb
st 
(kJ/mol), calculated at the MP2/aug-cc-pVDZ//MP2/6-31g+(d,p) level of theory and basis set, with 
BSSE corrected by the counterpoise method.  Ester-based tail fragments are: glycolic acid (GA), 
lactic acid (LA), and tetramethyl glycolic acid (TMGA).  The dipole moments (in Debye, D) for 
the tail fragments are shown in parenthesis.  The dipole moment was calculated in this work using 
partial charges from ab initio calculations. 
The results from Figure 5 indicate that, to a large extent, branching does not affect the Eb
st 
between propellant and the fragments.  The results also show that the performance of HFO-1234ze 
in terms of solvation is similar to HFA-134a, while HFA-227 has stronger solvation power than 
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both.  Because of the stronger dipole of HFA-134a, the distance of the dominant C-H1··O bond is 
shorter than that for HFO-1234ze (Table 4), and thus the slightly larger Eb
st’s (Figure 8 and Table 
3).  The overall number of F‥H bonds in HFA-134a is also greater than that for HFO-1234ze, but 
this effect is less clear cut as the distances of those bonds are smaller on average for HFO-1234ze. 
2.3.5.  Electrostatic Potential and Strong Interaction Sites 
Besides the dipole moments of the molecules, local dipoles (involving two atoms with large 
charge separation such as C=O or C-F) will also contribute to the magnitude of the pair interaction 
energies (Eb
st).  The electrostatic potential (ESP) charge distribution of the propellant and tail 
fragment dimers are also examined here to better understand the differences between different 
solvation behaviors of propellants between ethers and esters as well as the nature of strong 
interaction sites.  The ESP charge distribution was obtained at MP2/aug-cc-pVDZ level of theory 
using CHELPG, and is shown in Supplementary Material, in Tables S1, S2, and S3.  The ESP is 
determined for the propellants and fragments alone and then again for the optimized pair, so that 
the effect of polarization is also captured – and it is indicated as the change in the atomic partial 
charge before (alone) and after the optimization of the solvent- Tables S1, S2 
and S3.  The bond distance and partial charges for H participating in the strong C-H··O bonds 
between propellants and fragments are summarized in Table 4. 
It is believed that it is the acidity of the C-H group, and to a less extent the basicity of the 
oxygen that is expected to dictate the strength of the H-bonds.[176, 177]  Since we have C-H1··O 
strong interactions that are similar to the typical H-bonds, we focus our attention on the partial 
charge assumed by H1’s of the propellants, as they interact with the oxygen of the various 
fragments.  From Table 4 we can see that in HFO-1234ze-tail fragment pairs, the H1’s involved 
in strong interaction sites are more positive than those for HFA-134a and HFA-227-tail fragment 
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pairs, thus helping to enhance the Eb
st.  The most positive H1 in HFO-1234ze can be attributed to 
the C=C bond, which increases the level to which electrons delocalize.  The positive H1 hydrogen 
atoms in HFO-1234ze help compensate for the longer C-H1··O bond distances compared to that 
found with the HFA-134a and HFA-227 propellants. 
2.3.6. Tail-tail Self-interaction Binding Energy (Ebtt) and Enhancement Factor (Eenh) 
In colloidal dispersion systems, as for example particle suspensions, when the external medium 
is a low dielectric, such as the propellants being discussed here, the usual dominant mechanism of 
stabilization is steric.[178]  In that case, the dispersibility of those particles may be imparted by 
the presence of a polymer layer adsorbed or grafted to the particle.  This layer needs to represent 
a thick enough barrier so as to keep the attractive interaction (distance) between the particles of 
the order of thermal energy - kT.  In this way permanent aggregation may be avoided, and any 
weakly flocculated aggregates can be broken up by thermal energy alone.[179]  In order to prevent 
coagulation, therefore, not only the solvation forces (Eb
st) need to be strong – a topic addressed in 
our earlier discussions, but the self-interaction between the polymer fragments (Eb
tt) need to be 
minimized, so as to achieve that thick solvation layer.  In order to capture both effects, we employ 
here a quantity termed Enhancement Factor (Eenh), which is defined as the ratio between the 
solvent-tail interaction (binding) energy to tail-tail self-interaction (binding) energy; i.e., Eenh = 
Eb
st / Eb
tt .  Based on this definition, the Eenh is expected to be a better predictor of the ability of a 
given polymer to be able to sterically stabilize a dispersion in the low dielectric propellant HFO 
and HFAs.  Clearly, this definition misses a very important contribution in the steric stabilization 
process which is of entropic nature.[179]  Nonetheless, Eenh is expected to be a better predictor of 
the fragment’s ability to stabilize colloidal dispersions that Ebst alone.  In order to be able to 
calculate Eenh, we thus determine Eb
tt for the fragments discussed earlier.  We separate our 
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discussion in terms of the effect of the chemistry of the fragments and their structure (branching), 
as done in the discussion related to the solvation forces. 
2.3.7. Effect of Tail Polarity 
For different chemistries, tail-tail self-interaction energies are expected to depend to a large 
extent on their polarity.  This general trend is confirmed in our results, as shown in Figure 9. 
 
Figure 9 Effect of tail chemistry on the self-interaction binding energies of the different tail 
fragments (Eb
tt) (kJ/mol), calculated at the MP2/aug-cc-pVDZ//MP2/6-31g+(d,p) level of theory 
and basis set, with BSSE corrected by the counterpoise method.  Tail fragments are: pentane (C5), 
ethylene oxide (EO) and glycolic acid (GA), which are representatives of the alkane, ether and 
ester chemistries, respectively.  The dipole moments (in Debye, D) for the fragments are shown in 
parenthesis.  The dipole moment was calculated in this work using partial charges from ab initio 
calculations. 
The order of magnitude of Eb
tt is: GA (1.65D) > EO (1.30D) > C5 (0.09D), which correlates 
well with their dipole moments.  Self-interaction will magnify the importance of C-H··O strong 
interactions.  From Figure 10 we can see that C5-C5 pair has (obviously) no C-H··O interactions, 
while the EO-EO pair has 3 and the GA-GA pair has 6 C-H··O strong interactions.  Because the 
carbonyl oxygen is geometrically more available and is more negatively charged than the esters’, 
the self-interaction energy of GA is significantly larger than that of EO. 
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Figure 10 Optimized geometries of the self-interacting tail-tail fragments at the MP2/6-31g+(d,p) 
level of theory and basis set.  Tail fragments are: pentane (C5), ethylene oxide (EO) and glycolic 
acid (GA), which are representatives of the alkane, ether and ester chemistries, respectively.  
Dashed lines and numbers in parenthesis represent the “strong interaction” sites and the number 
of “strong interactions”, respectively.  “Strong interaction” is defined as those between O··H, and 
with a separation distance < 3Å.[31]  Results are summarized in Table 5.  
With the values for the tail-tail self interaction, the Eenh was determined, and the values are 
shown in Figure 11, and summarized (for all fragments) in Table 5. 
 
  
Figure 11 Effect of tail chemistry on their “Enhancement Factor” (Eenh).  Eenh is defined as the 
ratio of the interaction energy between propellant (solvent = s) and tail fragment (tail = t) (Eb
st) 
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over that of tail-tail self-interaction (Eb
tt): E = Eb
st / Eb
tt.  A summary of Eenh for all chemistries and 
propellants is provided in Table 5. 
 
Table 5 Summary of the “Enhancement Factors” (Eenh) for the different chemistries and 
propellants.  Eenh is defined as the ratio of the interaction energy between propellant (solvent = s) 
and tail fragment (tail = t) (Eb
st) over that of tail-tail self-interaction (Eb
tt): Eenh = Eb
st / Eb
tt.  All 
calculations at the MP2/aug-cc-pVDZ//MP2/6-31g+(d,p) level of theory and basis set, with BSSE 
corrected by counterpoise method.  The dipole moments (in Debye, D) for the fragments and 
propellants are shown in parenthesis.  The dipole moment was calculated in this work using partial 
charges from ab initio calculations.  The values for Eenh above one are highlighted in the table. 
 Enhancement Factor (Eenh) 
Tail 
fragments 
HFA134a 
(2.12) 
HFA227 
(1.46) 
HFO1234ze 
(1.14) 
C5 (0.09) 0.58 0.99 0.80 
ISO (0.15) 0.49 0.78 0.64 
EO (1.30) 1.26 1.68 1.30 
PO (1.23) 1.13 1.55 1.12 
GA (1.65) 0.79 0.95 0.76 
LA (1.69) 0.61 0.75 0.59 
TMGA (1.76) 1.28 1.58 1.27 
 
 
The results show that the largest Eenh, and the only above 1 (Eb
st > Eb
tt), is observed for the EO 
moiety.  The Eenh thus serve to further discriminate the EO and GA tail solvation, which could not 
be singled out solely based on Eb
st, as they were similar for both moieties.  Surprisingly, the 
magnitude of Eenh for GA is very similar to that of C5, our negative control.  This value was not 
anticipated, given the strong interaction between the propellants and GA.  However, the strong 
fragment-fragment interaction dominates the magnitude of Eenh for that system, so that Eenh < 1.  It 
is also interesting to observe that this predictor of particle stability suggests that dispersions in 
HFO-1234ze may be expected to be of similar quality to those observed in HFA-134a - or better, 
as their Eenh is similar. 
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2.3.8.  Effect of Tail Branching 
Because the selected group of ether tail fragments have similar dipole moments  - GA (1.65D), 
LA (1.69D) and TMGA (1.76D), it is particularly suitable to investigate the effect of tail branching 
on Eb
tt.  The results are summarized in Figure 12. 
 
Figure 12 Effect of the degree of branching (CH3) on the self-interaction binding energies between 
the ester-based tail ( t ) fragments (Eb
tt) (kJ/mol) calculated at the MP2/aug-cc-pVDZ//MP2/6-
31g+(d,p) level of theory and basis set, with BSSE corrected by the counterpoise method.  Tail 
fragments are: glycolic acid (GA), lactic acid (LA), and tetramethyl glycolic acid (TMGA).  The 
dipole moments (in Debye, D) for the fragments are shown in parenthesis.  The dipole moment 
was calculated in this work using partial charges from ab initio calculations. 
It is worth noticing in Figure 12 is that the tail-tail interaction energy actually increases upon 
adding a methyl branching group, which may be unexpected at first.  The results from Table 5 
indeed support the idea that the presence of the extra CH3 group in LA causes a decrease in the 
total number of strong interactions compared to GA, suggesting that the CH3 group indeed works 
as a steric barrier to tail-tail interaction. 
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Table 6 Summary of “strong interactions” between the tail-tail fragment pairs - glycolid acid 
(GA), lactic acid (LA), and tetramethyl glycolic acid (TMGA).  “Strong interaction” is defined as 
those between O··H, and with a separation distance < 3Å.[31] 
 
 
 
 
 
 
 
 
 
 
 
 
However, it can be seen that at the same time that the number of strong interactions decreases 
on going from GA to LA, the strength of the interactions increases (shorter bond distances).  The 
tail-tail binding energy for TMGA, which represents an addition of two CH3 groups compared to 
GA or one CH3 compared to LA, is seen to decrease not only relative to LA but also to GA – Figure 
12.  The results suggest that the extra degree of branching is capable of providing enough steric 
hindrance to reduce the number and strength of the contacts enough to reduce tail-tail interaction 
– Table 6.  
With the values for the tail-tail self-interaction at hand, the Eenh for the ether fragments as a 
function of branching was determined.  The results are shown in Figure 13, and summarized in 
Table 5.  
Bond 
Length 
(Å) 
GA+GA  
C=O··H 2.81 
C=O··H 2.69 
C=O··H 2.69 
C=O··H 2.81 
C-O··H 2.61 
C-O··H 2.61 
  
LA+LA  
C=O··H 2.65 
C=O··H 2.54 
C=O··H 2.80 
C-O··H 2.58 
  
TMGA+TMGA  
C=O··H 2.52 
C=O··H 2.52 
C-O··H 2.80 
C-O··H 2.80 
47 
 
 
Figure 13 Effect of the degree of branching (CH3) of the ester-based tail chemistries on their 
“Enhancement Factor” (Eenh).  Eenh is defined as the ratio of the interaction energy between 
propellant (solvent = s) and tail fragment (tail = t) (Eb
st) over that of tail-tail self-interaction (Eb
tt): 
E = Eb
st / Eb
tt.  A summary of Eenh for all chemistries and propellants is provided in Table 5. 
The results show that, out of the ether fragments, the only chemistry with Eenh > 1 is that for 
TMGA, that has two CH3 branching units.  TMGA has the lowest self-fragment interaction, and 
at the same time the strongest interaction with the propellants.  It is important to note that the steric 
hindrance effect should be amplified for all systems when going from a single fragment to a 
polymer system - every functional group will experience steric hindrances from CH3 on both side 
of the chain in a polymer and many fragment-propellant interactions will be present.  The expected 
effect here is to further decrease Eb
tt, and thus to further increase Eenh.  Also this effect will be more 
pronounced as the polarity of the fragments increases, as a decrease in number of strong bonds and 
the distance between strong bonds will cause a much greater decrease in Eb
tt. 
2.3.9.  Interactions in cluster of solvents 
It is important to note that, similar to limitations of the calculations of Eb
tt and thus Eenh, which 
focus on tail fragments vs. polymer chains, we focused on single solvent-tail fragment pairs in the 
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calculation of Eb
st instead of fully solvated fragments.  In order to better understand the effect of 
fully solvated fragments, we performed a series of simulations where the geometry of multiple 
propellant molecules were minimized in the presence of a tail fragment.  We focused on the new 
generation propellant HFO-1234ze, and three tail fragments: EO, GA and TMGA.  The results for 
EO and GA will allow us to determine the effect of polarity, while the results for GA and TMGA 
will provide us with information regarding the effect of branching. 
 
Figure 14 Study of the interactions between a cluster of HFO-1234ze molecules (n=6) surrounding 
a single tail fragment: (a) ethylene oxide (EO), (b) glycolic acid (GA), and (c) tetramethyl glycolic 
acid (TMGA).  “Strong interactions” with oxygen atoms are labeled with dashed line.  “Strong 
interaction” is defined as those between O··H, and with a separation distance < 3Å.[31]  Structure 
optimized HF-6-31g(d) basis set/level of theory.   
We can see from Figure 14a that for three possible configurations of 6 HFO propellants 
solvating the EO, only 1 strong interaction is formed – per possible configuration.  However, for 
GA tail (Figure 14b) in all 3 possible configurations containing the same number of propellant 
(a) 
(b) 
(c) 
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molecules in the solvation shell, 2 strong interactions were formed – per possible configuration.  
It is also worth noting that the GA system, the 2 strong interactions are formed either with one 
ether and one carboxyl oxygen (stronger interaction compared to EO) or both with the carbonyl 
oxygen (even stronger interaction compared to EO).  These results thus suggest that when the 
fragments are fully solvated, Eb
st for GA fragments should be significantly enhanced, and thus their 
Eenh should also increase.  Similar effect is expected for LA, but to a reduced extent as an extra 
CH3 groups is present in that moiety.  The results from Figure 14c show that upon adding two 
branching CH3 groups to the ester group - leading from the GA to the TMGA fragment, the number 
of possible strong interactions in a fully solvated environment is just one – similar to a the solvent-
fragment pair discussed earlier.  In this case we should still expect the solvation forces to increase 
due to cohesive interactions between the fragment and other solvents, but no further strong bonds 
are expected to be formed.  
2.4.  Conclusions 
In this work we studied the solvation of relevant tail fragments in HFO-1234ze using ab initio 
calculations.  The chemistries investigated are representative of additives of interest to the various 
industries where HFOs may find use as working fluids.  The tail fragments were selected to allow 
us to systematically probe the effect of both polarity and structure (degree of branching) on their 
solvation by HFOs.  Binding energies between the HFO-1234ze solvent (s) and the tail fragment 
(t) (Eb
st) indicate that the more polar ether- (EO and PO) and ester-based fragments (GA, LA and 
TMGA) are well-solvated by HFO-1234ze with Eb
st’s of ca. -20 kJ.mol-1.  The non-polar alkane-
based fragments (C5 and ISO) are not solvated to the same extent, with Eb
st’s of ca. -9 kJ.mol-1.  
However, polarity alone cannot be used to predict or discriminate which of the polar groups are 
best solvated.  The self-interaction between the tail fragments (Eb
tt) is used to determine a quantity 
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termed the Enhancement Factor (Eenh), which is defined as the ratio between Eb
st / Eb
tt .  Based on 
this definition, the Eenh is expected to be a better predictor of the solvation of a particular fragment 
compared to Eb
st alone, and can be used to further discriminate the effect of fragment 
chemistry/structure on their solvation.  Because the interaction between GA-GA is much stronger 
than that between EO-EO, the Eenh for the EO is much greater – the largest from all investigated 
fragment at Eenh = 1.30.  This quantity, Eenh, thus allow us to further discriminate solvation in HFO.  
Different from polarity, the branching of the tail chemistry is seen to have little effect on Eb
st.  
However, at high enough branching densities, it can significantly impact tail-tail interaction.  
While Eb
tt for GA-GA (no CH3 pendant group) is > -25 kJ.mol-1, that for TMGA-TMGA (two CH3 
pendant groups) is ca. -15 kJ.mol-1.  Branching can serve to reverse the trend in Eenh.  While for 
GA (no branching) and LA (one methyl pendant group) Eenh is less than one; that for TMGA (two 
methyl pendant groups) Eenh is greater than one (1.27), and very close to that for EO.  These results 
suggest that the structure of the tail fragment will also have a significant impact in its solvation, 
along with the polarity.  We also determined that the solvation in HFO-1234ze is similar to that of 
a working fluid currently being used in the industry, the HFA-134a.  In summary, the results shown 
here provide information that can be utilized to further evaluate the potential of this new generation 
of greener working fluids, the HFOs, in replacing the HFAs 
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CHAPTER 3 
THE MICROSTRUCTURE AND INTERFACIAL TENSION OF THE BARE AND 
SURFACTANT-MODIFIED HFO-1234ZE|WATER INTERFACE 
3.1.Introduction 
The consumption of hydrofluoroalkane (HFA) working fluids in 2010 totaled over 1,000 
million metric tons CO2 equivalent, with the refrigeration industry using the biggest share (79%), 
followed by foams (11%), aerosols (5%), fire extinguishing systems (4%) followed by the solvent 
industry (1%).[180]  The large usage of HFAs is of concern given that they are green house gases.  
Hydrofluoroolefins (HFOs) have thermophysical properties similar to HFAs,[181] but much lower 
global warming potential (GWP).  HFOs have thus emerged as the next generation high-pressure 
working fluids.  HFOs have been recently approved by European regulatory agencies that mandate 
that, starting in 2011, all new model vehicles should use refrigerants with a GWP < 150.[182, 183]  
This criterion makes HFAs’ phase out in the European automobile refrigerant market a must.  
HFOs are also making their way into the US market after receiving approval from the 
Environmental Protection Agency (EPA) for use as refrigerants in motor vehicles.[184] 
The reduced environmental impact of HFOs come from their shorter atmospheric half-lives 
that arises due to the introduction of a C=C bond into their semi-fluorinated back-bone.[185]  The 
GWP for 2,3,3,3-tetrafluoropropene (HFO-1234yf) and 1,3,3,3-tetrafluoropropene (HFO-1234ze) 
is only 4 and 6, respectively, compared to 1430 and 3220 for 1,1,1,2-tetrafluoroethane (HFA-134a) 
and 1,1,1,2,3,3,3- heptafluoropropane (HFA-227), respectively, which are the two most widely 
used working fluids.[186, 187]  HFO-1234ze not only has a low GWP, but also low toxicity profile, 
which is similar to HFAs, and is practically non-flammable, being, therefore, a viable candidate 
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substitute to HFAs.[145, 188]  While major environmental concerns in the use of such working 
fluids come understandably from use in the refrigeration industry, based on historic grounds, the 
transition of HFAs to new propellant systems in the refrigeration industry will eventually drive the 
transition in other industries as well.[189, 190]  This has been observed in the past as we 
transitioned from chlorofluorocarbons (CFCs) to HFAs, and is also clearly indicated once again 
by patenting trends, with HFOs being proposed as working fluids in different applications such as 
blowing agents,[191, 192] foam forming agents,[193] and medical aerosols.[194] 
With respect to the use of HFOs in medical aerosols, an interfacial system that is of relevance 
is the propellant-water interface.  HFOs are hydrophobic, and have, therefore, low mutual 
solubility with water.[147]  The propellant-water interface arises when water droplets are dispersed 
in the propellant in the form of emulsions or microemulsions, which may find use as topical foams 
and inhalers.[195]  The ability to understand the behavior of the bare- and surfactant-modified- 
HFO|H2O interface is of relevance in the design of surfactants for such medical sprays.  Surfactants 
serve to decrease the tension of the interface, thus facilitating the formation of the dispersions, and 
once formed, to stabilize the interface from aggregation and coalescence.[179]  While many 
studies have addressed the thermophysical properties of HFOs, including HFO-1234ze, no 
previous work has discussed the properties of the bare- or surfactant-modified- HFO|H2O interface, 
which is the focus of this work.  It is worth mentioning that this is a non-conventional interface in 
that HFOs are not only hydrophobic but are also lipophobic, and also because these propellants 
are under pressure at the conditions at interest. 
Based on the challenges and opportunities described earlier, the goal of this work was to 
rationally design surfactants for the HFO-1234ze|H2O interface using a combined computational 
and experimental approach.  Molecular dynamics (MD) simulations and high-pressure tensiometry 
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were used to determine the tension (γ) and microstructure of the bare HFO-1234ze|H2O interface 
using the SPC/E force field (FF) for water and a recently published 12-6 LJ FF for HFO-
1234ze.[196]  MD simulations were also used to systematically investigate the effect of surfactant 
tail chemistry on the HFO-1234ze|H2O interface, using a series of non-ionic (ethylene oxide, EO)-
based surfactants with the alkyl (CH), propylene oxide (PO) and lactide (LA) moieties as the HFO-
philes (tail chemistries).  Both the tension and microstructural properties of the interface were 
determined to probe the behavior of the surfactants.  Once the optimum surfactant tail chemistry 
had been identified, a series of copolymer surfactants, with varying hydrophilic-to-HFO-philic 
balance (HFB), or wt. ratio between EO and the HFO-phile were studied using MD simulations to 
determine the optimum surfactant balance.  Experimental tension results were also obtained with 
a series of non-ionic copolymer surfactants, and the results compared and contrasted with the MD 
simulations.  
3.2.Models and Methods 
3.2.1. Force Field and Simulation Details  
All Molecular Dynamics (MD) simulations were performed on the computer cluster at the Center 
for Scientific Computing at Wayne State University using NAMD 2.8, and VMD 2.9 for 
visualization.[197, 198]  The Force Field (FF) for HFO-1234ze has been recently published,[199] 
and the parameters are shown in Table 7. 
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Table 7 Intramolecular and Lennard-Jones force field parameters for HFO-1234ze. 
 
Force field from Rabee et al.[198] 
The FF for HFO-1234ze has been shown to be in quantitative agreement with the 
experimental VLE, liquid density and saturation properties of the propellant.[196]  Charges for the 
model, which had not been initially reported with the FF, were calculated in our work.  First, the 
Bond Force Constant: Kb (kcal·mol
-1·Å-2) r0 (Å) 
CM=CM 676.8  1.331 
CM-CT 317.6  1.511 
CT-FT 369.2  1.353 
CM-HC 388.9  1.086 
CM-FM 445.7  1.330 
CM-HM 388.9  1.086 
Angle Force Constant: Kɵ (kcal·mol
-1·rad-2) ɵ0 (deg) 
HM-CM=CM 36.35  120.6 
FT-CT-FT 87.86  107.5 
CM-CT-FT 74.85  111.3 
HM-CM-HM 29.31  118.7 
CM=CM-FM 50.52  122.6 
FM-CM-FM 85.38  112.6 
FM-CM-CT 76.38  112.5 
CM=CM-CT 50.12  124.1 
CM=CM-HC 36.35  120.6 
CT-CM-HC 32.33  115.1 
FM-CM-HM 30.00  113.0 
Dihedral Force constant: Kdih(kcal·mol
-1) N δ (deg) 
X-CM=CM-X 6.654 2 180 
HC-CM-CT-FT 0.178 3 0 
FM-CM-CT-FT 0.250 3 0 
CM=CM-CT-
FT 0.142 3 180 
Atom ε (kcal·mol-1)  Rmin/2(Å) 
CM -0.09899235  1.908185 
CT -0.07430927  1.908185 
FM -0.05644599  1.62757 
FT -0.05644599  1.650019 
HC -0.01570268  1.038277 
HM -0.01570268  1.487262 
55 
 
geometry of HFO-1234ze was optimized at B3LYP/DGDZVP level of theory and basis set, using 
Gaussian 03 (see Figure 15).[200]   
 
Figure 15 Optimized structure and atom assignment for HFO-1234ze from ab intio calculations 
using Gaussian 09. 
The partial charge distribution was then computed at HF/6-31G* level of theory and basis 
set, as described in the initial publication with the FF.  The charges are shown in Table 8.  More 
recently, the authors of the FF have published the charge distribution for HFO-1234ze.[201]  The 
two set of charges (from this work and the authors of the FF) are practically identical (deviation < 
1%), thus validating both works. 
 
 
 
 
 
 
 
 
   -       
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Table 8 Partial charge distribution for HFO-1234ze from ab intio calculations using Gaussian 09.  
Geometry optimized at B3LYP/DGDZVP level of theory using Gaussian 03 and the partial charge 
distribution determined at the HF/6-31G* level of theory.  Atom numbers are the same as those 
shown in Figure 15. 
 
 
 
 
 
 
 
The surfactant’s FFs were derived from the CHARMM 35 FF, with slight modifications to 
achieve overall charge neutrality of the molecules – see the FF parameters on Table S1 in 
Supplementary Material.[202, 203]  The SPC/E FF was employed for water as it has been shown 
to reproduce not only the experimental surface tension of water,[204] but also the interfacial 
tension of several water binary systems, and of those interfaces in the presence of a variety of 
surfactants.[205, 206] 
For the calculation of the HFO-1234ze surface tension, 127 HFO-1234ze molecules were 
placed in the center of a rectangular box (28*28*100 Å), giving rise to two HFO-1234ze|air 
interfaces.  The constant temperature and constant volume ensemble (NVT) was used to make sure 
a stable liquid-vapor binary system develops at 298 K, as well as for the production runs for this 
interface.  For HFO-1234ze|H2O simulations, 1470 H2O molecules were placed in one half of a 
simulation box (30*30*112 Å), and 254 HFO-1234ze molecules were placed in the other half, 
giving rise to two HFO-1234ze|H2O interfaces that are separated at a distance of 56 Å, so that the 
two interfaces will not interact with one another.  For the simulations of the surfactant-modified 
 HFO-1234ze1 
Atom # Type q(e) 
1 CM 0.25300 
2 HM 0.13300 
3 CM -0.48500 
4 HC 0.24500 
5 CT 0.77700 
6 FM -0.19200 
7 FT -0.24500 
8 FT -0.24300 
9 FT -0.24300 
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HFO-1234ze|H2O interface, equal number of surfactants were placed on each interface (12 each).  
A coverage of 75Å2/surfactant was thus established. 
All simulations were performed with a time step of 1 fs and at 298 K.  Except for the HFO-
1234ze|Air interfacial systems that were run in the NVT ensemble, all other simulations were 
performed at 10 atm (1.01MPa) of normal pressure (PN - pressure in the Z direction).  Traditional 
constant pressure MD algorithms (NPT) are isotropic and vary all cell vectors in an attempt to fix 
the average of the tangential and normal pressures.  With an interface, this results in a normal 
pressure that differs from the target pressure.[207]  In order to address this issue, the constant 
normal pressure and surface area ensemble (NPNAT) was used for all simulations of the HFO-
1234ze|H2O interface.  The cell dimensions in X and Y directions are fixed while the dimension in 
Z direction (perpendicular to the interface) is allowed to fluctuate.  Equilibration was monitored 
through the configurational energy as well as the periodic boundary size changes in the Z direction.  
The Langevin piston and Langevin thermostat were used to achieve the desired temperature and 
pressure.[208]  Periodic boundary conditions (PBC) were applied to all directions.  A cutoff of 14 
Å was applied to both vdW and electrostatic interactions.  VdW interactions were smoothly shifted 
to zero from 10-14 Å, while electrostatic interactions were smoothly shifted to zero from 0-14 Å.  
Particle Mesh Ewald (PME) was used to compensate for long range electrostatic interactions.[209, 
210] 
The interfacial tension was calculated using the following expression:[211, 212] 
𝛄 = ∫ [𝐏𝐍 − 𝐏𝐭(𝐳)]𝐝𝐳
𝐥
−𝐥
       Equation 4 
where γ is interfacial tension, PN is pressure tensor in the normal direction where constant 
pressure is applied, Pt(z) is tangential pressure tensor and it is a function of the Z coordinate.  A 
similar equation is used for the calculation of the surface tension.  According to this equation, only 
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the changes in the pressure component in the vicinity of the interface can contribute to the 
integral.[213]  Because we used PBC in our simulations, which gives two interfaces, and a normal 
pressure is applied to the Z direction, the equation becomes 
𝜸 =
𝟏
𝟐
∫ [𝑷𝒛𝒛 − 𝟏/𝟐(𝑷𝒙𝒙 + 𝑷𝒚𝒚)]𝒅𝒛
𝟏/𝟐𝑯𝒛
−𝟏/𝟐𝑯𝒛
     Equation 5 
where HZ is the box height/length in the Z direction, Pzz is the component of the pressure 
tensor in the Z direction, Pxx and Pyy are pressure tensor components in the tangential directions.  
In our simulations, the pressure tensor is measured every 1 Å distance along the z direction, these 
pressure tensors were reported to log files every 100 step (1fs/step) for analysis. 
3.2.2.  Surfactant Molecules Investigated in the MD Simulation Studies 
We included in our simulation work three non-ionic surfactants, all having the ethylene oxide 
(EO) as the head group, with alkyl- (CH), propylene oxide- (PO) and poly(lactic acid)- (LA) based 
surfactant tail groups.  The CH tail groups are representative of the Brij surfactant class 
( CH3(CH2)12(OCH2CH2)4OH or EO4-CH4, where CH4 contains the same number of heavy atoms 
along the back-bone chain as PO4 and LA4.  Because HFO-1234ze is hydrophobic, CH tails are 
expected to have poor solvation in HFO-1234ze, and thus serve as the negative control.  PO 
(H(OCH(CH3)CH2)4(OCH2CH2)4OH or EO4-PO4) and LA 
(H(OCH(CH3)C(=O))4(OCH2CH2)3OH or EO4-LA4) are moieties that find wide applicability in 
the pharmaceutical and medical industry, including their use in FDA-approved formulations.[214]  
Because of their local dipoles that arise due to the presence of oxygen atoms, they are expected to 
interact more favorably with the propellant.  The LA repeat unit is also expected to be more polar 
than PO, and those three tail groups help us to systematically investigate the effect of interaction 
strength between HFO-1234ze and the surfactant tail groups on their structure and interfacial 
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activity at the HFO-1234ze|H2O interface.  In the studies related to the surfactant balance, a series 
of EO8-POm surfactants, with m = 2 to 12, were investigated.  These surfactant class was chose as 
they turned out to be the most interfacially active as discussed below.  The homopolymers EO8 
and PO8 were also studied. 
3.2.3.  In situ (high-pressure) Tensiometry 
3.2.3.1. Materials 
A series of Pluronic surfactants (EOnPOmEOn) were kindly provided by BASF.  The 
homopolymers poly(ethylene oxide) 3,400Mw (PEG3400) was purchased from Acros Organics.  
All of the surfactants were used as received.  Their commercial names and corresponding 
structures are shown in Table 9.  Deionized water (NANOpure, Barnstead), with a resistivity of 
17.  MΩ.cm-1 and surface tension of 72 mN.m-1 at 298 K, was used in all experiments.  
Commercial grade HFO-1234ze was a gift from Honeywell (Hanover, Germany).  Basic alumina 
(99%) was purchased from Fisher Scientific and was used as received. 
Table 9 Commercial name, molecular weight (MW), molecular structure, wt.%EO and experimental 
tension of the various surfactants studied in this work at the HFO-1234ze|H2O interface. 
 
 
 
3.2.3.2. Purification of HFO-1234ze 
Surfactant MW Structure EO (wt.%) γ (mN.m-1)  
Pluronic L62 2,500 EO6PO34EO6 20 3.0±0.24 
Pluronic P84 4,200 EO19PO43EO19 40 1.2±0.02 
Pluronic P85 4,600 EO26PO40EO26 50 1.4±0.01 
Pluronic F87 7,700 EO61PO40EO61 70 4.0±0.13 
Pluronic F88 11,400 EO104PO40EO104 80 8.1±0.03 
PEG 3400 3,400 EO79 100 17.2±0.10 
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The purification of the commercial HFO-1234ze sample was done under pressure, using a 
similar procedure as described before.[206]  Briefly, the commercial sample was loaded into a 
variable-volume high-pressure cell, which was filled with basic alumina (25 vol.%).  The contents 
in the cell were thoroughly mixed for 5 h using a magnetic stirrer.  The alumina was then allowed 
to settle for 45-60 min.  Treated HFO-1234ze was transferred to another pressure cell for the 
interfacial tension measurements. 
3.2.3.3. Interfacial Tension Measurements 
The γ measurements were performed in a high-pressure pendant drop tensiometer similar to 
that described in the literature.[174]  The apparatus, schematically shown in Figure 16, consists 
of a variable-volume high pressure cell (MEASURING CELL) equipped with a front window and 
two side windows, which allows the visualization of the system under pressure and extraction of 
the droplet profiles with the help of the light source and a digital camera.  The temperature (T) was 
monitored inside the cell, close to the droplet, and controlled with a heating tape wrapped around 
the cell and a temperature controller (Cole Parmer, EW-89000-10) to ±0.2 K.  The pressure (P) 
was also monitored in the front part of the pressure cell with a pressure transducer (Sensotec 
FP2000) to ±0.07MPa.  The binary HFO-1234ze|H2O interfacial tension (γ0) and that of the 
surfactant modified interface (γ) were determined using the pendant drop technique.  Briefly, a 
pendant drop of propellant was formed at the tip of a capillary connected to a six-port injection 
valve (Valco Instruments).  For the γ measurements, the cell was initially filled with water - with 
or without surfactant.  Drops of HFO-1234ze was injected into the system and allowed to 
equilibrate until the saturation pressure of the system was reached.  Several drops were generated 
and their equilibrium tension was measured.  Equilibrium was assumed to be reached when the 
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variation in γ became less than the maximum expected experimental error and consistent with 
time.[215]  Every condition was repeated at least three times. 
 
 
Figure 16 Schematic diagram of the high-pressure tensiometer.  HFO = HFO-1234ze tank with dip 
tube.  PUMP  = ISCO computer controlled pump for pressurizing the system.  PURIFICATION CELL =  
cell for contact between HFO-1234ze and alumina for purification of the propellant.  MEASURING CELL 
= cell where the pendant drop of propellant is formed in bulk water with or without surfactant.  T = 
temperature controller.  P = pressure sensor.  CAMERA & LIGHT SOURCE = used to digitize the image 
on the computer where the droplet profile is extracted from. 
3.3. Results and Discussions. 
3.3.1.  Surface Tension of HFO-1234ze and the Effect of Temperature. 
The force field (FF) used was first validated by comparing surface tension of HFO-1234ze 
(σHFO) with experimental measurements from the literature.  The σHFO was evaluated at 3 different 
temperatures: 270K, 298K, and 330K.  The MD simulation results are summarized in Table 10, 
along with the experimental literature values. 
HFO PUMP
PT
PURIFICATION CELL
MEASURING CELL
LIGHT SOURCE CAMERA
6 PORT
VALVE
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Table 10 Computer simulation results for the surface tension of HFO-1234ze as a function 
of temperature (T).  Experimental results from the literature are also shown. 
 Surface Tension (mN.m-1) 
 HFO-1234ze 
T (K) This work Exptl.* 
270 13.8±1.1 13.3 
298 10.3±1.9 9.0 
330 5.2±1.9 4.9 
                           * Higashi et al.[144] 
The results range from 13.3-4.9 mN.m-1 as the temperature increases from 270K to 330K, 
with a σHFO of 9.0 mN.m-1 at 298K.  The calculated MD results show excellent agreement with the 
experimental values, and are also capable of quantitatively predict the effect of T on the surface 
tension, thus demonstrating the strength of this FF. 
The surface tension of HFO-1234ze (σ𝐻𝐹𝑂
@298 = 9.0 𝑚𝑁/𝑚) is quite similar to that observed 
for HFAs at 298k - 8.11 mN.m-1 for HFA-134a and 10.24 mN.m-1 for HFA-227.[140, 216]  In 
applications where fluorocarbon propellants are used to generate aerosols, the similarity of their 
surface tension will lead to easier transition from HFAs to HFOs.  For example, pressurized 
inhalers depend on an appropriate aerodynamic particle size distribution for efficient delivery,[217, 
218] and surface tension is the dominating factor of droplet formation,[219, 220] which eventually 
determines the aerosol particle size. 
3.3.2. The Binary HFO-1234ze|H2O Interface: Interfacial Tension and 
Microstructure 
Having validated the model for the calculation of the surface tension of HFO-1234ze, the next 
step was to determine the tension of the binary HFO-1234ze|H2O interface.  Both the calculated 
interfacial tension from MD simulations (γ0) and experimental interfacial tension values (γ0EXP) of 
the bare interface are shown in Table 11. 
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Table 11 Computer simulation results for the interfacial tension () of the bare and surfactant-
modified HFO-1234ze|H2O interface.  Conditions were 298K, 1.01 MPa, and surfactant density 
(at interface) of 75 Å2/molecule.  The difference between the HFO-1234ze|H2O binary interfacial 
tension (0) and that of the surfactant-modified interface is also shown ( = 0 – ) – this is equal 
to the surface pressure ().  The experimental value for the interfacial tension of the HFO-
1234ze|H2O binary interface (0EXP) determined in this work is also shown.  The subscripts indicate 
the number of repeat units in the head (EO) and tail (CH, PO, and LA) groups. 
 H2O 
EO4-CH4 
(mN/m) 
EO4-PO4  
(mN/m) 
EO4-LA4 
(mN/m) 
 0EXP 0 Δ         Δ         Δ 
HFO-1234ze 41.9 40.9 23.3    17.6 12.3     28.7 16.9      24.0 
 
The calculated interfacial tension of the bare interface at 298K was determined to be 
40.9±0.9mN.m-1.  This value is in quantitative agreement with the experimental value we 
determined using high-pressure pendant drop tensiometry of 41.9±0.2mN.m-1.  The interfacial 
tension of the HFO-1234ze|H2O interface is seen to be significantly higher than that of the HFA-
134a|H2O, reported to be 33.5mN.m
-1,[174] and that for HFA-227|H2O, which has been reported 
to be between 34mN.m-1 to 35mN.m-1.  The relative larger value of the interfacial tension HFO-
1234ze compared to HFAs cannot be rationalized based on the polarity of the propellants alone.  
The dipole moment of HFA-134a is 2.058D, and it is more polar than HFO-1234ze (1.443D).  A 
lower tension for HFA-134a is thus expected.  However, the same rationale cannot be applied 
when comparing the tension for HFO-1234ze to that of HFA-227.  The dipole moment for HFA-
227 0.94D, which is much lower than that for HFO-1234ze, but its interfacial tension against water 
is still smaller than that for HFO-1234ze.  Some of the more hydrophobic nature of HFO-1234ze 
may be attributed to its C=C.  The higher tension of the HFO-1234ze|H2O interface is expected to 
serve as a stronger driving force for surfactant adsorption. 
To a large extent, the region closest to interface (a few molecular diameter’s thick), where the 
tangential stresses are pronounced, and the system is attempting to minimize unfavorable contacts, 
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gives rise to the system interfacial energy/tension (γ).[221]  One way to probe the microstructure 
in the vicinity of the interfacial region is to determine its Z-density profile, which is shown in 
Figure 17.   
 
Figure 17 Z-density profile for the HFO-1234ze|H2O interface at 298K and 1.01MPa. 
It can be seen from Z-density profile that, away from the interface, the density (ρ) of both 
phases oscillates around the correct experimental value.[24]  It is also important to note that a 
stable interface is formed.  These results further indicate the appropriateness of the models for 
HFO-1234ze and water.  The interfacial width can be defined as the distance through which both 
phases have lower than 90% of their bulk density – this is also referred to as the 10-90 density-
defined interfacial width. According to this, the 10-90 interfacial width of bare HFO-1234ze|H2O 
is 5.6 Å, which is comparable to that of HFA-134a|H2O interface (ca. 5).[206]  
3.3.3. The Surfactant-modified HFO-1234ze|H2O Interface: Microstructure, 
Interfacial Tension, and Surfactant Balance. 
3.3.3.1. Effect of the Surfactant Tail Chemistry. 
   -       
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The effect of the surfactant tail chemistry on the tension of the HFO-1234ze|H2O interface 
was determined at 298K, 1.01MPa and at 75Å2/surfactant coverage.  A summary of the interfacial 
tension (γ) results as a function of tail chemistry from the MD simulations is shown in Table 11.  
The difference between the HFO-1234ze|H2O binary interfacial tension (γ0) and that of the 
surfactant-modified interface, which is equal to the surface pressure (γ), is also shown in Table 11. 
The results show that all surfactants are interfacially active in the sense that they reduce the 
interfacial tension of the binary system.  The non-ionic surfactant with the PO tail group (EO4-
PO4) is seen to induce the largest interfacial tension reduction – Δγ = 28.7 mN.m-1.  The surfactant 
with the CH tail group (EO4-CH4), our negative control, is the least interfacially active, with a Δγ 
of only 17.6 mN.m-1.  These results correlate well with the ability of HFO to solvate these moieties.  
Using ab initio calculations, we have determined the pair interaction energy (Eb
st) between HFO 
and these tail chemistries, which directly relates to the strength of interaction between HFO and 
the fragments, and thus the ability of HFO to solvated those groups.  We observed that while the 
Eb
st between HFO and CH tail group was ca. -9 kJ.mol-1, that for LA was more than double at -19 
kJ.mol-1.  When comparing the tension reduction between the PO- and LA- based surfactants, we 
see that the PO-based surfactant is more interfacially active at the HFO-1234ze|H2O interface, 
while the calculated binding energies are nearly the same at -19 kJ.mol-1.  The higher active of the 
PO-based surfactants can come from a more appropriate surfactant balance or structural 
differences, as will be discussed in more detail below. 
3.3.3.2. Microstructure of the HFO-1234ze|H2O Interface in the presence of surfactant. 
As discussed earlier, there is a strong relationship between the microstructure of the interfacial 
region and the interfacial tension.  The Z-density profile of all species, including HFO-1234ze, 
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H2O, and the surfactants’ head and tail groups were determined at 298K, 1.01MPa and 
75Å2/surfactant, and are shown in Figure 18 as a function of surfactant tail chemistry. 
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Figure 18 Z-density profile for the HFO-1234ze|H2O interface modified with (a) EO4-CH4 
surfactant; (b) EO4-PO4 surfactant; (c) EO4-LA4 surfactant, at 298K, 1.01MPa and 75 Å
2/molecule. 
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We can observe that the EO head group, for all three surfactants systems, has considerable 
overlap with both phases.  This interesting behavior is observed because the EO group in the 
surfactant is not only hydrophilic, but is also HFO-philic.  As we have pointed out before, our ab 
initio calculations showed that ether groups are well solvated by HFO.  In this case, EO does not 
have the same traiditonal behavior as head-group (hydrophilic) as it is also HFO-philic, and thus 
the balance of the surfactant is more nuanced than compared to traditional interfaces. 
As for the tail groups, we can observe that while the CH moiety has very little overlap with 
H2O, both PO and LA tails have considerably more overlap with H2O.  The tail group position in 
the Z-density profile depends on their hydrophilicity and HFO-philicity.  CH seems to largely 
overlap with HFO-1234ze, but it is the least capable of reducing the γ of the interface.  The HFO-
1234ze|H2O system is different from the water-organic system in that a hydrophobic group is not 
necessarily fluoroolefin-philic, and hydrophilic is not necessarily fluoroolefin-phobic (as 
discussed earlier).  In this case, we have previously shown that CH is not well solvated by HFO.  
The overlap of the CH moiety with HFO-1234ze is largely driven by its hydrophobicity (and not 
because it is HFO-philic).  Thus, in spite of its overlap with the HFO phase, it does not help much 
in reducing interfacial tension, which is achieved upon minimizing the less favorable contacts 
between H2O and HFO-1234ze. 
We can also observe that the interface is broadened in the presence of surfactants.  The 10-90 
density profile defined interface width increased from 5.6 Å for bare HFO-1234ze|H2O interface 
to 19.5 for CH4-EO4, 22.7 Å for PO4-EO4, and 23.3 Å for LO4-EO4.  The broadening of the 
interface indicates a reduction in the unfavorable contacts between HFO-1234ze and H2O, and as 
a consequence, a reduction in interfacial tension.[222]  For binary systems, the interfacial tension 
arises from the fact that molecular interactions in the bulk cannot be completely satisfied (loss of 
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enthalpy) as the interface is approached; i.e., the inevitable contacts between dissimilar molecules 
at the interface are not as favorable as those with the like molecules in bulk.[179, 223]  Because 
surfactants have head and tail groups that can interact favorably with H2O and HFO-1234ze, 
respectively, they will (i) create an exclude volume area/ barrier that will naturally displace HFO-
1234ze and H2O from the interface (bulkier head and tail groups will occupy more space), and in 
doing so, they will decrease those less favorable contacts; and (ii) the surfactant will provide (more) 
favorable interaction sites between HFO-1234ze and the tail fragment when compared to HFO-
1234ze and water contacts that existed before the addition of surfactant; and also more favorable 
contacts between H2O and the head-group - compared to water and HFO-1234ze.  Effectively, the 
surfactant creates two other interfacial regions, which have an overall lower total interfacial energy 
when compared to the original HFO-1234ze-water interface. 
We can see from the RDF profiles shown in Figure 19 that the contacts between HFO-1234ze 
and H2O are greatly reduced in the presence of surfactants, when compared to the bare interface. 
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Figure 19 RDF of oxygen (O) atoms from H2O to fluorine (F) atoms from HFO-1234ze.  
Conditions are 298K, 1.01MPa and 75 Å2/molecule. 
We can observe that, in spite of the fact that the CH-based surfactant provided the least 
reduction in interfacial tension, it is the one most capable of decreasing the contacts between HFO-
1234ze and H2O.  The solvation profiles of the tail groups, to discussed next, will help explain this 
apparent discrepancy.  We then turn our attention to the second attribute of the surfactant layer, 
which is to provide favorable contact points to water and HFO through the head and tail groups.  
We focus here on understanding the effect of solvation of the tail groups by HFO-1234ze - shown 
in Figure 20, as the solvation of EO by water has been addressed in the literature.[224]  
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Figure 20 Radial distribution function (RDF) of fluorine atoms (F) from HFO-1234ze and 
the backbone carbon (C) atoms of the tail group of (a) EO4-CH4; (b) EO4-PO4; (c) EO4-LA4 
surfactants.  C1 = carbon atom furthest from the EO head-group; C4 or C10 = carbon atoms closest 
to the EO head-group.  Conditions are 298K, 1.01MPa and 75 Å2/molecule.  
These RDF profiles show that the CH tail group (Figure 20a) is indeed poorly solvated by 
HFO-1234ze.  A solvation shell of HFO-1234ze around the C atoms of the tail group is poorly 
defined, except for the C atom furthest form the tethering point to the surfactant head-group (C1), 
which is simply pushed towards the outer surfactant layer due to the hydrophobic nature of the 
surfactant, as discussed earlier.  In contrast, we can see that a first and second solvation shell is 
observed for both the PO and LA tail groups (Figure 20b and 20c), and for all C atoms along those 
backbones.  One interesting fact to observe from Figure 20b is that the tail end (C1) is the least 
solvated C by HFO-1234ze in the PO tail group.  This is related to the fact that the terminus of the 
PO tail is OH, and thus it will tend to point towards the water-bulk layer. 
3.3.3. Surfactant Balance at the HFO-1234ze|H2O Interface 
In the process of rationally designing surfactants for HFO-1234ze|H2O interface, the first step 
in our study was focused on discriminating the most appropriate surfactant tail group chemistry, 
which was determined to be the ether-based moiety – PO.  The next step in the optimization 
consists in finding the optimum balance in the head/tail group for the best surfactant studied; i.e., 
the EO/PO ratio.  For this study, we investigated a surfactant series with the following structure – 
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EO8-POm, where m varies from 2 to 12, with the homopolymers of EO8 and PO8.  This is equivalent 
of varying the EO% from 0 to 100.  The MD simulation results of the effect of the EO wt% at the 
HFO-1234ze|H2O interface at 298K, 1.01MPa, and 75Å
2/molecule are summarized in Figure 21. 
 
Figure 21 Interfacial tension (γ) of the surfactant-modified HFO-1234ze|H2O interface a 
function of EO % (weight) of the surfactant.  MD simulations (EO8POm, with m = 2 to 12, and the 
homopolymers EO8 and PO8) and experimental measurements (EOnPOmEOn, Mw from 2,500 to 
11,400) at 298K and saturation pressure of the propellant (1.034MPa).  Simulations at 75 
Å2/molecule. 
It can be observed that the homopolymers (EO8 and PO8) have substantial activity at the HFO-
1234ze|H2O interface, with a decrease in the tension of the binary system of more than 8mN.m
-1.  
We can also observe that a minimum in tension is found during the scan in EO wt.%.  As the wt.% 
EO increases (from the PO homopolymer), the tension of the interface decreases because the 
surfactant partitions more towards the interface.  At the minimum in tension, the surfactant is said 
to be at the balanced point.  This is called the hydrophilic-to-HFO-philic balance (HFB), and is 
located at ca. 62 EO wt.% for this surfactant class.  As more EO is added, the surfactant starts 
partitioning more to the other side (aqueous) of the interface, and the tension starts increasing again.  
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Such fundamental understanding of the surfactant at the interface is relevant as it can directly guide 
the identification of effective surface active agents, and also because it is directly related to the 
ability to form and stabilize dispersions of water and HFO, and can also be used to determine the 
preferred curvature of emulsions and microemulsions formed with such non-miscible solvents.  
This knowledge is of industrial relevance when preparing medical foams and other medical sprays 
with HFOs.[140, 225] 
The interfacial tension of the HFO1234-ze|H2O interface was also determined experimentally.  
A series of EOnPOmEOn block copolymer surfactants, having a similar number of PO units were 
employed.  Their structures are presented in Table 11.  The tension of the homopolymer PEG340 
was also evaluated.  All the measurements were performed at 298K, saturation pressure (1.034MPa) 
of the propellant, and 1mM surfactant solution.  All surfactants were solubilized in the aqueous 
phase.  The results are summarized in Table 11, and plotted as a function of wt.% EO in Figure 
21, together with the MD results. 
The homopolymer (EO79) showed a high interfacial activity, with a tension reduction close to 
24.7mN.m-1.  This result is similar to that observed in the MD results, but more pronounced due 
to the higher MW of the EO used in the experimental work.  This is a result from the fact that EO 
is highly hydrophilic and simultaneously HFO-philic.  This behavior is very different from what 
is expected on traditional interfaces as discussed earlier, where the second phase is usually an 
alkyl-based hydrophobic solvent, and where interactions with EO would arise simply from 
dispersive forces.  In HFO propellants, local dipole interactions are not only possible, but 
potentially very strong, as we have shown in our ab initio calculations.  Because of this unique 
interaction between EO and water and at the same time HFO, the V-shaped curve traditionally 
observed when the tension is scanned as a function of the % hydrophile is somewhat shallow in 
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this case.  The HFB for the experimental system with the PO-based copolymers is less well-defined 
because of the fact that there is less control in the surfactant architecture than those surfactants set 
up in the MD simulations.  However, the HFB can be identified to be between 40 and 50 wt.% EO, 
the two lowest values in the tension vs. wt.% EO curve.; i.e., at the HFB is ca. 45wt.% EO, where 
the γ is close to 1.2 mN.m-1.  This minimum in tension represents a reduction of ca. 40mN.m-1 
when compared with the binary system.  The discrepancy in HFB between experimental and 
computational results can be largely attributed to differences in structure and size of the copolymer 
surfactants.  These results suggest that such surfactant class could not only aid in the formation of 
emulsion in HFO-1234ze-water systems, but possibly to form reverse aggregates, which may have 
special relevance in the development of medical sprays. 
3.4. Conclusions 
In this work we used a combined computational and experimental approach to rationally 
design surfactants for the HFO-1234ze|H2O interface.  A recently developed 12-6LJ FF for HFO-
1234ze[226] was shown to quantitatively predict the experimental surface tension of HFO-1234ze 
as a function of temperature, thus establishing the relevance of the model to interfacial systems.  
MD results for the tension of HFO-1234ze|SPC/E H2O interface (40.9mN.m
-1) was shown to be 
also in quantitative agreement with the experimental value obtained in this work (41.9mN.m-1) 
using a high-pressure pedant drop tensiometer.  MD simulations were then used to understand the 
behavior of non-ionic (EO-based) surfactants with tail chemistries of systematically varying 
polarity: CH (EO-CH); PO (EO-PO) and LA (EO-LA).  The interfacial tension and structural 
information from MD simulations of the surfactant-modified interface provided a microscopic 
view to understand the surfactant effect, and to screen the most appropriate tail chemistry.  The 
EO-PO surfactant was found to be the most active at the HFO-1234ze|H2O interface, with an 
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interfacial tension reduction of 28.7 mN.m-1.  Once the best chemistry was identified, MD 
simulations were used to determine the optimum surfactant balance; i.e. the ratio of the EO head-
group to PO tail-group that would reduce the tension of the interface the most, which is defined as 
the hydrophilic-to-HFO-philic balance (HFB).  The HFB was determined to be located at ca. 62wt.% 
EO.  The trend in tension vs. wt.%EO from the MD results are in good agreement with the 
experimental values found for the tri-bock EO-PO-EO, with the observed differences being 
attributed to the difference in structure of the two surfactant classes and in the MW.  The 
experimental HFB for EO-PO-EO was found to be at ca. 45 wt.%EO.  The low tension values 
obtained for the surfactants close to the optimum balance suggest that they are capable of forming 
emulsions and potentially microemusisons of systems involving HFO-1234ze and water.  The 
relevance of this work stems from the fact that this is the first time that the properties of the bare 
and surfactant modified HFO-1234ze|H2O interface has been reported – either experimental or 
computational results.  In summary, the results suggest HFO-1234ze may be a suitable alternative 
to HFAs in the formation of aerosols containing dispersions of water and HFO-1234ze for medical 
applications  
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CHAPTER 4 
PEGYLATED, NH2-TERMINATED PAMAM DENDRIMERS: A MICROSCOPIC 
VIEW FROM ATOMISTIC COMPUTER SIMULATION 
 
4.1. Introduction 
Dendrimers are well defined, highly branched, nanostructured polymers comprised of dendritic 
arms branching out from a common core.[227]  Their unique structure, which is characterized by 
high size uniformity, low polydispersity, and a large number of surface groups that can be easily 
modified, make them very attractive for a variety of biomedical applications, including in vivo and 
in vitro diagnostics,[228] and drug and gene delivery.[229]  PAMAM dendrimers, with their low 
cytotoxicity and biocompatibility, are one of the most studied dendrimer nanocarriers (DNCs) in 
drug delivery applications.[230]  The conjugation of ligands onto the surface of nanocarriers has 
been extensively employed to enhance their efficacy.[231]  Of special interest is poly(ethylene 
glycol) (PEG).  PEG can help protect the payload, improve biocompatibility of the carrier, decrease 
the rate of elimination from systemic circulation, and can also serve as flexible linkers between 
DNCs and targeting moieties that can be used to promote tissue, cellular and subcellular 
targeting.[232, 233]  
The potential behavior and applicability of dendrimers and their conjugates as drug carrying 
molecules are greatly impacted by their microstructure and surface properties, as they dictate how 
these nanocarriers will interact with the physiological environment, and their eventual fate, as well 
as the fate of the therapeutic cargo associated with them.[234-238]  Understanding their 
microstructure is, therefore, of great relevance.  Experimental diffraction techniques such as small-
angle neutron scattering (SANS) and small-angle X-ray scattering (SAXS) are best suited among 
all experimental techniques to probe the structure of DNCs.[239]  A number SANS and SAXS 
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studies have helped elucidate the effect of important variables such as the generation, surface 
functionalization and pH on the microstructure of PAMAM dendrimers.[240-244]  However, 
SANS and SAXS alone cannot easily provide direct and/or model-free atomic level information 
of key aspects of these carriers and their conjugates, such as the position of functional surface 
groups and the interaction of ligands with the dendrimer surface.[245-247] 
Computational studies, therefore, fill an important gap in this area, as they have the potential 
to provide atomic level information on the microstructure of DNCs, and the impact of relevant 
variables such as the effects of generation, pH, surface chemistry and the presence of ligands.[248, 
249]  Initial computational studies have focused on systems in vacuum that do not resemble the 
physiological environment.[250]  Several united-atom models of PAMAM dendrimers have been 
also proposed.[251-254]  While those models have certain limitations on what can be extracted 
with regards to the dendrimer microstructure, they serve an important purpose, which is to allow 
for the extension of dendrimer studies to more complex systems, such as understanding the 
interactions between DNCs and lipid membranes.[255, 256]  With enhanced computational power, 
more recent computational work on PAMAM dendrimers have addressed their structure at the 
atomic level,[257-261] albeit to a limited extent.  Moreover, up to now, there has been no report 
on fully atomistic models for PEGylated PAMAM dendrimers, and very little work has been 
published on the microstructure of such conjugates from an experimental perspective.[262]  This 
is a strong limitation as PEG is highly used ligand as discussed above. 
In order to address the challenges and opportunities discussed above, the objective of this work 
was to study the microstructure of PEGylated, amine(NH2)-terminated PAMAM dendrimers using 
fully atomistic and solvated models.  We first investigated the microstructures of NH2-terminated 
PAMAM as a function of their generation (GXNH2, where X is the generation) from X = 2 through 
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5.  We then investigated the effect of PEGylation density (no, low, medium and high density), and 
the molecular weight of PEG (Mw = 500 or 1000) conjugated onto the PAMAM dendrimers 
(GXNH2-NPEG500 or GXNH2-NPEG1000, where N is the number of PEGs).  We report the 
results in terms of experimentally accessible variables, such as radius of gyration (Rg), and 
compare those with available experimental and computational information.  We also take an in 
depth look at the microstructure of the dendrimers using a number of tools such as the radial atom 
distribution (RAD) and radial distribution functions (RDF).  These tools allow us to determine 
important microstructural information such as the position and solvation of the terminal surface 
groups, and the structure of the PEG-layer.  We discuss our results from a drug-delivery 
perspective; i.e., how the accessed microstructure information may impact the dendrimer 
conjugate as a drug carrier system.  
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4.2. Methods and Models 
All simulations in our study were performed remotely on Ranger, from the Texas Advanced 
Computing Center,[263] using NAMD 2.8 for the Molecular Dynamics (MD) simulations and 
VMD 2.9 for visualization.[264, 265]  The all-atom (AA) force field (FF) for the GXNH2 
dendrimers was developed from a combination of the CHARMM 35 FF and ab initio calculations 
performed in our laboratories.  Bond distance, bond angle, dihedral and vdW potential parameters 
were from CHARMM 35 FF.[266, 267]  Ab initio calculations were used to adjust the charge 
distribution within amidoamine monomers.  Gaussian 09 was used at the MP2 level of theory and 
6-31g(d) basis set for structural optimization, and charge distributions were obtained from 
CHELPG analysis.[268]  Charge distribution of the residues were adjusted so as to achieve the 
correct overall charge of the fully protonated dendrimer, while maintaining those charges as close 
as possible to those from the original CHARMM FF.  Terminal (primary) amines are fully 
protonated, which corresponds to the experimental condition of GxNH2 at physiological pH.[269]  
The FF for PEG is a revised and well-tested CHARMM FF for ethers (C35r).[270]  The TIP3PM 
water model was employed in this work.  From now on, however, we use the notation TIP3P for 
simplicity.  The TIP3P FF has been shown to give reasonable structural and energetic results for 
pure water and is also optimized for CHARMM FF, which we used to derive our FF for the GXNH2 
dendrimers.[271]  Details on all FF parameters can be found in Supplemental Information. 
All simulations were performed in the isobaric-isothermal (NPT) ensemble, at 298K and 1 atm.  
These conditions were maintained with the Langevin thermostat and Langevin piston method.[272, 
273]  A 1 fs step length was used to conserve energy.  A cut off of 12Å was applied for both VDW 
and electrostatic interactions.  VDW interactions were smoothly shifted to zero from 10-12Å, and 
the real part of the electrostatic interactions were smoothly shifted to zero from 0-12Å.  Particle 
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Mesh Ewald (PME) was used to compensate for the long-range electrostatic interactions.[210]  
Periodic boundary conditions (PBC) were used in all directions.  The solvation boxes were 
carefully built such that GXNH2 dendrimers or the PEGylated GXNH2 dendrimers did not see their 
own PBC copy, which mimics the desired infinite dilute solution of the dendrimers.  The initial 
coordinates of the dendrimers were generated using GaussView 5.0.[274]  A 20 ps minimization 
was performed to remove bad contacts in vacuum, and then the solvation (water) box was added 
to the system.  Equal number of Cl- ions to the number of protonated primary amines in the 
dendrimers were added to the solvation box in order to neutralize the system.  The solvated systems 
were minimized again for 20 ps to remove bad contacts, and then MD simulations were carried 
out to equilibrate the solvated structures.  The simulations were run for 27ns.  Statistics were taken 
from the last 2 ns of the runs, when the solvated structures had been equilibrated. 
4.3. Results and discussions 
4.3.1. Effect of generation on the size and shape of GXNH2 dendrimers. 
In order to understand the effect of dendrimer generation (X in GXNH2), PEGylation density 
(N in GXNH2-NPEG), and molecular weight (Mw) of the conjugated PEG (500 or 1000 Mw) onto 
the dendrimer microstructure, we first characterized the nanocarriers with respect to their radius 
of gyration (Rg).  Rg was chosen as the first benchmark as it can be directly compared to 
experimental results.  Moreover, knowledge of the size and shape of the dendrimers is of great 
relevance and key properties that determine their potential applicability, as is the case in the 
selection of dendrimers as nanocarriers for drug delivery applications[237, 275]. 
The Rg for a dendrimer with N atoms is given by 
𝑹𝒈
𝟐 =
𝟏
𝑴
∑ [𝒎𝒌(𝒓𝒌 − 𝒓𝒎𝒆𝒂𝒏)
𝟐]𝑵𝒌=𝟏    Equation 6 
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where rmean is the center of the dendrimer, (rk-rmean) is the distance of the k
th atom from the 
center, mk is the mass of the k
th atom, and M is the total mass of the dendrimer.  The evolution of 
Rg for GXNH2 as a function of generation (X) is shown in Figure 22. 
 
Figure 22 Time course of the radius of gyration (Rg) of the NH2-terminated PAMAM 
dendrimers generation 2-5 – GXNH2 - where X denotes the generation.  Average and deviation of 
the molecular dynamics (MD) simulations were calculated from the last 2 ns, using block sizes of 
0.1 ns.  NPT ensemble - 298K and 1 atm. 
These results are summarized in Table 12, and compared with the available computational 
results, and the range of experimental values reported from SANS and SAXS. 
 
 
 
Table 12 Radius of gyration (Rg) as a function of the generation of the NH2-terminated 
PAMAM dendrimers (GXNH2).  Literature results (experimental range and computational) are 
also shown for comparison. 
Radius of gyration (Rg) (Å) 
Figure 2. Time course of the radius of gyration (Rg) of NH2-terminated
PAMAM dendrimers generation 2-5 - GXNH2 - where X is the generation.
Average and deviation of the molecular dynamics (MD) simulations were
calculated from the last 2 ns, using block sizes of 0.1 ns. NPT ensemble -
298K and 1 atm. SANS xperimental results are also included in the plot -
dashed line.
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Generat
ion 
SANS
a 
SAXS
b 
United atom 
modelc 
All atom 
modeld 
This 
study 
G2NH2    14.5 11.9±0.
9 
G3NH2 16.2 14.7-
16.5 
13.1 10.4-19.7 15.0±1.
3 
G4NH2 18.0-
21.6 
17.1-
18.6 
21.7-23.2 16.7-26.7 21.8±1.
1 
G5NH2 22.9-
25.9 
21.9-
25.3 
25.1-26.7 20.7-32.8 23.8±1.
9 
a Range of values reported from small angle neutral scattering (SANS) experiments.[242, 
243, 276] 
b Range of values reported from small angle X-ray scattering (SAXS) experiments.[257, 277] 
c [278, 279] 
d [248, 280] Only models using explicit water are included here for comparison. 
The values determined for Rg in this work are seen to be in excellent agreement with the 
experimental results.  All values fall within the range reported for SANS/SAXS.  These results 
suggest that the proposed FF is adequate to represent the microstructure of the dendrimer 
nanocarriers.  It is worth noticing that while it may be relatively simple to fit the FF parameters to 
reproduce a single condition (generation), the fact that the selected FF is capable of reproducing 
the experimental Rg for a range of generations further indicates the strength of the model.  The 
results are also in agreement with previous computational results for those dendrimers whose 
generations have been studied.[42, 46, 252, 256, 281-290] 
The equilibrium behavior of the dendrimers was determined via the autocorrelation function 
of the Rg (CRg ) - cross-correlation of time course of Rg with itself.  The CRg curves are shown in 
Figure 2. 
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Figure 23 Autocorrelation function of the radius of gyration (Rg) as a function of time 
( Rg(t)) for NH2-terminated PAMAM dendrimers generation 2-5 - GXNH2, where X denotes the 
generation.  Relaxation times, calculated as  Rg (t) = 1/e, and are shown as an inset table. 
The results show that after about 10 ns of equilibration, the autocorrelation functions for 
G2NH2 through G5NH2 fluctuate around 0, indicating that their overall structure is well 
equilibrated.  Relaxation times, defined as the time when CRg(t) = 1/e, were also determined.  These 
results are included as an inset table in Figure 23.  Relaxation time is the characteristic time scale 
of a process, and in this case is related to the relaxation behavior of the solvated polymer - based 
on which Rg is calculated.  It is worth noticing that the results show a decrease in relaxation time 
when going from G3NH2 to G4NH2 – 2.93ns compared to 1.75ns; i.e., the relaxation time 
decreased with an increase in molar mass of the polymer, contrary to the scaling law from polymer 
theory which states that:[291] 
𝜂0 = 𝑎𝑀𝑤
𝑧  
0 5 10 15 20 25
-0.3
0.0
0.3
0.6
0.9
1.2
C
R
g
(t
)
Time (ns)
 G2NH
2
 G3NH
2
 G4NH
2
 G5NH
2
84 
 
where η0 is the zero shear viscosity, a is a pre-factor, Mw is the molecular weight of the polymer, 
and z is the scaling factor, which is ca. 3.3-3.5 for monodispersed linear flexible polymers.  The 
larger the η0, the longer the time required for the polymer to assume different conformations.  
According to this theory, η0 should thus increase with an increase in the Mw of the polymer.  
Consequently, the relaxation time should also increase with an increase in Mw, to a degree that 
will depend on the polymer structure and solvent conditions.  The reverse trend observed for 
G3NH2 and G4NH2 seen here is attributed to the unique characteristics of these hyperbranched 
polymers.  PAMAM dendrimers are macromolecules with many degrees of freedom, and are thus 
capable of undergoing changes in conformation without changing their size - which is 
characterized by Rg.  For example, it was observed from SANs experiment that the Rg of G4NH2 
remains nearly invariant even with significant changes in its radial density profile are induced as 
the protonation level of the dendrimer changes.[292] 
Further examination of the screenshots of equilibrium configurations of the dendrimers also 
helps to explain the relaxation times discussed above.  The conformations shown in Figure 24 
reveal that G4NH2 does not assume a densely packed structure like G2NH2 or G3NH2, but instead 
it assumes an “open” structure, which is segmented into several relatively independent subunits. 
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Figure 24 Snapshots of equilibrium conformations of the NH2-terminated PAMAM 
dendrimers generation 2-5 – GXNH2, where X denotes the generation.  Atoms represented as VDW 
spheres.  Snapshots of starting configurations are those taken after 20 ps of initial minimization.  
Equilibrium configurations are snapshots taken after 27 ns.  Solvated (water) systems at 298K and 
1 atm.  Water and  l- ions were removed from the snapshots to improve visualization of 
dendrimers. 
The relaxation time for G3NH2 is thus dependent on the molecule as a whole, while that for 
G4NH2 is dependent on its subunits, which have a smaller molar mass than the G3NH2, thus 
leading to shorter relaxation times.  G5NH2 also assumes a segmented structure, but the relaxation 
time did not decrease relative to G3NH2 because the subunits for G5NH2 have larger Mw than 
G3NH2 itself. 
Our observations agree with description of dendrimer microstructures obtained from SAXS, 
in which the scattering curve suggests that lower generation PAMAM dendrimers do not assume 
a hard sphere shape, and as generation grows from G4NH2 to G8NH2, PAMAM dendrimers will 
eventually evolve from star- to sphere-like structures.[277]  These observations have important 
implications when considering the use of such nanocarriers as drug delivery systems.  The fact that 
these higher generation dendrimers (G4NH2 and G5NH2) present “open” structures with compact 
subunits indicate the potential of the carriers to transport therapeutics that interact with the carrier 
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surface through physical forces (dispersion/H-bonding/electrostatic), but less so as “encapsulated” 
within (expected) “cavities”.[293-295] 
The “segmented open” structure of G4NH2 and G5NH2 discussed here, will also serve to 
reconsider the way we interpret related experimental observations.  For example, in earlier SANS 
experiments, the calculation of water penetration into G4NH2-G6NH2 PAMAM dendrimers was 
attempted using “appropriate molecular boundary radius”, which already assumed a simplified 
compact structure.[296]  However, considering a “segmented open” structure of G4NH2 and 
G5NH2 PAMAM dendrimers as shown here, different interpretation of the experimental results 
are expected.  Further discussions will be carried out later in this manuscript regarding the concept 
of “segmented open” structure, and details about how this different understanding in 
microstructure can lead to different interpretations of experimental observations. 
In order to better understand the microstructure of the nanocarriers, we analyzed their radial 
atom distribution (RAD) profiles, which represent the number of atoms at a distance r from a 
carbon atom at the center of the dendrimer core.  These profiles are similar to the radial density 
profiles used to resolve the debate between “dense-core” vs. “dense-shell” models proposed for 
the dendrimers.[297]  However, RADs, are easier to interpret due to the much less overlap between 
the profiles.  RADs for the different dendrimer generations are shown in Figure 25. 
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Figure 25 Radial atom distribution (RAD) of the NH2-terminated PAMAM dendrimers as a 
function of their generation - GXNH2, where X is the generation.  The RAD is the number of atoms 
at a distance (r) from a carbon atom at the center of the dendrimer core. 
We can see from Figure 25 that as the generation increases, more atoms are present in a 
specific layer, thus resulting in a higher peak, and more extended distributions, as expected.  We 
also notice that for the region where r < 10 Å, G2NH2-G5NH2 have very similar atoms 
distributions, which indicates that, at least for the generations considered in our study, the core of 
all the dendrimers remains structurally similar.  It is also interesting to observe that the peak for 
G5NH2 is observed to be at almost the same position as for G4NH2.  There are two competing 
factors leading to a more collapsed structure of G5NH2.  As the generation goes up, the number of 
protonated primary amines increases, and so does the repulsion between the terminal groups that 
oppose the collapsing forces generated by dispersive interactions within atoms in the core.  
However, as the generation increases, so does the overall size of the dendrimers, and the distance 
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between primary amines increases, thus resulting in less repulsion, and facilitating the collapse.  
The second reason for the collapse is related to the fact that as generation of the dendrimers 
increases, the number of atoms (Na) increases with generation (X) as Na~2
X+2.  To maintain a 
densely packed structure, the space those monomers need to fill (V) scales with X as V~X3, so that 
to a certain generation, in our case X=4, the number of monomers cannot fill up the increase in 
space, resulting in (i) the peak of RAD to be shifted to the left (or less to the right), and (ii) the 
dendrimer assuming a more “opened” structure. 
4.3.2. Distribution and solvation of primary and branching amines 
4.3.2.1.  Branching amines.  In dendrimer theory, the dendrimers’ structural behavior 
mostly depend on spacer length and distribution of branching points.[259]  The behavior of 
branching amines in terms of their separation distance and solvation are thus key properties to 
understand dendrimer microstructure.  We used G4NH2 as an example to study the behavior of the 
branching amines.  In our system, the spacer length can be characterized by the distance between 
two neighbor branching amines (Ni-Nj).  Radial distribution function (RDF) of branching amines 
to branching amines of different generations (gNi-Nj) for G4NH2 are shown in Figure 26.  N4 
represents the primary amines and N0 represents branching amines closest to the core of G4 
PAMAM dendrimer. 
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Figure 26 Radial pair distribution function (gNi-Nj) of branching amines (Ni) to different 
generation branching amines (Nj) for the G4NH2 dendrimer.  N4 represents the primary amines 
and N0 represents the branching amines closest to the core. 
The peak position shows the separation distance between two generation branching amines, 
which corresponds to the spacer length.  All peaks appear between 7-8 Å which means the 
amidoamine monomer (spacer) is quite rigid on itself.  The inner most monomer (spacer), N1-N0, 
shows the sharpest peak, which means all the inner most monomers (spacers) are very close in 
term of length.  From N1-N0 to N4-N3 the peak slightly shifts to the left.  This is a result from the 
fact that the outermost monomer (spacer) has a much lower density, and it is thus easier for the 
N4-N3 monomer to assume a more relaxed conformation compared to others. 
The solvation behavior of primary amines and branching amines is a very important 
consideration in developing strategies for the use of GXNH2 dendrimers as drug carriers, because 
therapeutic molecules are either conjugated to the GXNH2 dendrimers’ primary amines[298] or 
complexed/encapsulated with/to dendrimers through non-bonded interactions formed between the 
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therapeutics and both the primary and branching amines.[299]  Solvation behavior of primary 
amines and branching amines will tell to what extent those amines have access to solvent 
environment, usually aqueous, and consequently, the ability to perform chemistry with those 
functionalizable groups and to efficiently load therapeutics onto the nanocarriers.  In Figure 27 
we show the solvation profiles for different generation branching amines (Ni) of G4NH2 – the 
radial distribution profiles between branching amines Ni and oxygen from water (Ow), where N4 
represents the primary amines and N0 the branching amines closest to the core. 
 
Figure 27 Radial pair distribution function (solvation profiles) between the oxygen of H2O 
( w) and the branching amines of G4NH2 (Ni) (g w-Ni)  N4 represents the primary amines, and N0 
represents the branching amines closest to the core. 
Because the bond length between N-C is longer than that of C-H, the first solvation peak 
position is slightly different for branching amines compared to primary amines, which is reflected 
on the profiles shown in Figure 27.  As expected, we observe that the primary amines (N4) have 
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the highest first solvation peak.  Less expected is the fact that the inner most branching amines (N0) 
have a higher first solvation peak than middle branching amines (N1, N2, N3).  This observation is 
in agreement with the results discussed in terms of Figure 1.  G4NH2 assumes an “open” structure 
with the core (N0) having good accessibility to water, while middle branching amines that are 
confined in each subunit by hydrophobic interactions, thus have the least water accessibility.  
Given this microscopic picture, one can conclude that the loading of therapeutics onto G4NH2 via 
hydrophobic interactions is most likely to happen first through interactions with the inner most 
branching amines, and then be possibly trapped within the “opening area” between two subunits. 
4.3.2.2.  Primary amines.  The surface chemistry of nanocarriers is of great relevance in 
drug delivery applications as those characteristics will greatly influence the interactions between 
the carrier and the physiological environment, and thus dictates the fate of the carrier and 
consequently of the cargo associated with the carrier.  In the case of GXNH2 dendrimers, the 
position and solvation of their primary amines is of even greater relevance, as those are the 
functionalizable surface groups where drugs [300], imaging agents[301] and other ligands[302] 
may be conjugated.  Of course, such chemistry (conjugation) cannot be achieved or it will be 
greatly hindered if the primary amines are not available at the exterior surface of the dendrimers.  
Because of its relevance, there has been great interest in understanding the location of those 
terminal groups, through both experimental investigations[303] and also computer simulations.[42, 
281]  We thus provide a detailed analysis with regards to the position and solvation of the terminal 
NH2 groups for the dendrimers G2NH2-G5NH2.  In Figure 28 (a) snapshots of the equilibrium 
configurations of the GXNH2 dendrimers are shown.  All primary amines are labeled as yellow 
VDW spheres, while and all inner branching amines are labeled as blue VDW spheres.  All other 
atoms and bonds are represented by colored lines. 
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Figure 28 (a) Screen shots of GXNH2 dendrimers after equilibration.  All primary amines are 
labeled as yellow VDW spheres, and all inner branching amines are labeled as blue VDW spheres.  
All other atoms and bonds are represented by colored lines.  (b) Radial pair distribution functions 
of the primary amines of G2-G5NH2 (Np) to the oxygen of H2O ( w) (gNp- w). 
Through this simple (qualitative) representation, it can be inferred that all primary amines 
reside in the outer shell of G2NH2-G5NH2 dendrimers.  In order to provide a quantitative 
assessment to this observation, we also studied the primary amines’ solvation profiles for G2NH2-
G5NH2.  Those results are shown in Figure 28 (b).  The first solvation peaks of the primary amines 
are seen to remain virtually the same for all dendrimers, independent of their generation - G2NH2-
G5NH2.  This demonstrates that they are equally accessible to water, and thus quantitatively 
establishes that all primary amines reside in the outer shell or surface of the dendrimers.  These 
results help address a long standing debate in the dendrimer literature on whether primary amines 
“back-fold” into the dendrimer structure or remain on their surface.[304] 
While most studies agree that for lower generation GXNH2 dendrimers, including G2NH2 and 
G3NH2, primary amines reside in the outer shell or surface of the dendrimers,[42, 305] some 
studies have suggested that the terminal amine-groups of higher generations GXNH2 “back-fold” 
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into the dendrimer structure.[240, 241, 304]  The fact that our results show that the RDF profiles 
of primary amines to O from water for G4NH2 and G5NH2 are very close to those for G2NH2 and 
G3NH2, strongly suggest that those higher generation dendrimers do not “back-fold”.  This 
conclusion also makes thermodynamic sense as a very unfavorable enthalpic penalty would be 
expected for a fully protonated primary amine to insert itself within the internal of dendrimers 
which are highly hydrophobic.  This observation does not conflict with some experimental studies 
that shows primary amines or terminal monomers can be found quite close to core of dendrimers 
– which could be thought of as “back-folding”.[240, 259, 306]  The key to understand these 
experiments is to realize that G4NH2 and G5NH2 assume a “segmented open” structure, with the 
presence of subunits.  Regions close to the core of the dendrimer are thus accessible to primary 
amines without the need to back-fold into the dendrimer structure. 
4.3.3. Effect of PEGylation on PAMAM dendrimer microstructure 
There are several advantages in PEGylating dendrimer nanocarriers.  They help improve 
biocompatibility,[44, 290, 307] enhance aqueous solubility, which is especially relevant to achieve 
high density of conjugation of hydrophobic therapeutics,[308] increase plasma circulation 
time,[309] and are also used as flexible linkers for the attachment of ligands for cellular[310] and 
organelle targeting.[311]  In this work, we systematically investigated the effect of PEGylation 
density and PEG Mw on the microstructure of G3NH2 dendrimer. 
4.3.3.1. Effect of PEGylation density on the microstructure of G3NH2 
The Rg of G3NH2 was determined at different densities of PEG 500 Mw.  The effect of PEG 
density was studied both on size of the core of the conjugate (G3NH2 alone) and onto the overall 
size of the conjugate (G3NH2-NPEG500).  The results are shown in Figure 29. 
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Figure 29 Evolution of the radius of gyration (Rg) of PEGylated G3NH2 conjugates as a 
function of graft density of PEG 500 Mw – G3NH2-XPEG500, where X is the number of 
conjugated PEG 500 Mw.  (a) Rg of the whole conjugate – including PEG.  (b) Rg of the 
dendrimer core only. 
As we increase the density of PEG500 (N) on G3NH2-NPEG500, we observe that the Rg of the 
PAMAM-PEG conjugation increased, but only slightly so - Figure 29 (a).  This suggests low Mw 
PEG grafting on PAMAM dendrimers will have only small effects on overall size of DNC 
conjugate, in agreement with the literature.[290]  Rg of the dendrimer part of the conjugate alone, 
however, did not show a monotonic increase with increasing PEG density - Figure 29 (b).  For 
the core of the conjugate (G3NH2 part only), as the PEG 500 density increases from no PEG500 
to 8 PEG500, the Rg of the core increased, indicating that the PAMAM part is being swollen.  As 
there should not be any crowding effect at this low grafting density, the swelling is attributed 
mostly to the fact that PEG is well solvated by water, and this solvation provides an outward force 
pull on the PAMAM core, which results in the swelling of the core.  However, as the PEG 500 
density increases from 8 to 16 PEG500, the Rg of the core decreased.  While the same type of 
forces that promote the outward pulling of the core still exist as the density increases from 8 to 16 
PEG500, other forces counterbalance this outward pull.  For every PEG chain tethered onto the 
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primary amines of the PAMAM dendrimers, there also will be the neutralization of a +1 charged 
site from the protonated primary amines.  These protonated primary amines (before addition of 
PEG) act to oppose the collapse of the dendrimers, as discussed earlier.  At some point, in the case 
of for G3NH2 as the PEG 500 density increases from 1/4 to 1/2 grafting density, the surface charges 
are reduced to a critical point in which their density is not able to sustain the attractive interactions 
of the PAMAM core.  The core thus collapses because of lack of electrostatic repulsion between 
primary surface amines. 
To investigate the changes induced by PEGylation density onto the dendrimer microstructure 
in more detail, we determined their RAD profiles.  The RAD profiles in Figure 30 (a) show that 
as the PEG density at the surface increases, the RADs of G3NH2-NPEG500 show a wider 
distribution.  G3NH2-16PEG500 has a thick layer, of almost 1 nm of PEG, which surrounds the 
dendrimer.  This “coat” is expected to have a significant impact on its interaction with the 
physiological environment, and may also affect the release of therapeutic molecules (especially 
hydrophobic) that may be directly conjugated onto the dendrimer surface, as they will need to 
diffuse through this extra barrier.  Figure 30 (b) shows the RADs of the PAMAM core only.  The 
two competing effects of PEG solvation and electrostatic repulsion by the primary charged amines 
discussed above are clearly observed in Figure 30 (b).  By increasing the PEG density on G3NH2 
from 8 to 16, the RHS of the RAD curve is further pulled/shifted outward compared to the other 
dendrimers, which corresponds to a stronger pull out force induced by a larger number of PEG 
chains.  However, the LHS of the RAD curve is shifted to the left, which corresponds to a collapse 
induced by the reduction of the electrostatic repulsions from primary amines that are no longer 
charged.  The RAD profiles show that the two effects compete with each other for all PEG densities.  
For G3NH2-16PEG500, the competition results in shrinkage of PAMAM part. 
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Figure 30 Radial atom distribution (RAD) of PEGylated G3NH2 conjugates (G3NH2-
NPEG500) as a function of number of PEG 500 Mw grafts (N).  (a) R D of the whole conjugate 
– including PEG.  (b) R D of the dendrimer core only. 
We also examined the primary amines’ solvation profile for the G3NH2 dendrimers PEGylated 
with different densities of PEG 500 Mw.  The results are shown in Figure 31 (a).  The solvation 
peaks of the primary amines of PEGylated G3NH2 are seen to be smaller than that of G3NH2 with 
no PEG500, and the peaks decrease as the PEGylation density increases.  PEGylation impacts 
solvation of primary amines in two ways: (i) in a direct way, the conjugation of PEG500 converts 
primary amines to secondary amines (amines with 2 organic substituents), and (ii) in an indirect 
way, there is a steric blocking of water from the remaining primary amines due to interaction 
between O of PEG and the primary amines themselves, as will be discussed in more detail later.  
The picture is very different, however, for inner branching amines (Ni), whose profiles are shown 
in Figure 31 (b).  PEGylation is seen to significantly reduce the height of the first and second 
solvation peaks, which may be attributed, at least in part, to a collapse of the dendrimer core as 
PEGylation increases. 
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Figure 31 Radial pair distribution function of H2O oxygen (Ow) to (a) primary amines (Np) 
(gNp- w) and (b) inner amines (Ni) (gNi- w) of PEGylated G3NH2 conjugates as a function of graft 
density of PEG 500 Mw – G3NH2-NPEG500, where N is the number of conjugated PEG 500 Mw. 
Understanding the solvation behavior of the primary amines of PEGylated dendrimers is of 
relevance as any impact on their solvation (the ones not covalently modified) will in turn affect 
their interaction with the physiological environment, as for example non-specific interactions with 
proteins, tissues and cell walls.  The presence of this thick and strongly interacting PEG layer is 
expected to impact the zeta potential of the carriers above and beyond that which should be 
observed by the simple removal of the primary amine charges that happen upon conjugation of the 
PEG grafts.  This impact is expected due to the electrostatic screening of the unmodified primary 
amines by the PEG layer. 
4.3.3.2. Effect of PEG molecular weight on microstructure of G3NH2 
Besides PEG density, PEG molecular weight is another major factor that can be utilized to 
change the microstructure of drug nanocarriers, and thus to optimize their efficiency.[288]  Here 
we investigate the effect of PEG Mw on the microstructure of G3NH2 by comparing three systems: 
G3NH2 with no PEG; G3NH2-8PEG500 and G3NH2-8PEG1000.  The Rg’s for the conjugates are 
 
0 5 10 15
0.0
0.2
0.4
0.6
0.8
1.0
1.2
g
N
i-
O
W
r (Å)
 G3NH
2
-0PEG500
 G3NH
2
-4PEG500
 G3NH
2
-8PEG500
 G3NH
2
-16PEG500
0 5 10 15
0.0
0.5
1.0
1.5
2.0
2.5
g
N
p
-O
W
r (Å)
 G3NH
2
-0PEG500
 G3NH
2
-4PEG500
 G3NH
2
-8PEG500
 G3NH
2
-16PEG500
(a) (b) 
98 
 
shown in Figure 32 (a) (of whole conjugate).  The Rg for the dendrimer part of the conjugate are 
shown in Figure 32 (b) (core only). 
 
Figure 32 Evolution of the radius of gyration (Rg) of G3NH2 conjugates as a function of 
PEG length – PEG 500 Mw and PEG 1000 Mw.  (a) Rg of the whole conjugate – including PEG.  
(b) Rg of the dendrimer core only.  
The Rg increased from G3NH2-8PEG500 to G3NH2-8PEG 1000, as expected.  The increase of 
Rg from 8 PEG500 to 8 PEG1000 is larger than the increase in Rg from 8 PEG500 to 16 PEG 500.  
Considering the total molecular weight of 16 PEG500 is same as 8 PEG1000, this means PEG 
length has a larger effect on the size of PAMAM dendrimer than number of PEGs conjugated.  The 
larger effect of PEG length can be attributed again to the competition between the two effects of 
PEG on dendrimers.  The outward pulling force from 8PEG1000 is same as from 16PEG500, but 
with fewer PEG chains, G3NH2-8PEG1000 has more unmodified primary amines which provides 
for a stronger repulsion coming from the dendrimer core and more pronounced increase in Rg 
compared to G3NH2-1 PEG500.  Another reason for 8PEG1000’s bigger impact on overall size 
of DNCs could be the degree of interactions between primary amines and PEG chain, which will 
be discussed later.  In Figure 32 (b) we report the Rg of PAMAM part of the PAMAM-PEG 
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conjugates.  The impact of PEG length on the size of the PAMAM core is not significant.  
Combined, these results suggest that the solvation and crowding effect of larger Mw PEGs are 
very significant in the overall dendrimer conjugate size. 
Radial atom distributions (RAD) were again used to probe further into the dendrimer 
microstructure.  The RADs for PEGylated G3NH2 as a function of PEG size are shown in Figure 
12.  In Figure 33 (a) we show the RAD of the conjugates. NH2-8PEG1000 have ~1nm thick layer 
compared to G3NH2, which is similar to that of 16PEG500, but with less interactions with primary 
amines, and assuming a more extended conformation as a result (Figure 34).  As for the impact of 
the PEG length on the size of the core, the RADs shown in Figure 33 (b) indicate that the LHS of 
the RAD plot for G3NH2-8PEG1000 did not shift as much to the left as that for G3NH2-16PEG500, 
which comes from the difference in their number of unmodified primary amines.  This is relevant, 
as the number of functional groups accessible for conjugation of the therapeutic cargo can be 
maximized that way – by having fewer PEGs of larger Mw. 
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Figure 33 Radial atom distribution (RAD) of PEGylated G3NH2 conjugates as a function of 
the PEG length.  (a) R D of the whole conjugated – including PEG.  (b) R D of the dendrimer 
core only. 
4.3.3.3. Effect of PEG density and molecular weight combined on the microstructure 
of G3NH2 
To determine the effect of both PEG density and Mw combined on the microstructure of 
G3NH2, we first examined their equilibrium structures visually as shown in Figure 34. 
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Figure 34 Screenshots of the equilibrium configurations of PEGylated G3NH2 conjugates as 
a function of PEG density (N in G3NH2-NPEG) and PEG length (500 or 1000Mw).  Dendrimer 
atoms represented in red and PEG atoms in yellow VDW spheres. 
Those snapshots indicate that the PEG chains grafted onto the dendrimers are flexible enough 
and interact strongly enough with the protonated primary amine surface groups of the dendrimers, 
so as to fold in close contact with the surface (strong adsorption).  Such information has not been 
available until now as atomic level information is not easily accessible experimentally, and no 
fully atomistic simulations of PEGylated dendrimers have been carried out in the past.[312, 313]  
We also studied the radial pair functions between primary amines (Np) of dendrimers and the 
Oxygen in PEG (OPEG) to better understand this interaction.  The results are shown in Figure 35. 
 
 
     -             -        
 
     -              -         
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Figure 35 Radial pair distribution function between the oxygen from PEG (OPEG) and primary 
amines (Np) (gNp- P  ) of dendrimers with generation 2-5 - GXNH2, where X represents the 
generation. 
All PAMAM-PEG conjugates show strong interactions between primary amines of dendrimers 
and Oxygen from PEG, albeit to different extent.  The first peak is at 3.2 Å, which is close to 
typical hydrogen bond distance of 3 Å.  This makes sense because all unmodified primary amines 
are positively charged (+1e） and Oxygen atoms from PEG have a negative partial charge that is 
strong enough to form hydrogen bonds with those primary amines.[314]  Because we have seen 
from Figure 31 (a) that up to 16 PEG, G3NH2 will not significantly block water from solvating 
primary amines, we can safely say that while Oxygen atoms from PEG interact strongly with 
primary amines, this has a relatively small impact on the primary amines’ accessibility to small 
molecules like water. 
In Figure 34, G3NH2-8PEG1000 is seen to have some PEG chains stretched out to water, 
indicating less interaction with primary amines – compare to G3NH2-16PEG500, for example, 
which has the same number of total repeat units.  From Figure 35 it can be observed that G3NH2-
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8PEG1000 also shows the smallest peak in RDF between Np and OPEG.  These results indicate, 
therefore, that as PEG Mw increases, the fraction of the PEG chain that will be strongly interacting 
with the surface of dendrimer will decrease, and the fraction of PEG that will assume a more 
extended conformation will increase.  Nonetheless, it can be seen from Figure 34 that quite a 
significant amount of the surface is still “covered” by PEG repeat units that interact with the 
primary amines.  It is expected that the PEGylation will impact the zeta potential of this carriers 
through the strong interaction between ether oxygen in PEG and termal NH2 groups that have not 
been modified.  Some experimental studies support that view; decrease in zeta potential is greater 
than expected simply due to substitution of terminal amines by PEG;[315] while other studies have 
suggested a more direct correlation between degree of PEGylation and zeta potential.[316] 
This effect of PEG Mw on the PEG layer microstructure may have great implications on the 
development of active targeting nanocarriers.  First, targeting moieties located at the end of flexible 
PEG chains will have a better change to interact with their receptors in cases when PEG is extended 
out into the bulk aqueous environment compared to those systems where PEG populates the 
vicinity of the dendrimer surface, which will decrease the opportunity for those targeting moieties 
to interact with their receptors.  Secondly, the presence of a PEG layer on the surface may also act 
as a diffuse barrier for the release of therapeutics into the bulk phase after the labile bond 
connecting the dendrimer and the therapeutic is cleaved. 
4.4. Conclusions 
In this work we investigated the microstructure of PEGylated, amine-terminated PAMAM 
dendrimers using molecular dynamics (MD) simulations with fully atomistic models.  We show 
that the proposed force field (FF) for the PAMAM dendrimers is capable of correctly capturing 
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available SAXS and SANS experimental information on their size – Rg.  We also show that G4NH2 
and G5NH2 have a “segmented opened” structure that allows for the primary amines to locate close 
to the dendrimer core, without “back-folding”.  We provide here an alternative view to the concept 
of back-folding in protonated PAMAM dendrimers.  Our results point to a thermodynamically 
favorable structure where primary amines may reside close to the core, and are yet on the 
dendrimer’s surface, a configuration that can be assumed in such segmented open structures 
observed here.  These results can be reconciled with experimental SANS/SAXS studies and yet 
represent a thermodynamically favorable conformation.  Primary amines for G2NH2-G5NH2 are 
shown to reside in outer shells, and their solvation peaks remain the same.  PEGylation was found 
to influence the microstructures in many ways, including an increase in the overall size of the 
DNCs, while not affecting much the solvation of unmodified terminal (primary) amines.  PEG at 
low densities are shown to form a thick layer that closely interacts with the surface of the dendrimer, 
providing a “barrier” that may impact the release profile of conjugated/adsorbed therapeutics, and 
how these nanocarriers interact with the physiological environment.  The microstructure of PEG 
can be dramatically altered by modifying the number of grafts while keeping the overall number 
of PEG units constant.  Grafting of 8PEG1000 to G3NH2 produces a coat that partially extends out 
into the aqueous phase, while 16PEG500 grafts are more collapsed onto the surface of the 
dendrimer.  This will have great implications on the use of PEG as a flexible linker to targeting 
moieties.  The understanding of such microscopic structural information of PAMAM dendrimers 
has great implications in terms of the design of such carriers for drug and gene delivery and 
imaging applications. 
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CHAPTER 5 
THE CHEMISTRY OF THE TERMINAL SURFACE GROUPS OF PAMAM 
DENDRIMERS DETERMINE THE MICROSTRUCTURE OF THE GRAFTED PEG 
LAYER 
5.1. Introduction 
Dendrimers are synthetic hyperbranched polymers, characterized by high size uniformity, low 
polydispersity, and the presence of multifunctional surface groups that are readily modifiable.[317-
319]  These characteristics make dendrimers very attractive for a variety of potential biomedical 
applications, including as nanocarriers for drug and gene delivery, and as imaging agents.[317, 
320-322]  Poly(amido amine) (PAMAM) dendrimers are one of the most studied dendrimer 
nanocarriers (DNCs).  PAMAM dendrimers contain an alkyl-diamine core and tertiary amine 
branching points.[298]  Because of their structure, PAMAM dendrimers contain a large number 
of surface groups per molecular volume.[323]  Their surface groups can be neutral (e.g. hydroxyl 
– OH),[324] cationic (e.g. amine-terminated – NH2) or anionic (e.g. carboxyl – COOH),[317, 325, 
326] and the number of surface groups and overall size (molar mass) can be precisely controlled 
by varying their generation (G). 
There are several strategies for loading the therapeutic cargo onto PAMAM DNCs.  
Biomacromolecules such as DNAand RNA,[327] as well as small molecules can be complexed 
with DNCs via electrostatic interactions.[328, 329]  The therapeutic cargo can also be 
‘encapsulated’ in the DNCs through hydrophobic interactions.  Finally, drug molecules can be 
conjugated to DNCs through the formation of labile covalent bonds, for improved spacial and 
temporal drug release resolution.[330-332]  Besides the loading of the therapeutic cargo, there are 
many advantages in modifying the DNCs with ligands in order to improve their interaction with 
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the physiological environment, and thus improve the pharmacokinetic profile of the 
therapeutics.[333]  For example, arginine can be conjugated to PAMAM dendrimer to achieve 
enhanced gene transfections efficiency,[322] triphenylphosphonium can be conjugated to 
PAMAM dendrimer to target mitochondria,[302] folate can be conjugated to PAMAM dendrimer 
to target tumor cells that over express folate receptors.[334]  PEG is a particularly popular ligand 
that is widely used to impart special characteristics to DNCs.  PEG can help protect payload, 
improve biocompatibility of the carrier, decrease the rate of elimination form systemic circulation, 
modulate the transport across cellular barriers and also serve as a flexible linker between dendrimer 
and targeting moieties that can be used to better present ligands and promote targeting.[335-338] 
The microstructure of the DNCs is crucial to their functions.  They impact on the 
loading/encapsulation/conjugation (chemistry) of the therapeutic cargo, and how the DNCs 
interact with the physiological environment, and thus with their effectiveness as drug delivery 
carriers.[339]  The chemistry of the surface terminal groups of DNCs in turn are expected to impact 
the structure of the DNCs as they are not only directly exposed and thus solvated by the 
physiological aqueous environment surrounding the carrier, but also control the balance of 
hydrophobic forces of the core (that tend to collapse the dendrimer structure) to repulsive 
(solvation, electrostatic repulsion or steric) forces of the terminal surface groups.  The structure of 
DNCs can be to some extent assessed through small angle neutron scattering (SANS)[242, 340] 
or small angle x-ray scattering (SAXS).[277]  However, there are certain limitations as to the 
extent of the microstructure that can be probed with those experimental techniques, and 
computational studies such as molecular dynamics (MD) simulations can provide atomistic-level 
information of the carriers, and thus serve as complementary tool to understand the microstructure 
of DNCs. 
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In light of the opportunities for PAMAM dendrimers discussed above, and the relevance of 
their structure in biomedical applications, in this work we probe the effect of the chemistry of the 
terminal surface groups of PAMAM dendrimers on their microstructure using MD simulations.  
We study three dendrimers with the same generation but varying the chemistry of the surface group: 
G3OH, G3NH3
+, and G2.5COO-.  We also study the effect of conjugating PEG of 1000 Mw 
(PEG1000) onto the dendrimer surface, on the microstructure of the nanocarriers.  We report 
results in terms of experimentally accessible variables, such as radius of gyration (Rg), and 
compare those with available experimental and computational information.  We also discuss the 
microstructure of the solvent environment around the dendrimers, so as to understand the 
accessibility of primary functional groups to water molecules, or interactions between dendrimer 
terminal groups and PEG chain.  Results are discussed form a drug / gene delivery perspective, 
that is, how the accessed microstructure information may impact the dendrimer as drug delivery 
carriers. 
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5.2. Methods and Models 
All molecular dynamics (MD) simulations in our study were performed remotely on Kraken 
using NAMD 2.8.[264]  The systems were visualized using VMD2.9.[265]  The all-atom (AA) 
force field (FF) for the PAMAM dendrimers were developed from a combination of CHARMM 
35 FF,[341, 342] and ab initio calculations performed in our laboratories.  Bond distance, bond 
angle, dihedral, and van der Waals (vdW) potential parameters were from CHARMM 35 FF, while 
ab initio calculations were used to adjust the charge distribution within amido amine monomers.  
The terminal amines and carboxyl groups of dendrimers studied in this work are fully ionized to 
NH3
+ and COO-, thus representing physiological conditions.[343-345]  Gaussian 09 was used at 
the MP2 level of theory and 6-31g(d) basis set for structural optimization of amido amine 
monomers.[164]  We optimized for a fragment larger than a single amido amine monomer in the 
ab initio study to ensure that every atom in a single amido amine monomers is in a bonding 
environment that is similar to being in a dendrimer. Charge distributions were obtained from the 
CHELPG analysis.[346]  Charge distribution of the residues were adjusted to achieve the realistic 
overall charge of the dendrimers in physiological condition, while maintaining those charges as 
close as possible to the original CHARMM 35 FF.  The CHARMM 35 FF (C35r) was used for 
PEG.[347]  The CHARMM TIP3PM FF was used as the water model for it has been shown to 
give reasonable structural and energetic results for pure water,[271] and is optimized for the 
CHARMM FF being used to treat the PAMAM dendrimers and PEG.  We use the notation TIP3P 
(instead of TIP3PM) for now on for simplicity.  32 Cl- ion were added to the solvation box in the 
system containing the amine-terminated dendrimers in order to neutralize the 32 NH3
+ groups 
present at physiological pH.  Similarly, 32 Na+ ions were added to the solvation box in order to 
neutralize the 32 COO- groups present in the carboxyl terminated dendrimers at physiological 
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conditions.  Because G3OH is neutral at physiological pH, 16 Cl- and 16 Na+ were added to 
solvation box in order to achieve similar ionic strength to G3NH3
+ and G2.5COO-.  The FF for 
ions (Na+ and Cl-) are from CHARMM 35.  Further detail of the FF for G3OH and G3COOH can 
be found in supplemental information.  The FF for NH2-terminated PAMAM dendriemr has been 
published by our group recently and is not repeated here.[348]  
All simulations were performed in the isobaric-isothermal (NPT) ensemble at 298 K and 1 atm.  
Langevin thermostat and Langevin piston were used to maintain the desired temperature and 
pressure.[349]  A 1 fs step length was used to conserve energy.  A cutoff of 12 Å was applied for 
both vdW and electrostatic interactions.  The vdW interactions were smoothly shifted to 0 from 10 
to 12 Å, and the real part of electrostatic interactions was smoothly shifted to 0 from 0 to 12 Å.  
Particle mesh Ewarld (PME) was used to compensate for long-range electrostatic interactions.  
Periodic boundary conditions (PBC) were used in all directions.[350]  The solvation boxes were 
carefully built such that PAMAM dendrimers or PEGylated PAMAM dendrimers did not see their 
own PBC copy, thus mimicking the desired infinite dilute solution of the dendrimers.  The initial 
coordinates of the dendrimers were generated using GaussView 5.0.[351]  A 20 ps minimization 
was performed to eliminate bad contacts in vacuum, and then the solvation (water) box was added 
to the system to equilibrate the solvated structures.  The simulations were run for 27 ns.  Statistics 
were taken from the last 2 ns of the runs. 
5.3. Results and discussions 
5.3.1. Effect of terminal chemistry on size and shape of generation 3 PAMAM 
dendrimers 
5.3.1.1. . Effect of terminal groups chemistry on the size of PAMAM dendrimers.  In order 
to understand the effect of the chemistry of the terminal surface groups of the PAMAM dendrimers 
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on their size, we determine the radius of gyration (Rg) of the G2.5COO
- and G3OH nanocarriers.  
The results for G3NH3
+ have been reported in our previous work.[348]  Rg can be used to quantify 
the size of non-spherical objects, and it is also a relevant quantity to ascertaining the 
appropriateness of the all atom (AA) FFs proposed in this work as it can be directly compared to 
experiments such as small angle neutron scattering (SANS) and small angle x-ray scattering 
(SAXS) when available, or to previous simulation works.[242, 243, 248, 257, 340]  Moreover, 
knowledge of the size of the dendrimers is of great importance as it is one of the key properties 
that determines their potential applicability, as is the case in the selection of dendrimers as 
nanocarriers for drug delivery applications. 
The Rg for a dendrimer with N atoms is given by 
𝑹𝒈
𝟐 =
𝟏
𝑴
∑ [𝒎𝒌(𝒓𝒌 − 𝒓𝒎𝒆𝒂𝒏)
𝟐]𝑵𝒌=𝟏        Equation 7 
where rmean denotes the center of the dendrimer, (rk-rmean) denotes the distance of the kth atom 
from the center, mk denotes the mass of the dendrimer.  The evolution of Rg for the G3 PAMAM 
dendrimers as a function of the chemistry of the terminal surface groups are shown in Figure 36. 
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Figure 36. Time course of the radius of gyration (Rg) of generation 3 PAMAM dendrimers as a 
function of the chemistry of the terminal surface group.  Average Rg’s were calculated from the 
last 10 ns of equilibration.  NPT ensemble - 298K and 1 atm 
 Rg of G3NH3
+reported in our MD simulation not only is about average of those reported from 
all-atom model molecular dynamics simulations (10.4-19.7Å), but is also in close agreement with 
those reported from SANS and SAXS (14.7-16.5Å).  While there is no experimental SANS or 
SAXS Rg results for G3OH or G2.5COO
-, the close agreement between the experimental results 
and computational Rg values observed for G3NH3
+, whose FF was the same except for terminal 
monomers, suggesting the appropriateness of the FF.  It can be seen from Figure 36 that the Rg 
for G2.5COO- is the smallest, as expected, due to its half generation.  G3OH has an Rg = 12.6Å, 
which is larger than that for C2.5COO- (Rg = 11.7Å), but significantly smaller than the Rg of 
15.0Å found for G3NH3
+ that has a similar MW.  Because of the absence of surface charges that 
should balance the cohesive forces of the surface groups on the center of the dendrimer, G3OH is 
significantly more collapsed than G3NH3
+.[348] 
15.0 Å
12.6 Å
11.7 Å
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5.3.1.2.  Effect of terminal groups chemistry on the shape of PAMAM dendrimers.  Screen 
shots of the equilibrium configurations of the different dendrimer structures are shown in Figure 
37. 
 
Figure 37. Snapshots of equilibrium conformations of generation 3 PAMAM dendrimer as a 
function of the chemistry of the terminal surface group.  Atoms represented as VDW spheres.  
Snapshots of starting configurations are those taken after 20 ps of initial minimization.  
Equilibrium configurations are snapshots taken after 27 ns simulation time.  Solvated (water) 
systems at 298K and 1 atm.  Water and Cl- / Na+ ions were removed from the snapshots to improve 
visualization of the dendrimers.  
 
Further examination of the screenshots indicates that G3NH3
+ and G2.5COO- assume a less 
dense packed structure when compared with G3OH.  Again, this comes from the fact that G3NH3
+ 
and G2.5COO- have charged terminal groups, giving rise to electrostatic repulsive forces that are 
able to prevent the core from collapsing, and consequently from assuming a more dense packed 
structure.  Another effect of the charged terminal groups on the shape of the dendrimers is that, in 
an effort to enlarge average distances between charged terminal groups, the charged dendrimers 
G3NH3
+
+32e
G3OH
0e
G2.5COO-
-32e
Equilibrate
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will try to maximize surface areas, and assume a non-globular structure, which has been described 
in the literature as “open” structures.[348] 
The conformation of the PAMAM dendrimers is of great relevance with respect to their drug 
and gene carrier ability.  During drug conjugation (via covalent bond) and complexation (via 
electrostatic forces) to load drug / gene onto dendrimer nanocarriers, it is most likely for the drug 
/ gene to be trapped into “opening” of G3NH3+ and G3COO-.  Because by doing this, drug / gene 
will create the most contacts with surface groups of dendrimers, which maximize the electrostatic 
interactions or the chance to form covalent bonds.  In terms of using dendrimers as drug carriers 
upon complex formations with therapeutic molecules, the “open” structure observed for G3NH3+ 
and G2.5COO- suggest that the use of the term “encapsulation” is somewhat misleading as no true 
“cavity” is present.  The concept of an opening vs. cavity has been also discussed in the light of 
experimental SANS results.[348] 
5.3.2.  Different terminal groups will lead to different microstructure of PEGylated 
DNCs 
5.3.2.1.  The chemistry of terminal surface groups greatly affects their location.  The 
surface chemistry of the PAMAM dendrimers is of relevance in drug delivery applications, as 
those characteristics will greatly influence how the nanocarriers interact with the physiological 
environment, and thus dictates various aspects of the efficacy and efficiency of dendrimer 
nanocarriers.  The location of the terminal groups also impacts the ability to transform those 
surface groups, which is necessary in order to conjugate the therapeutic cargo and other ligands. 
There has been a great deal of interest in understanding the location of terminal groups of 
PAMAM dendrimers.[276, 352, 353]  While earlier reports suggested that the terminal amines of 
PAMAM would fold back into the core of the dendrimer,[276, 354, 355] our recent studies indicate 
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that there is no “back-folding” observed for NH2-terminated PAMAM from G2-G5.[348]  These 
studies were reconciled with experimental SANS and SAXS results that show terminal amine 
groups close to the core,[340] by demonstrating that the dendrimers have opened structures where 
ionized groups can remain close to the core and yet be fully solvated by the aqueous environment. 
Here we discuss the effect of the chemistry of the terminal surface-groups on their position.  In 
Figure 38, equilibrium conformation of all the three dendrimers are shown.  The terminal surface 
groups (N for NH3
+, O for OH, ether O for COO-) are labeled as yellow vdW spheres and inner 
branching amines are labeled as blue vdW spheres.  All other atoms and bonds are represented by 
colored lines.   
 
Figure 38. Snapshots of equilibrium conformations of generation 3 PAMAM dendrimer as a 
function of the chemistry of the terminal surface group after 27ns simulation time.  Heavy atoms 
from terminal groups of PAMAM dendrimer are shown in yellow VDW spheres, branching amine 
atoms are shown in blue VDW spheres.   
Through this qualitative representation, it can be seen that no “back-folding” is seen for 
G3NH3
+ or G2.5COO-, while for G3OH, some of the terminal groups do seem to insert themselves 
into the inner structures of the dendrimer.  A study of the solvation profile of terminal groups can 
quantify the effect of terminal groups’ back-folding of G3OH.  
G3NH3
+
+32e
G3OH
0e
G2.5COO-
-32e
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Figure 39. RDF of heavy atoms of terminal groups (terminal N for G3NH3
+, terminal O for 
G3OH, terminal ether O for G2.5COO-) to O atom of H2O. 
We have discussed in earlier publications that, there is no back-folding of terminal primary 
amines for G2NH3
+-G5NH3
+.  And this conclusion is based on the fact that terminal primary 
amines of G2NH3
+-G5NH3
+ all have clear water solvation single peak.  It can be seen from Figure 
39 that, G3NH3
+ and G2.5COO- both have clear water solvation single peak, suggesting there is 
no back-folding of terminal groups of G2.5COO-.  Which is reasonable as it will be 
thermodynamically unfavorable for charged terminal groups to insert themselves into PAMAM 
dendriemr core which is hydrophobic.  While for G3OH, there is not a sharp and clear first 
solvation peak.  Instead, the first peak split into two neighboring bumps.  Two bumps means not 
all terminal groups are in identical solvation environment, and the only logical explanation is that 
there is back-folding of terminal groups for G3OH.  
Given that the inner branching monomers of all three PAMAM dendrimers are identical, the 
difference between locations of terminal groups can only be attributed to the difference of terminal 
chemistry.  In the absence of electrostatic repelling forces, G3OH collapses into a “globular” 
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structure, which has minimum surface area for that fixed volume.  This leads to the back-folding 
of some of the terminal groups.  Because the terminal group of G3OH (OH) is not charged at 
physiological pH, it is thermodynamically more acceptable that they are inserted into the 
hydrophobic core of the PAMAM dendrimer. 
5.3.3. Effect of PEGylation on microstructures of PAMAM dendrimers with 
different terminal chemistry 
In order to better discuss the effect of PEGylation, we focus on two issues that are 1) PAMAM 
dendrimer terminal chemistry’s effect on PEG layer and 2) PEG chain’s effect on microstructures 
of PAMAM dendrimer.  DNC will be used to refer to PEGylated PAMAM dendrimers (including 
PEG part), while G3NH3
+, G3OH, G2.5COO- will be used to refer to un-pegylated PAMAM 
dendrimers, PAMAM dendrimer core will be used to refer to dendrimer part of the pegylated 
PAMAM dendrimers. 
5.3.3.1.PAMAM dendrimer terminal chemistry’s effect on PEG layer 
There are several benefits in PEGylation of dendrimers.  PEG can increase solubility of the 
DNC, modulate release profile, reduce cytotoxicity of DNC and serve as flexible linker to better 
present targeting ligands to their receptors.  All those benefits PEG has to offer are associated with 
PEG layer’s microstructure – they are dependent on the right amount of PEG layer formation, right 
density of PEG attached, and right length of conjugated PEG chain. 
In this study, PEGylation is seen to have significantly different microstructures based on 
different terminal chemistry.  As we can see from Figure 40 that for G3NH2, PEG seem to be quite 
collapsed and tend to insert themselves into dendrimer opening.  For G3OH, PEG chains are quite 
extended while for G3COOH, PEG chain is even more extended. 
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Figure 40. Snapshots of the equilibrium configurations of PEGylated G3 PAMAM dendrimers as 
a function of the chemistry of the terminal surface group.  All dendrimers at a constant grafting 
density of 8 PEG, Mw. 1000.  Dendrimer atoms represented in red and PEG atoms in yellow VDW 
spheres. Equilibrium configurations are snapshots taken after 27 ns simulation time.  Solvated 
(water) systems at 298K and 1 atm.  Water and Cl- / Na+ ions were removed from the snapshots to 
improve visualization of the dendrimers.  
Terminal groups’ effect on PEG microstructure is not discussed before, but it was reported 
previously that for G2-G5 NH2 terminated PAMAM dendrimers, conjugated PEG chain all adhere 
to the surface or opening of the dendrimers.[348]  The collapsed PEG microstructures have great 
implications in the development of active targeting nanocarriers.  First, targeting ligands located 
in the end of flexible PEG chains most likely will be buried in PEG chains within dendrimer 
opening, which will have much less chance to interact with their receptors compared to those with 
PEG extended to bulk physiological environment, and thus the DNCs’ function of targeting is 
compromised.  Also, the presence of a PEG layer adheres to the surface / opening of dendrimers 
will create a diffuse barrier for the release of payload inside DNCs, thus modulating the release 
profile of the DNC.  G3NH2 is thus expected to have a significant different behavior upon 
PEGylation concerning ease of conjugation, solubility enhancement upon PEGylation, release 
profile and toxicity profile when compared with G3OH and G3COOH.   
G3NH3
+-8PEG1000 G3OH-8PEG1000 G2.5COO--8PEG1000
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While Figure 40 depicts qualitatively the microstructures of PEG that are conjugated to 
PAMAM dendriemrs, MD study also enable us to use more atomic scale tools to study 
quantitatively the interactions between terminal groups of PAMAM dendrimer and PEG chian.   
Figure 41 shows the integrated radial distribution function (RDF) between heavy atoms of 
terminal groups of PAMAM dendrimers to the heavy atoms of PEG chain (O).   
 
Figure 41. Solvation profile of primary functional of G3 PAMAM dendrimers by water.  Solvation 
profile before and after PEGylation.  (a) NH3+ terminated  (N atom), (b) OH terminated (O atom), 
(c) COO- terminated (ether O atom).  
It can be seen from Figure 41 that, in each layer of a certain distance to heavy atoms from 
terminal group of PAMAM dendrimers - N atoms from terminal groups of G3NH2 has most O 
from PEG, which means G3NH2 terminal groups interact the most with PEG chain, while 
G3COOH terminal groups interact the least with PEG chian.  It was proposed before that the 
collapse of PEG chain for PEGylated NH2 terminated PAMAM dendrimer is caused by 
electrostatic interactions between positively charged NH2 groups from PAMAM dendrimers and 
negatively charged O atom from PEG chain.  Terminal chemistry of PAMAM dendrimers’ effect 
on PEG microstructure observed in this study confirmed again that positively charged terminal 
groups (NH3
+) will interact strongly with PEG chain.  Although PEG is neutral in physiological 
pH, but the O atom in PEG chain carry a negative partial charge that is known to be enough for 
strong electrostatic interactions like hydrogen bond.[356]   
(a) (b) (c)
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It is clear from Figure 41 that PEG interacts strongly with positively charged NH3
+ terminal 
group when compared with OH terminal group, and the electrostatic interactions forces will have 
significant effect on PEG’s microstructures (more collapsed) as shown in Figure 40.  While it is 
also observed from Figure 5 that negatively charged COO- terminal group interact less with PEG 
chain when compared with OH terminal group, no significant effect on PEG’s microstructures can 
be seen from Figure 40.  The effect of the difference between COO- and OH seen in Figure 41 
will be seen on microstructures of PAMAM dendrimers (sec. 3.3.2).   
5.3.3.2. Effect of PEGylation on PAMMA dendrimers’ microstructure 
Terminal group chemistry of PAMAM dendrimers will affect microstructures of PEG, and 
PEG will also affect microstructures of PAMAM dendrimers to which it is conjugated in multiple 
ways.  By conjugating a PEG chain onto one terminal group of charged PAMAM dendrimers 
(G3NH3
+, G2.5COO-), the charge associated with that terminal group will be eliminated in this 
process.  Less charge leads to less electrostatic repelling forces, which will affect size and shape 
of PAMAM dendrimer.   
PAMAM dendrimers’ structure can be seen as a hydrophobic core shelled by hydrophilic 
terminal monomers.  The hydrophilic shell becomes more hydrophilic upon PEGylation, which 
will serve to stretch the inner hydrophobic core more toward water.  Upon PEGylation, terminal 
groups will no longer reside in the outer shell of dendrimers.  This could have a few effects on 
DNC’s functions.  One of the major effects is that PEG layer will change the way terminal groups 
are presented to physiological environment.   
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Figure 42. Integral of the radial pair distribution function (RDF) of the terminal heavy atoms (N 
for NH3+, O for OH, O for COO-) of G3 PAMAM dendrimers to oxygen (O) atoms of the PEG 
chain.  
 
As can be seen from Figure 42, PEGylation will change water accessibility of terminal group 
for all three dendrimers.  It is not surprising to see that for G3NH3
+ and G3OH, PEGylation cut 
down the water accessibility of terminal groups.  By surrounding PAMAM dendrimers they 
conjugated to, PEG will limit to some extent water accessibility naturally.   
But for G2.5COO-, water accessibility of terminal groups is found to be slightly increased after 
PEGylation as shown in Figure 42.  This is related to the change in microstructures of G2.5COO- 
after PEGylation.  Because G2.5COO- has the least interaction with PEG chain, one effect is that 
PEG chain is stretched into water rather than closely surrounding G2.5COO-, so G2.5COO- is 
minimally shielded by the existence of the PEG layer.  Another effect is that G2.5COO- is stretched 
by PEG chain to a “star” shaped conformation.  During this microstructure transformation, 
terminal groups’ local environment is changed from being presented next to a surface to being 
presented as the end of a branch of the “star”.  Geometrically being in the end of a branch of the 
“star” will have more accessibility to water.   
G3NH3
+
G3OH
G2.5COO-
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The start shape of PEGylated G2.5COO- will also have profound effect on DNCs’ efficacy and 
efficiency in drug delivery.  G2.5COO--8PEG1000 thus can benefit the most from PEG’s solvation 
enhancement, while still present modifiable terminal groups quite well when compared to G3NG3
+.  
This could make a huge difference when it comes to certain applications where payload needs to 
be conjugated to PAMAM dendrimer terminal groups after PEGylation.  For example, in order to 
conjugate both payload and PEG onto terminal groups of PAMAM dendrimers, it is desirable to 
have PEG first conjugated just to minimize the exposure of the payload to reactions.  Also for 
some payload which carries charge, it is hard for chemical reactions to happen because electrostatic 
forces will either be attractive and help to form strong complex or to repel.  So it is also important 
that PEG be conjugated first so to decrease zeta potential of PAMAM dendrimers.  
The interactions between PEG and dendrimers are also reflected by size.  Dendrimer terminal 
chemistry’s effect on microstructures of PEG chain can be seen from Rg of PEGylated PAMAM 
dendrimers.  PEG chains’ effect on PAMAM dendrimers’ microstructure can be seen from Rg of 
the dendrimer part of PEGylated PAMAM dendrimers.  Rg calculated from different part of DNCs 
are demonstrated and summarized in Table 1.  
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Table 13 Radius of gyration (Rg) of equilibrated DNCs.  For PEGylated PAMAM dendrimers, 
Rg of the whole molecule as well as Rg of the dendrimer part of the molecule (PEG chain 
excluded) were calculated and compared. 
 Rg(Å) G3NH3+ G3OH G3COO-  
 
Dendrimer without  
pEGylation 
15.0±0.9 12.6±0.8 11.7±0.8  
 
PEGylated dendrimer 17.3±0.2 22.2±0.6 29.5±1.1  
 
Dendrimer part of  
pEGylated dendrimer  
15.3±0.2 13.9±0.5 14.0±0.6  
It is not surprising to see that PEGylated G3 PAMAM dendrimers are bigger than un-
PEGylated G3 PAMAM dendrimers.  Different terminal chemistry will affect microstructures of 
PEG layer, and this can also be reflected by their Rg increase upon PEGylation.  For G3NH3
+, Rg 
increases only 2.28 Å (from 15.0 Å to 17.28 Å) upon PEGylation.  While for G3COO-, Rg increases 
17.77 Å upon PEGylation (from 11.7 Å to 29.5 Å) (Table 13).   
PEG will have three major effect on size of dendrimer part of the conjugate.  PEG is well 
solvated by water, and this solvation provides an outward force pull on the dendrimer part, which 
results in the swelling of the dendrimer part inside.  Also for charged PAMAM dendrimers like 
G3NH3
+ and G2.5COO-, every PEG chain conjugated will neutralize 1 charged site from the 
terminal groups and decrease electrostatic forces, which results in the shrinking of the dendrimer 
part inside.  The third effect is that PEG interacts with PAMAM dendrimers, and PEG layer’s 
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microstructure will greatly change the way how its solvation force can serve to pull the dendrimer 
core outward. 
We can see from Table 1 that dendrimer part of G3NH3
+-8PEG1000 (15.3Å) does not show 
much difference in size from G3NH3
+ (15.0Å), which means the swelling effect from solvation 
force provided by PEG is similar in magnitude to the shrinking effect from less electrostatic force 
by conjugation of PEG.  The dendrimer part of G2.5COO--8PEG1000 (14.0) is significantly bigger 
than the size of G3COO-(11.7).  Although the neutralization of charged terminal groups and the 
length and number of PEG chain is the same for both G3NH3
+-8PEG1000 and G3COO—
8PEG1000, PEG’s microstructure is quite different.   
The difference can be attributed to different microstructures of PEG layer for G3NH3+ and 
G2.5COO-.  As mentioned above, PEG conjugated onto G3NH3
+ has the most collapsed 
microstructure which contributes to least increase in Rg upon PEGylation, and PEG conjugated 
onto G2.5COO- has the least collapsed microstructure.  The less collapsed PEG microstructure 
contribute to the much bigger outward pulling force for dendrimer part of G3COO—8PEG1000, 
thus contribute to the biggest increase in Rg upon PEGylation.  
5.4. Conclusionsions 
In this work, we investigated the microstructures of generation 3(or 2.5) PAMAM dendrimers 
of different terminal chemistry, and how PEG affect their microstructures differently.  Due to 
surface charge at physiological condition, G3NH3
+ and G3COO- assume a less dense packed, 
“open” microstructure.  With no surface charge at physiological condition, G3OH has a more 
densely packed microstructure.  The difference in microstructure can be reflected on the solvation 
profile of heavy atoms from terminal groups of PAMAM dendrimers, which is critical for 
PAMAM dendrimers’ biomedical applications.  O atom in PEG chain has negative partial charges 
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that are capable of strong electrostatic interactions.  And as a consequence, PEG conjugated to 
positively charged G3NH3
+ has the most collapsed microstructures while PEG conjugated to 
negatively charged G3COO- has the least collapsed microstructures.  Terminal groups chemistry 
will affect PEG layers’ microstructures, and PEG layers’ microstructures also will affect PAMAM 
dendrimers to which it is conjugated.  PEGylation can change the way terminal groups’ water 
accessibility, and thus PAMAM dendrimers’ behavior in biomedical applications.  PEG can serve 
to swell the dendrimer part by solvation force pulling outward, and to shrink the dendrimer part 
by decrease electrostatic forces.  G3NH3+-8PEG1000 has the least increase in Rg of dendrimer 
part compared with G3NH3
+ because the more collapsed PEG chain provide less solvation force 
pulling outward.  G3COO- has the most increase in Rg of dendrimer part when compared with 
G3COO- because it has the least collapsed PEG chain, thus the most solvation forced pulling 
outside from PEG chain.  
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CONCLUSIONS 
In Chapter one we studied the solvation of relevant tail fragments in HFO-1234ze using ab 
initio calculations.  The chemistries investigated are representative of additives of interest to the 
various industries where HFOs may find use as working fluids.  The tail fragments were selected 
to allow us to systematically probe the effect of both polarity and structure (degree of branching) 
on their solvation by HFOs.  Binding energies between the HFO-1234ze solvent (s) and the tail 
fragment (t) (Eb
st) indicate that the more polar ether- (EO and PO) and ester-based fragments (GA, 
LA and TMGA) are well-solvated by HFO-1234ze with Eb
st’s of ca. -20 kJ.mol-1.  The non-polar 
alkane-based fragments (C5 and ISO) are not solvated to the same extent, with Eb
st’s of ca. -9 
kJ.mol-1.  However, polarity alone cannot be used to predict or discriminate which of the polar 
groups are best solvated.  The self-interaction between the tail fragments (Eb
tt) is used to determine 
a quantity termed the Enhancement Factor (Eenh), which is defined as the ratio between Eb
st / Eb
tt .  
Based on this definition, the Eenh is expected to be a better predictor of the solvation of a particular 
fragment compared to Eb
st alone, and can be used to further discriminate the effect of fragment 
chemistry/structure on their solvation.  Because the interaction between GA-GA is much stronger 
than that between EO-EO, the Eenh for the EO is much greater – the largest from all investigated 
fragment at Eenh = 1.30.  This quantity, Eenh, thus allow us to further discriminate solvation in HFO.  
Different from polarity, the branching of the tail chemistry is seen to have little effect on Eb
st.  
However, at high enough branching densities, it can significantly impact tail-tail interaction.  
While Eb
tt for GA-GA (no CH3 pendant group) is > -25 kJ.mol-1, that for TMGA-TMGA (two CH3 
pendant groups) is ca. -15 kJ.mol-1.  Branching can serve to reverse the trend in Eenh.  While for 
GA (no branching) and LA (one methyl pendant group) Eenh is less than one; that for TMGA (two 
methyl pendant groups) Eenh is greater than one (1.27), and very close to that for EO.  These results 
suggest that the structure of the tail fragment will also have a significant impact in its solvation, 
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along with the polarity.  We also determined that the solvation in HFO-1234ze is similar to that of 
a working fluid currently being used in the industry, the HFA-134a.  In summary, the results shown 
here provide information that can be utilized to further evaluate the potential of this new generation 
of greener working fluids, the HFOs, in replacing the HFAs. 
In Chapter 2 we used a combined computational and experimental approach to rationally 
design surfactants for the HFO-1234ze|H2O interface.  A recently developed 12-6LJ FF for HFO-
1234ze was shown to quantitatively predict the experimental surface tension of HFO-1234ze as a 
function of temperature, thus establishing the relevance of the model to interfacial systems.  MD 
results for the tension of HFO-1234ze|SPC/E H2O interface (40.9mN.m
-1) was shown to be also 
in quantitative agreement with the experimental value obtained in this work (41.9mN.m-1) using a 
high-pressure pedant drop tensiometer.  MD simulations were then used to understand the behavior 
of non-ionic (EO-based) surfactants with tail chemistries of systematically varying polarity: CH 
(EO-CH); PO (EO-PO) and LA (EO-LA).  The interfacial tension and structural information from 
MD simulations of the surfactant-modified interface provided a microscopic view to understand 
the surfactant effect, and to screen the most appropriate tail chemistry.  The EO-PO surfactant was 
found to be the most active at the HFO-1234ze|H2O interface, with an interfacial tension reduction 
of 28.7 mN.m-1.  Once the best chemistry was identified, MD simulations were used to determine 
the optimum surfactant balance; i.e. the ratio of the EO head-group to PO tail-group that would 
reduce the tension of the interface the most, which is defined as the hydrophilic-to-HFO-philic 
balance (HFB).  The HFB was determined to be located at ca. 62wt.% EO.  The trend in tension 
vs. wt.%EO from the MD results are in good agreement with the experimental values found for 
the tri-bock EO-PO-EO, with the observed differences being attributed to the difference in 
structure of the two surfactant classes and in the MW.  The experimental HFB for EO-PO-EO was 
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found to be at ca. 45 wt.%EO.  The low tension values obtained for the surfactants close to the 
optimum balance suggest that they are capable of forming emulsions and potentially 
microemusisons of systems involving HFO-1234ze and water.  The relevance of this work stems 
from the fact that this is the first time that the properties of the bare and surfactant modified HFO-
1234ze|H2O interface has been reported – either experimental or computational results.  In 
summary, the results suggest HFO-1234ze may be a suitable alternative to HFAs in the formation 
of aerosols containing dispersions of water and HFO-1234ze for medical applications. 
In Chapter 3 we investigated the microstructure of PEGylated, amine-terminated PAMAM 
dendrimers using molecular dynamics (MD) simulations with fully atomistic models.  We show 
that the proposed force field (FF) for the PAMAM dendrimers is capable of correctly capturing 
available SAXS and SANS experimental information on their size – Rg.  We also show that G4NH2 
and G5NH2 have a “segmented opened” structure that allows for the primary amines to locate close 
to the dendrimer core, without “back-folding”.  We provide here an alternative view to the concept 
of back-folding in protonated PAMAM dendrimers.  Our results point to a thermodynamically 
favorable structure where primary amines may reside close to the core, and are yet on the 
dendrimer’s surface, a configuration that can be assumed in such segmented open structures 
observed here.  These results can be reconciled with experimental SANS/SAXS studies and yet 
represent a thermodynamically favorable conformation.  Primary amines for G2NH2-G5NH2 are 
shown to reside in outer shells, and their solvation peaks remain the same.  PEGylation was found 
to influence the microstructures in many ways, including an increase in the overall size of the 
DNCs, while not affecting much the solvation of unmodified terminal (primary) amines.  PEG at 
low densities are shown to form a thick layer that closely interacts with the surface of the dendrimer, 
providing a “barrier” that may impact the release profile of conjugated/adsorbed therapeutics, and 
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how these nanocarriers interact with the physiological environment.  The microstructure of PEG 
can be dramatically altered by modifying the number of grafts while keeping the overall number 
of PEG units constant.  Grafting of 8PEG1000 to G3NH2 produces a coat that partially extends out 
into the aqueous phase, while 16PEG500 grafts are more collapsed onto the surface of the 
dendrimer.  This will have great implications on the use of PEG as a flexible linker to targeting 
moieties.  The understanding of such microscopic structural information of PAMAM dendrimers 
has great implications in terms of the design of such carriers for drug and gene delivery and 
imaging applications. 
In Chapter 4, we investigated the microstructures of generation 3(or 2.5) PAMAM dendrimers 
of different terminal chemistry, and how PEG affect their microstructures differently.  Due to 
surface charge at physiological condition, G3NH3
+ and G3COO- assume a less dense packed, 
“open” microstructure.  With no surface charge at physiological condition, G3OH has a more 
densely packed microstructure.  The difference in microstructure can be reflected on the solvation 
profile of heavy atoms from terminal groups of PAMAM dendrimers, which is critical for 
PAMAM dendrimers’ biomedical applications.  O atom in PEG chain has negative partial charges 
that are capable of strong electrostatic interactions.  And as a consequence, PEG conjugated to 
positively charged G3NH3
+ has the most collapsed microstructures while PEG conjugated to 
negatively charged G3COO- has the least collapsed microstructures.  Terminal groups chemistry 
will affect PEG layers’ microstructures, and PEG layers’ microstructures also will affect PAMAM 
dendrimers to which it is conjugated.  PEGylation can change the way terminal groups’ water 
accessibility, and thus PAMAM dendrimers’ behavior in biomedical applications.  PEG can serve 
to swell the dendrimer part by solvation force pulling outward, and to shrink the dendrimer part 
by decrease electrostatic forces.  G3NH3+-8PEG1000 has the least increase in Rg of dendrimer 
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part compared with G3NH3
+ because the more collapsed PEG chain provide less solvation force 
pulling outward.  G3COO- has the most increase in Rg of dendrimer part when compared with 
G3COO- because it has the least collapsed PEG chain, thus the most solvation forced pulling 
outside from PEG chain.  
We have Chapter 1 and Chapter 2 dedicated to systemically screening and optimization of 
biocompatible moieties for the steric stabilization of suspension formulations in HFO-based 
propellants (Aim #1), by utilizing ab initio calculations, molecular dynamics simulations and high 
pressure tensiometry.  We have Chapter 3 and Chapter 4 dedicated to design PAMAM functional 
dendrimer nanocarriers for the delivery of therapeutics to and through the lungs (Aim #2), by 
studying their microstructures using molecular dynamics simulation.  Those results and 
discussions all contribute to the development of pressurized metered dose inhalers (pMDIs). 
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APPENDIX A: SUPPLEMENTAL INFORMATION FOR CHAPTER 2 
Table S1: Partial charge distribution of the HFA-134a and ester-based tail fragment pairs.  Partial charges 
are obtained at the MP2 level of theory and aug-cc-pVDZ basis set, from geometries optimized at MP2/6-
31g+(d,p).  Change in atom charge (Δ) is relative to the charge of the propellant or tail when not interacting.  
Bold atoms are involved in “strong interactions”, in which O··H or F··H distances < 3 Å.  Atom numbers 
correspond to those shown in Figure 9.  Tail fragments are: glycolic acid (GA), lactic acid (LA), and 
tetramethyl glycolic acid (TMGA). 
 HFA-134a-GA  HFA-134a-LA  HFA-134a-TMGA 
 charge Δ  chage Δ  charge Δ 
H1 0.103 -0.007 H1 0.089 -0.021 H1 0.095 -0.015 
C2 0.057 0.039 C2 0.08 0.062 C2 0.063 0.045 
C3 0.497 -0.037 C3 0.492 -0.042 C3 0.543 0.009 
H4 0.098 -0.012 H4 0.094 -0.016 H4 0.095 -0.015 
F5 -0.215 -0.008 F5 -0.218 -0.011 F5 -0.22 -0.013 
F6 -0.19 0.025 F6 -0.2 0.015 F6 -0.211 0.004 
F7 -0.162 0.014 F7 -0.139 0.037 F7 -0.17 0.006 
F8 -0.188 -0.012 F8 -0.192 -0.016 F8 -0.198 -0.022 
C9 0.146 0.04 C9 0.094 0.014 C9 -0.025 0.03 
H10 0.019 -0.02 H10 0.04 -0.008 H10 0.066 -0.015 
H11 0.064 0.01 H11 0.069 0.011 H11 0.087 -0.005 
H12 0.026 -0.013 H12 0.031 -0.011 H12 0.069 -0.012 
C13 0.773 0.019 C13 0.625 -0.093 C13 0.599 -0.032 
C14 -0.157 -0.045 C14 0.217 0.099 C14 0.359 0.034 
H15 0.046 0.008 H15 -0.037 -0.02 C15 -0.311 0.03 
H16 0.056 0.018 C16 -0.161 0.085 H16 0.057 -0.016 
C17 0.014 0.047 H17 0.049 -0.027 H17 0.067 -0.011 
H18 0.021 -0.008 H18 0.029 -0.027 H18 0.072 -0.001 
H19 -0.007 -0.016 H19 0.028 -0.019 O19 -0.324 0.005 
H20 -0.001 -0.01 O20 -0.403 0.03 O20 -0.521 -0.002 
O21 -0.465 -0.008 O21 -0.505 0.021 C21 -0.245 -0.024 
O22 -0.537 -0.013 C22 -0.268 -0.132 H22 0.032 0 
   H23 0.047 0.023 H23 0.064 0.004 
   H24 0.065 0.032 H24 0.045 0.006 
   H25 0.073 0.025 C25 -0.195 0.026 
      H26 0.028 -0.004 
      H27 0.049 -0.011 
      H28 0.029 -0.01 
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Table S2: Partial charge distribution of the HFA-227 and ester-based tail fragment pairs.  Partial charges 
are obtained at the MP2 level of theory and aug-cc-pVDZ basis set, from geometries optimized at MP2/6-
31g+(d,p).  Change in atom charge (Δ) is relative to the charge of the propellant or tail when not interacting.  
Bold atoms are involved in “strong interactions”, in which O··H or F··H distances < 3 Å.  Atom numbers 
correspond to those shown in Figure 10.  Tail fragments are: glycolic acid (GA), lactic acid (LA), and 
tetramethyl glycolic acid (TMGA). 
 HFA227-GA  HFA227-LA  HFA227-TMGA 
 charge Δ  charge Δ  charge Δ 
H1 0.18 -0.008 H1 0.16 -0.028 H1 0.176 -0.012 
C2 -0.077 0.054 C2 0.015 0.146 C2 -0.019 0.112 
C3 0.566 0.025 C3 0.51 -0.031 C3 0.51 -0.031 
F4 -0.179 -0.011 F4 -0.155 0.013 F4 -0.157 0.011 
F5 -0.192 -0.012 F5 -0.168 0.012 F5 -0.179 0.001 
F6 -0.169 -0.018 F6 -0.176 -0.025 F6 -0.167 -0.016 
C7 0.502 -0.039 C7 0.579 0.038 C7 0.59 0.049 
F8 -0.159 -0.018 F8 -0.194 -0.053 F8 -0.188 -0.047 
F9 -0.154 -0.003 F9 -0.173 -0.022 F9 -0.177 -0.026 
F10  -0.155 0.025 F10 -0.215 -0.035 F10 -0.211 -0.031 
F11 -0.162 0.006 F11 -0.186 -0.018 F11 -0.186 -0.018 
C12 -0.002 0.031 C12 -0.219 0.027 C12 -0.291 0.05 
H13 -0.003 -0.012 H13 0.045 -0.002 H13 0.06 -0.013 
H14 0.027 -0.002 H14 0.045 -0.011 H14 0.059 -0.014 
H15 0 -0.009 H15 0.066 -0.01 H15 0.072 -0.006 
C16 -0.127 -0.015 C16 0.151 0.033 C16 0.0317 -0.2933 
H17 0.049 0.011 H17 -0.021 -0.004 C17 0.626 -0.005 
H18 0.043 0.005 C18 0.651 -0.067 C18 -0.05 0.016 
C19 0.767 0.013 C19 0.08 0 H19 0.088 0.007 
C20 0.164 0.058 H20 0.052 0.004 H20 0.095 0.003 
H21 0.029 -0.01 H21 0.071 0.003 H21 0.078 -0.003 
H22 0.062 -0.002 H22 0.044 0.002 O22 -0.322 0.007 
H23 0.011 -0.028 O23 -0.391 0.042 O23 -0.544 -0.025 
O24 -0.469 -0.012 O24 -0.544 -0.018 C24 -0.262 -0.041 
O25 -0.543 -0.019 C25 -0.147 -0.012 H25 0.076 0.016 
   H26 0.052 0.004 H26 0.046 0.014 
   H27 0.025 0.001 H27 0.047 0.008 
   H28 0.026 -0.007 C28 -0.242 -0.021 
      H29 0.066 0.006 
      H30 0.051 0.012 
      H31 0.041 0.009 
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Table S3(a). Partial charge distribution of the HFO-1234ze and tail fragment pairs.  Partial charges are 
obtained at the MP2 level of theory and aug-cc-pVDZ basis set, from geometries optimized at MP2/6-
31g+(d,p).  Change in atom charge (Δ) is relative to the charge of the propellant or tail when not interacting.  
Bold atoms are involved in “strong interactions”, in which O··H or F··H distances < 3 Å.  Atom numbers 
correspond to those shown in Figure 9.  Tail fragments are: pentane (C5), iso-hexane (ISO), ethylene oxide 
(EO), propylene oxide (PO). 
 HFO-1234ze-ISO  HFO-1234ze-EO  HFO-1234ze-PO 
 charge Δ  charge Δ  charge Δ 
H1 0.207 -0.026 H1 0.188 -0.045 H1 0.279 0.046 
H2 0.103 -0.018 H2 0.143 0.022 H2 0.106 -0.015 
C3 0.22 0.002 C3 0.129 -0.089 C3 0.204 -0.014 
C4 -0.348 0.041 C4 -0.212 0.177 C4 -0.364 0.025 
C5 0.601 -0.035 C5 0.446 -0.19 C5 0.544 -0.092 
F6 -0.216 -0.003 F6 -0.205 0.008 F6 -0.193 0.02 
F7 -0.204 0.004 F7 -0.147 0.061 F7 -0.194 0.014 
F8 -0.185 0.023 F8 -0.147 0.061 F8 -0.195 0.013 
F9 -0.183 -0.003 F9 -0.178 0.002 F9 -0.176 0.004 
C10 -0.299 0.03 C10 -0.108 0.086 C10 -0.327 -0.007 
H11 0.063 -0.009 H11 0.033 0 H11 0.074 0.008 
H12 0.052 -0.008 H12 0.015 -0.043 H12 0.091 0.014 
H13 0.049 -0.013 H13 0.039 -0.019 H13 0.082 -0.002 
C14 0.372 -0.026 C14 0.221 -0.157 C14 0.48 -0.048 
H15 -0.066 0 C15 -0.008 0.037 H15 -0.034 0.016 
C16 0.162 -0.058 C16 -0.002 0.043 C16 0.363 -0.021 
H17 -0.034 0.019 C17 0.219 -0.159 H17 -0.036 -0.005 
H18 -0.013 0.024 H18 -0.004 0.041 H18 -0.024 0.024 
C19 -0.196 -0.028 H19 -0.009 0.036 C19 -0.215 -0.005 
H20 0.049 0.016 C20 -0.086 0.108 H20 0.045 -0.009 
H21 0.037 0.009 H21 0.009 -0.049 H21 0.046 0.016 
H22 0.043 0.015 H22 0.028 -0.005 H22 0.067 0.013 
C23 -0.229 0.069 H23 0.033 -0.025 O23 -0.524 0.001 
H24 0.026 -0.04 O24 -0.398 0.089 C24 -0.277 0.065 
H25 0.05 0.007    H25 0.052 -0.046 
H26 0.045 -0.014    H26 0.064 0.003 
C27 -0.175 -0.029    H27 0.06 -0.008 
H28 0.032 0.019       
H29 0.039 0.022       
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Table S3(b). Partial charge distribution of the HFO-1234ze and ester-based tail fragment pairs.  Partial 
charges are obtained at the MP2 level of theory and aug-cc-pVDZ basis set, from geometries optimized at 
MP2/6-31g+(d,p).  Change in atom charge (Δ) is relative to the charge of the propellant or tail when not 
interacting.  Bold atoms are involved in “strong interactions”, in which O··H or F··H distances < 3 Å.  Atom 
numbers correspond to those shown in Figure 11.  Tail fragments are: glycolic acid (GA), lactic acid (LA), 
and tetramethyl glycolic acid (TMGA). 
 HFO-1234ze-GA  HFO-1234ze-LA  HFO-1234ze-TMGA 
 charge Δ  charge Δ  charge Δ 
H1 0.213 -0.02 H1 0.222 -0.011 H1 0.23 -0.003 
H2 0.134 0.013 H2 0.125 0.004 H2 0.125 0.004 
C3 0.162 -0.056 C3 0.183 -0.035 C3 0.183 -0.035 
C4 -0.26 0.129 C4 -0.304 0.085 C4 -0.316 0.073 
C5 0.455 -0.181 C5 0.545 -0.091 C5 0.546 -0.09 
F6 -0.194 0.019 F6 -0.213 0 F6 -0.206 0.007 
F7 -0.158 0.05 F7 -0.194 0.014 F7 -0.193 0.015 
F8 -0.155 0.053 F8 -0.163 0.045 F8 -0.181 0.027 
F9 -0.181 -0.001 F9 -0.182 -0.002 F9 -0.183 -0.003 
C10 0.017 0.05 C10 -0.235 0.01 C10 -0.204 0.137 
H11 -0.02 -0.029 H11 0.042 -0.005 H11 0.039 -0.034 
H12 -0.006 -0.015 H12 0.051 -0.005 H12 0.02 -0.053 
H13 0.021 -0.008 H13 0.068 -0.008 H13 0.051 -0.027 
C14 -0.115 -0.003 C14 0.185 0.067 C14 0.288 -0.037 
H15 0.034 -0.004 H15 -0.037 -0.02 C15 0.678 0.047 
H16 0.045 0.007 C16 0.671 -0.047 C16 -0.023 0.043 
C17 0.761 0.007 C17 0.091 0.011 H17 0.075 -0.006 
C18 0.203 0.098 H18 0.041 -0.007 H18 0.086 -0.006 
H19 0.014 -0.025 H19 0.057 -0.011 H19 0.067 -0.014 
H20 0.051 -0.013 H20 0.045 0.003 O20 -0.346 -0.017 
H21 -0.009 -0.048 O21 -0.416 0.017 O21 -0.549 -0.03 
O22 -0.474 -0.017 O22 -0.534 -0.008 C22 -0.272 -0.051 
O23 -0.538 -0.014 C23 -0.135 0.001 H23 0.049 0.017 
   H24 0.025 0.001 H24 0.051 0.012 
   H25 0.005 -0.028 H25 0.075 0.015 
   H26 0.047 -0.001 C26 -0.263 -0.042 
      H27 0.072 0.012 
      H28 0.053 0.014 
      H29 0.048 0.016 
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Figure S1.  Optimized geometries of the self-interacting tail-tail fragments at the MP2/6-31g+(d,p) level 
of theory and basis set.  Tail fragments are: (a) glycolic acid (GA), (b) lactic acid (LA) and (c) tetramethyl 
glycolic acid (TMGA), which are all representatives of the ester chemistries, but with increasing degree of 
branching.  Dashed lines and numbers in parenthesis represent the “strong interaction” sites and the number 
of “strong interactions”, respectively.  “Strong interaction” is defined as those between O··H, and with a 
separation distance < 3Å.[31] 
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APPENDIX B: SUPPLEMENTAL INFORMATION FOR CHAPTER 3 
 
 
Table S2. Atom type and charges for PEG chain, which is the repeating unit of PEG head chain. 
Atom # Atom type Charge (e) 
1 CLP -0.01 
2 HLP 0.09 
3 HLP 0.09 
4 OLP -0.34 
5 CLP -0.01 
6 HLP 0.09 
7 HLP 0.09 
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Table S3. Atom type and charges for PEG chain, which is the terminal unit of PEG head chain. 
Atom # Atom type Charge (e) 
1 CLP -0.01 
2 HLP 0.09 
3 HLP 0.09 
4 OLP -0.34 
5 CLP 0.10 
6 HLP 0.15 
7 HLP 0.15 
8 OLP -0.65 
9 HLP 0.42 
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Table S3. Atom type and charges for residue CH3, which is the terminal unit of CH tail chain. 
Atom # Atom type Charge (e) 
1 CL1 -0.27 
2 HL1 0.09 
3 HL1 0.09 
4 HL1 0.09 
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Table S4. Atom type and charges for residue CH2, which is the repeating unit of CH tail chain. 
Atom # Atom type Charge (e) 
1 CL2 -0.18 
2 HL1 0.09 
3 HL1 0.09 
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Table S5. Atom type and charges for PO chain, which is the repeating unit of PO tail chain. 
Atom # Atom type Charge (e) 
1 CPO -0.1633 
2 HPO 0.0957 
3 HPO 0.0957 
4 CPO 0.4264 
5 HPO -0.0132 
6 CPO -0.5319 
7 HPO 0.1400 
8 HPO 0.1400 
9 HPO 0.1400 
10 OPO -0.3303 
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Table S6. Atom type and charges for PO chain, which is the terminal unit of PO tail chain. 
Atom # Atom type Charge (e) 
1 CPO -0.1633 
2 HPO 0.0957 
3 HPO 0.0957 
4 CPO 0.4264 
5 HPO -0.0132 
6 CPO -0.5319 
7 HPO 0.1360 
8 HPO 0.1360 
9 HPO 0.1360 
10 OPO -0.6500 
11 HPO 0.3350 
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Table S7. Atom type and charges for LA chain, which is the repeating unit of LA tail chain. 
Atom # Atom type Charge (e) 
1 CA3 0.6200 
2 OA1 -0.5200 
3 CA2 0.1100 
4 HA1 0.1300 
5 CA1 -0.2700 
6 HA1 0.0900 
7 HA1 0.0900 
8 HA1 0.0900 
9 OA2 -0.3400 
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Table S8. Atom type and charges for LA chain, which is the terminal unit of LA tail chain. 
Atom # Atom type Charge (e) 
1 CA3 0.6200 
2 OA1 -0.5200 
3 CA2 0.1100 
4 HA1 0.1300 
5 CA1 -0.2700 
6 HA1 0.0900 
7 HA1 0.0900 
8 HA1 0.0900 
9 OA2 -0.4300 
10 HA1 -0.0900 
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Table S9. Force field parameters used.  All potential energies below 
are based on kcal/mol 
𝑈𝐿𝐽 = −𝜀[(
𝑅𝑚𝑖𝑛
𝑟𝑖𝑗
)12 − 2(
𝑅𝑚𝑖𝑛
𝑟𝑖𝑗
)6] 
Atom     Ɛ         Rmin/2 (Å) 
Cl -0.09339870   2.020428 
Fl -0.04868656   1.638792 
Hl -0.01987206   1.403075 
OT -0.15535373   1.776854 
HT -0.00000000   0.000000 
CM -0.09799235   1.908185 
CT -0.07430927   1.908185 
FM -0.05644599   1.627570 
FT -0.05644599   1.650019 
HM -0.01570268   1.487262 
HC -0.01570268   1.038277 
CL2 -0.05600000   2.010000 
CL1 -0.07800000   2.010000 
HL1 -0.03500000   1.340000 
Clp -0.05500000   2.175000 
Olp -0.10000000   1.650000 
Hlp -0.02200000   1.320000 
CPO -0.05600000   2.010000 
HPO -0.02200000   1.320000 
OPO -0.10000000   1.650000 
CA1 -0.07800000   2.040000 
CA2 -0.05600000   2.010000 
CA3 -0.07000000   2.000000 
OA1 -0.12000000   1.700000 
OA2 -0.15210000   1.770000 
HA1 -0.02200000   1.320000 
 
 
𝑈𝑏𝑜𝑛𝑑 = 𝑘(𝑟𝑖𝑗 − 𝑟0)
2 
Atom         k        r0 (Å) 
Cl  Hl     500.0      1.0900  
Cl  Cl     500.0      1.5290  
Cl  Fl     500.0      1.3600  
OT  HT     450.0      1.0000  
HT  HT     500.0      1.5139  
CM  CM     676.8      1.331  
CM  CT     317.6      1.511  
CT  FT     369.2      1.353  
CM  HM     388.9      1.086  
CM  FM     445.7      1.330  
CM  HC     388.9      1.086  
Clp Hlp    317.13     1.100  
Clp Clp    222.50     1.530  
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Clp Olp    360.00     1.415  
Cl2 Olp    360.00     1.415  
HLP OLP    450.00     0.957  
CL1 HL1    309.00     1.111  
CL1 CL2    222.50     1.528  
CL2 HL1    322.00     1.111  
CL2 CL2    222.50     1.530  
CPO HPO    327.5      1.090  
CPO CPO    309.0      1.520  
CPO OPO    369.5      1.400  
CPO OLP    369.5      1.400  
OPO HPO    450.0      0.957  
CA3 OLP    150.0      1.334  
CA1 HA1    322.0      1.111  
CA1 CA2    222.5      1.530  
CA2 HA1    309.0      1.111  
CA2 CA3    200.0      1.522  
CA2 OA2    150.0      1.334  
CA3 OA1    750.0      1.220  
CA3 OA2    150.0      1.334  
HA1 OA2    450.0      0.957  
 
 
𝑈𝑎𝑛𝑔𝑙𝑒 = 𝑘𝜃(𝜃 − 𝜃0)
2 
Atoms         kӨ              𝜃0  
Cl  Cl  Hl   37.51       110.70 
Cl  Cl  Fl   50.01       109.50 
Hl  Cl  Hl   33.00       107.80 
Hl  Cl  Fl   40.01       107.00 
Fl  Cl  Fl   77.02       109.10 
HT  OT  HT   90.00       109.47 
HM  CM  CM   36.35       120.60 
FT  CT  FT   87.86       107.50 
CM  CT  FT   74.85       111.30 
HM  CM  CT   32.33       115.10 
HM  CM  HM   29.31       118.70 
CM  CM  FM   50.52       122.60 
FM  CM  FM   85.38       112.60 
FM  CM  CT   76.38       112.50 
CM  CM  CT   50.12       124.10    
CM  CM  HC   36.35       120.60 
CT  CM  HC   32.33       115.10 
FM  CM  HM   30.00       113.00 
CLp CLp HLp  34.50       110.00   
HLp CLp OLp  60.00       109.50   
Hlp Clp Hlp  35.50       109.00   
CLp CLp OLp  45.00       111.50   
Cl2 Olp Clp  95.00       123.00   
Clp Olp Clp  95.00       123.00   
HLP OLP CLP  57.5        106.00   
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HL1 CL1 HL1  35.0        109.00   
CL2 CL1 HL1  34.50       110.00   
CL1 CL2 Hl1  34.50       110.00   
CL1 CL2 CL2  58.35       113.60  
HL1 CL2 HL1  35.00       109.00   
CL2 CL2 HL1  26.50       110.10  
CL2 CL2 CL2  58.35       113.60  
CL2 CL2 OLP  35.00       111.50   
HL1 CL2 OLP  50.00       109.50  
HPO CPO HPO  38.50       108.30   
CPO CPO HPO  42.9        109.48  
CPO CPO CPO  54.00       111.33  
CPO OPO CPO  74.5        109.23  
OPO CPO HPO  56.0        110.07  
OPO CPO CPO  59.5        108.86  
HPO CPO Olp  56.0        110.07  
CPO CPO OLP  59.5        108.86  
CPO OPO HPO  57.5        106.00   
CLP OLP CPO  74.5        109.23  
CPO CPO HPO  42.9        109.49  
CA1 CA2 HA1  33.0        109.50   
CA1 CA2 CA3  54.0        111.33  
CA1 CA2 OA2  55.0        109.00   
HA1 CA1 HA1  35.0        109.00   
CA2 CA1 HA1  33.0        109.50   
CA2 CA3 OA1  70.0        125.00   
CA2 CA3 OA2  55.0        109.00   
CA2 OA2 CA3  40.0        109.60   
CA3 CA2 HA1  33.0        109.50   
HA1 CA2 OA2  60.0        109.00   
CA3 CA2 OA2  75.0        110.00   
OA1 CA3 OA2  90.0        125.90   
CA3 OLp CLp  74.5        109.20   
CA2 CA3 OLp  45.0        111.50   
OA1 CA3 OLp  30.0        110.00   
CA2 OA2 HA1  57.5        106.00   
 
 
 
 
𝑈𝐷𝑖ℎ𝑒𝑑𝑟𝑎𝑙 = 𝑘(1 + cos (𝑛𝜑 + ∅)) 
Atoms                    k         n    ∅ 
Fl  Cl  Cl  Fl            0.01127    0   0 
Fl  Cl  Cl  Fl            0.00389    1   0 
Fl  Cl  Cl  Fl           -0.04865    2   180 
Fl  Cl  Cl  Fl            2.12491    3   0 
Fl  Cl  Cl  Hl           -0.02911    0   0 
Fl  Cl  Cl  Hl            0.00316    1   0 
Fl  Cl  Cl  Hl            0.01978    2   180 
Fl  Cl  Cl  Hl            2.11393    3   0 
HM  CM  CT  FT            0.17806    3   0 
FM  CM  CT  FT            0.24964    3   0 
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CM  CM  CT  FT            0.14223    3   180  
HM  CM  CM  CT            6.65392    2   180  
HM  CM  CM  FM            6.65392    2   180  
HM  CM  CM  HC            6.65392    2   180   
HC  CM  CM  FM            6.65392    2   180   
HC  CM  CT  FT            0.17806    3   0       
CT  CM  CM  FM            6.65392    2   180     
HLp CLp CLp HLp           1.20000    2   180  
HLp CLp CLp OLp           0.00000    1   0  
OLp CLp CLp OLp           0.59000    1   180 
OLp CLp CLp OLp           1.1600     2   0     
HLp CLp OLp CLp           0.2000     3   0     
CLp CLp OLp CLp           0.4000     1   0     
CLp CLp OLp CLp           0.4900     3   0      
CLp CLp OLp CL2           0.4000     1   0     
HLp CLp OLp CL2           0.2000     3   0     
CLP OLP CL2 CL2           0.5700     1   0    
CLP OLP CL2 HL1           0.2840     3   0     
CLP CLP OLP HLP           1.3300     1   0     
CLP CLP OLP HLP           0.1800     2   0     
CLP CLP OLP HLP           0.3200     3   0     
HLP CLP OLP HLP           1.8000     2   180   
HL1 CL1 CL2 HL1           0.1600     3   0     
HL1 CL1 CL2 CL2           0.2000     3   0     
CL1 CL2 CL2 HL1           0.2000     3   0    
CL1 CL2 CL2 CL2           0.1510     2   0     
CL1 CL2 CL2 CL2           0.0813     3   180   
CL1 CL2 CL2 CL2           0.1082     4   0     
CL1 CL2 CL2 CL2           0.2039     5   0     
HL1 CL2 CL2 HL1           0.1900     3   0     
HL1 CL2 CL2 CL2           0.2000     3   0     
CL2 CL2 CL2 CL2           0.0645     2   0     
CL2 CL2 CL2 CL2           0.1498     3   180  
CL2 CL2 CL2 CL2           0.0946     4   0     
CL2 CL2 CL2 CL2           0.1125     5   0    
CL2 CL2 CL2 OLP           0.3900     2   0     
HL1 CL2 CL2 OLP           0.1600     3   0     
HPO CPO CPO OPO          -0.1700     3   180   
HPO CPO CPO CPO          -0.1400     3   180   
HPO CPO CPO HPO          -0.1400     3   180   
CPO OPO CPO HPO          -0.4050     3   180   
OPO CPO CPO OPO          -0.1450     1   180   
OPO CPO CPO OPO          -0.1220     2   180   
OPO CPO CPO OPO          -0.1700     3   180   
!CPO CPO OPO CPO          1.5045     1   180   
!CPO CPO OPO CPO          0.510      2   180   
CPO CPO OPO CPO           0.4000     1   0     
CPO CPO OPO CPO           0.4900     3   0     
CPO CPO OPO CPO           0.2500     3   180   
OLP CPO CPO HPO           0.0000     0   0        
OLP CPO CPO CPO           0.0000     0   0         
OLP CPO CPO OPO           0.0000     0   0         
HPO CPO OLP CLP           0.0000     0   0        
CPO CPO OLP CLP           0.0000     0   0        
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OPO CPO CPO CPO           0.9850     1   180   
OPO CPO CPO CPO           0.0150     2   180   
CPO CPO OPO HPO           0.0000     0   0     
HPO CPO OPO HPO           0.0000     0   0     
CLP CLP OLP CPO           0.4000     1   0     
CLP CLP OLP CPO           0.4900     3   0     
HLP CLP OLP CPO           0.2000     3   0     
CA1 CA2 CA3 OA1           0.0500     6   180   
CA1 CA2 CA3 OA2           0.0500     6   180   
CA1 CA2 OA2 CA3           0.7000     1   180   
HA1 CA1 CA2 HA1           0.1600     3   0     
HA1 CA1 CA2 CA3           0.1600     3   0     
HA1 CA1 CA2 OA2           0.1600     3   0     
CA2 CA3 OA2 CA2           0.0000     3   0     
HA1 CA2 CA3 OA1           0.0500     6   180   
HA1 CA2 CA3 OA2           0.0500     6   180   
HA1 CA2 OA2 CA3           0.0000     3   0     
CA3 CA2 OA2 CA3           0.0000     3   0     
OA1 CA3 OA2 CA2           0.9650     1   180   
OA2 CA2 CA3 OA1           0.0500     6   180   
OA2 CA2 CA3 OA2           0.0500     6   180   
CLp CLp OLp CA3           0.0000     3   0     
HLp CLp OLp CA3           0.0000     3   0     
CLp OLp CA3 CA2           0.0000     3   0     
CLp OLp CA3 OA1           0.0000     3   0     
OA2 CA2 CA3 OLp           0.0500     6   180   
CA1 CA2 CA3 OLp           0.0500     6   180   
HA1 CA2 CA3 OLp           0.0500     6   180   
CA1 CA2 OA2 HA1           0.0000     3   0     
HA1 CA2 OA2 HA1           0.0000     3   0     
CA3 CA2 OA2 HA1           0.0000     3   0     
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APPENDIX C: SUPPLEMENTAL INFORMATION FOR CHAPTER 4 
 
Force Field Development. 
  We have considered many different approaches when developing the charge distribution for the 
proposed force field (FF), including the one mentioned by reviewer – charge neutrality for the 
internal residues.  However, we decided to take a different approach; one in which not only the 
overall charge of the dendrimer is considered, but also one that conforms as close as possible to 
the CHARMM FF – the potential of that approach is clear in terms of the ability to extend the FF 
to other more complex simulation environments.  We found out that indeed, when charges were 
taken either from the CHARMM FF or from our own ab initio calculations, they do not support 
neutrality of the internal residues.  Therefore, we decided not to artificially force neutrality of the 
residues.  For that reason we kept the charges as close as possible to the original CHARMM FF, 
with minimal modifications supported by our ab intio work, so as to conform to the restriction/to 
provide an overall charge that corresponds to the fully protonated dendrimer - condition of interest 
here, as the dendrimers are fully protonated under physiological conditions.  For G3NH2 PAMAM 
dendrimer, there is, therefore, 1 core unit (-0.6e each), 28 branching monomers (-0.15e each), and 
32 terminal units (+1.15 each).  This could be easily extended to dendrimers under different 
conditions/different degrees of protonation by adjusting the charge of the terminal units. 
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Figure S1. Structure of residue AMC, the core of PAMAM dendrimer.  
Color code: N in blue, C in grey, H in white.  All atoms are numbered 
the same as in table S1. 
Table S14 Atom type and charges for residue AMC 
Atom # Atom type Charge (e) 
1 CL1 -0.35 
2 HL1 0.25 
3 HL1 0.25 
4 CL1 -0.35 
5 HL1 0.25 
6 HL1 0.25 
7 NL2 -0.45 
8 NL2 -0.45 
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Figure S2.  Structure of residue AMT, the monomer (repeating unit) of 
PAMAM dendrimer.  Color code: N in blue, C in grey, O in red, H in 
white.  All atoms are numbered the same as in table S2. 
Table S15 Atom type and charge for residue AMT (monomer). 
Atom # Atom type Charge (e) 
1 CL1 -0.35 
2 HL1 0.25 
3 HL1 0.25 
4 CL2 0.50 
5 CL1 -0.04 
6 HL1 0.10 
7 HL1 0.10 
8 CL1 -0.35 
9 HL1 0.25 
10 HL1 0.25 
11 NL1 -0.47 
12 HL1 0.31 
13 NL2 -0.45 
14 CL1 -0.18 
15 HL1 0.09 
16 HL1 0.09 
17 OL1 -0.50 
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Figure S3.  Structure of residue AMH, the terminal monomer (surface 
group) of PAMAM dendrimer.  Color code: N in blue, C in grey, O in 
red, H in white.  All atoms are numbered the same as in table S3. 
Table S16 Atom type and charge for residue AMH (monomer at surface).  
When it is grafted with PEG, #15 and #16 will not be part of the 
chain, and #13 will have -0.41e. 
Atom # Atom type Charge (e) 
1 CL1 -0.35 
2 HL1 0.25 
3 HL1 0.25 
4 CL2 0.51 
5 CL1 -0.04 
6 HL1 0.10 
7 HL1 0.10 
8 CL1 0.13 
9 HL1 0.09 
10 HL1 0.09 
11 NL1 -0.47 
12 HL2 0.31 
13 NL2 -0.30 
14 HL1 0.33 
15 HL1 0.33 
16 HL1 0.33 
17 CL1 -0.18 
18 HL1 0.09 
19 HL1 0.09 
20 OL1 -0.51 
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Figure S4.  Structure of residue LIK, the linker between the PEG and 
PAMAM dendrimer.  Color code: C in grey, O in red. 1 is connected to 
dendrimer (N) while 2 is connected to PEG (C). All atoms are numbered 
the same as in table S4. 
 
Table S4 Atom type and charge for residue LIK (linker). 
Atom # Atom type Charge (e) 
1 CL1 0.63 
2 OL1 -0.34 
3 OL1 -0.52 
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Figure S5.  Structure of residue PEG, the monomer for PEG chain.  
Color code: C in grey, O in red, H in white. All atoms are numbered 
the same as in table S5. 
 
Table S4 Atom type and charge for residue LIK (linker). 
Atom # Atom type Charge (e) 
1 CLP -0.01 
2 HLP 0.09 
3 HLP 0.09 
4 CLP -0.01 
5 HLP 0.09 
6 HLP 0.09 
7 OLP -0.34 
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Figure S6.  Structure of residue MET, at the end of PEG chain.  Color 
code: C in grey, H in white. All atoms are numbered the same as in 
table S6. 
 
Table S6 Atom type and charge for residue LIK (linker). 
Atom # Atom type Charge (e) 
1 CLP -0.27 
2 HLP 0.09 
3 HLP 0.09 
4 HLP 0.09 
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Table S7. Force field parameters employed in this study. 
All potential energies below are based on kcal/mol 
𝑈𝐿𝐽 = −𝜀[(
𝑅𝑚𝑖𝑛
𝑟𝑖𝑗
)12 − 2(
𝑅𝑚𝑖𝑛
𝑟𝑖𝑗
)6] 
Atom    Ɛ       Rmin/2 (Å) 
Cl1 -0.06800 2.000 
Cl2 -0.11000 2.000 
Nl1 -0.35000 1.850     
Nl2 -0.20000 1.850 
Hl1 -0.02200 1.320 
Hl2 -0.03000 1.403 
Ol1 -0.24000 1.950 
Clp -0.05500 2.175 
Olp -0.10000 1.650 
Hlp -0.02200 1.320 
 
 
𝑈𝑏𝑜𝑛𝑑 = 𝑘(𝑟𝑖𝑗 − 𝑟0)
2 
Atom         k           r0 (Å) 
Cl1  Hl1     317.13      1.100  
Cl1  Cl1     222.00      1.530  
Cl1  Nl2     320.00      1.430  
Cl1  Cl2     365.00      1.502  
Cl2  Ol1     650.00      1.230  
Cl2  Cl1     365.00      1.502  
Nl1  Hl2     480.00      1.000  
Cl1  Nl1     320.00      1.430  
Nl1  Cl2     430.00      1.360  
Hl1  Nl2     480.00      1.000  
Clp  Olp     360.00      1.415  
Ol1  P       237.00      1.580  
Clp  Hlp     317.13      1.100  
Clp  Clp     222.50      1.530  
Cl1  Ol1     650.00      1.230  
Cl1  Olp     650.00      1.320  
Clp  Ol1     650.00      1.320  
 
𝑈𝑎𝑛𝑔𝑙𝑒 = 𝑘𝜃(𝜃 − 𝜃0)
2 
Atoms         kӨ              𝜃0  
Cl1 Cl1 Hl1   50.00       120.0  
Hl1 Cl1 Hl1   35.50       109.0  
Hl1 Cl1 Cl2   50.00       120.0  
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Hl1 Cl1 Nl1   51.50       109.5  
Hl1 Cl1 Nl2   51.50       109.5  
Ol1 Cl2 Nl1   80.00       122.5  
Ol1 Cl2 Cl1   80.00       121.0  
Nl1 Cl1 Cl1   80.00       116.5  
Nl1 Cl2 Cl1   80.00       116.5  
Nl2 Cl1 Cl1   80.00       116.5  
Cl1 Nl1 Hl2   34.00       123.0  
Cl1 Nl1 Cl2   50.00       120.0  
Cl1 Cl1 Cl2   40.00       120.0  
Cl2 Nl1 Hl2   50.00       111.0  
Hl1 Nl2 Cl1   34.00       123.0  
Hl1 Nl2 Hl1   23.00       120.0  
Cl1 Nl2 Cl1   50.00       120.0  
Cl1 Cl1 Ol1   80.00       121.0  
Cl1 Ol1 Cl1   40.00       109.0  
Hl1 Cl1 Ol1   50.00       122.0  
Ol1 Cl1 Ol1   50.00       123.0  
Nl2 Cl1 Ol1   80.00       122.5  
Hlp Clp Hlp   35.50       109.0  
CLp CLp HLp   34.50       110.0  
HLp CLp OLp   60.00       109.5  
CLp CLp OLp   45.00       111.5  
CL1 OLp CLp   95.00       109.7  
HLp CLp OL1   60.00       109.5  
CLp CLp OL1   45.00       110.0  
CL1 OL1 CLp   95.00       109.7  
HL1 CL1 OLp   60.00       109.5  
Olp Clp Olp   50.00       123.0  
Clp Olp Clp   95.00       123.0  
 
 
 
𝑈𝐷𝑖ℎ𝑒𝑑𝑟𝑎𝑙 = 𝑘(1 + cos (𝑛𝜑 + ∅)) 
Atoms                   k         n     ∅ 
Nl2 Cl1 Cl1 Nl2         0.6000    1     0     
Nl2 Cl1 Cl1 Hl1         0.0000    1     0     
Nl2 Cl1 Cl1 Cl2         0.0000    1     0     
Nl2 Cl1 Cl1 Nl1         0.6000    1     0     
Nl1 Cl2 Cl1 Cl1         0.0000    1     0     
Nl1 Cl2 Cl1 Hl1         0.0000    1     0     
Nl1 Cl1 Cl1 Hl1         0.0000    1     0     
Ol1 Cl2 Cl1 Cl1         1.4000    1     0     
Ol1 Cl2 Cl1 Hl1         0.0000    1     0     
Ol1 Cl2 Nl1 Hl2         2.5000    2     180   
Ol1 Cl2 Nl1 Cl1         2.5000    2     180   
Hl1 Cl1 Cl1 Hl1         1.4000    2     180   
Hl1 Cl1 Cl1 Cl2         0.0500    3     180   
Hl1 Cl1 Nl1 Cl1         0.0000    1     0     
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Hl1 Cl1 Nl1 Hl2         2.5000    2     180   
Hl2 Nl1 Cl1 Cl1         2.5000    2     180   
Cl1 Cl1 Nl1 Cl2         0.2000    2     180   
Cl1 Nl2 Cl1 Cl1         0.2000    1     180   
Hl1 Nl1 Cl1 Cl1         2.5000    2     180   
Hl1 Nl2 Cl1 Hl1         1.4000    2     180   
Cl1 Nl2 Cl1 Hl1         0.0000    1     0     
Cl1 Cl2 Nl1 Hl2         2.5000    2     180   
Cl1 Cl2 Nl1 Cl1         0.2000    1     180   
Cl2 Nl1 Cl1 Hl1         0.0000    1     0     
Cl1 Cl1 Nl2 Hl1         2.5000    2     180   
CL1 NL2 CL1 OL1         0.0000    2     180   
HL1 NL2 CL1 OL1         2.5000    2     180   
HLp CLp CLp HLp         1.2000    2     180   
HLp CLp CLp OLp         0.0000    1     0     
OLp CLp CLp OLp         0.5900    1     180   
OLp CLp CLp OLp         1.1600    2     0     
HLp CLp OLp CLp         0.2000    3     0     
CLp CLp OLp CLp         0.4000    1     0     
CLp CLp OLp CLp         0.4900    3     0     
CLp CLp OLp CL1         0.5700    1     0     
HLp CLp OLp CL1         0.2840    3     0     
CLp OLp CL1 HL1         0.2000    3     0     
OL1 CLp CLp HLp         0.0000    3     180   
OL1 CLp CLp OLp         0.0000    1     0     
OL1 CLp CLp OLp         0.0900    3     0     
HLp CLp OL1 CL1         0.2840    3     0     
CLp CLp OL1 CL1         0.4000    1     0     
CLp CLp OL1 CL1         0.4900    3     0     
NL2 CL1 OL1 CLp         0.0000    1     0     
OL1 CL1 OL1 CLp         0.0000    1     0     
Olp Clp Olp Clp         0.0000    1     0     
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Table S8. Radius of gyration (Rg) as a function PEG chain length and 
number of grafts.   
 G3NH2 G3NH2-
4PEG500 
G3NH2-
8PEG500 
G3NH2-
16PEG500 
G3NH2-
8PEG1000 
Rg(Å) 15.0 15.6 16.2 16.9 18.1 
Rg-core(Å) 15.0 15.1 16.3 14.1 15.5 
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APPENDIX D: SUPPLEMENTAL INFORMATION FOR CHAPTER 5 
 
Figure S1. Structure of residue AMC, the core of PAMAM dendrimer 
(G3NH3
+, G3OH, G2.5COO-).  Color code: N in blue, C in grey, H in 
white.  All atoms are numbered the same as in table S1. 
Table S17 Atom type and charges for residue AMC 
Atom # Atom type Charge (e) 
1 CL1 -0.35 
2 HL1 0.25 
3 HL1 0.25 
4 CL1 -0.35 
5 HL1 0.25 
6 HL1 0.25 
7 NL2 -0.45 
8 NL2 -0.45 
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Figure S2.  Structure of residue AMT, the monomer (repeating unit) of 
PAMAM dendrimer (G3NH3
+, G3OH, G2.5COO-).  Color code: N in blue, C in 
grey, O in red, H in white.  All atoms are numbered the same as in 
table S2. 
Table S18 Atom type and charge for residue AMT (monomer). 
Atom # Atom type Charge (e) 
1 CL1 -0.35 
2 HL1 0.25 
3 HL1 0.25 
4 CL2 0.50 
5 CL1 -0.04 
6 HL1 0.10 
7 HL1 0.10 
8 CL1 -0.35 
9 HL1 0.25 
10 HL1 0.25 
11 NL1 -0.47 
12 HL1 0.31 
13 NL2 -0.45 
14 CL1 -0.18 
15 HL1 0.09 
16 HL1 0.09 
17 OL1 -0.50 
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Figure S3.  Structure of residue AMH, the terminal monomer (surface 
group) of G3NH3
+ PAMAM dendrimer.  Color code: N in blue, C in grey, O 
in red, H in white.  All atoms are numbered the same as in table S3. 
Table S19 Atom type and charge for residue AMH (monomer at surface).  
When it is grafted with PEG, #15 and #16 will not be part of the 
chain, and #13 will have -0.41e. 
Atom # Atom type Charge (e) 
1 CL1 -0.35 
2 HL1 0.25 
3 HL1 0.25 
4 CL2 0.51 
5 CL1 -0.04 
6 HL1 0.10 
7 HL1 0.10 
8 CL1 0.13 
9 HL1 0.09 
10 HL1 0.09 
11 NL1 -0.47 
12 HL2 0.31 
13 NL2 -0.30 
14 HL1 0.33 
15 HL1 0.33 
16 HL1 0.33 
17 CL1 -0.18 
18 HL1 0.09 
19 HL1 0.09 
20 OL1 -0.51 
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Figure S4.  Structure of residue LIK, the linker between the PEG and 
G3NH3
+ PAMAM dendrimer.  Color code: C in grey, O in red. 1 is 
connected to dendrimer (N) while 2 is connected to PEG (C). All atoms 
are numbered the same as in table S4. 
 
Table S4 Atom type and charge for residue LIK (linker). 
Atom # Atom type Charge (e) 
1 CL1 0.63 
2 OL1 -0.34 
3 OL1 -0.52 
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Figure S5.  Structure of residue PEG, the monomer for PEG chain.  
Color code: C in grey, O in red, H in white. All atoms are numbered 
the same as in table S5. 
 
Table S4 Atom type and charge for residue PEG. 
Atom # Atom type Charge (e) 
1 CLP -0.01 
2 HLP 0.09 
3 HLP 0.09 
4 CLP -0.01 
5 HLP 0.09 
6 HLP 0.09 
7 OLP -0.34 
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Figure S6.  Structure of residue MET, at the end of PEG chain.  Color 
code: C in grey, H in white. All atoms are numbered the same as in 
table S6. 
 
Table S6 Atom type and charge for residue MET. 
Atom # Atom type Charge (e) 
1 CLP -0.27 
2 HLP 0.09 
3 HLP 0.09 
4 HLP 0.09 
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Figure S7.  Structure of residue AMX, the terminal monomer (surface 
group) of G3OH PAMAM dendrimer.  Color code: N in blue, C in grey, O 
in red, H in white.  All atoms are numbered the same as in table S7. 
Table S7 Atom type and charge for residue AMX (monomer at surface)of 
G3OH PAMAM dendrimer.  When it is grafted with PEG, #17 and #18 will 
not be part of the chain. 
Atom # Atom type Charge (e) 
1 CL1 -0.35 
2 HL1 0.25 
3 HL1 0.25 
4 CL1 -0.18 
5 HL1 0.09 
6 HL1 0.09 
7 CL2 0.51 
8 CL1 -0.04 
9 HL1 0.10 
10 HL1 0.10 
11 CL1 0.05 
12 HL1 0.09 
13 HL1 0.09 
14 OL1 -0.51 
15 NL1 -0.47 
16 HL2 0.31 
17 OL2 -0.65 
18 HL1 0.42 
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Figure S8.  Structure of residue LIN, the linker between G3OH PAMAM 
dendrimer and PEG chain.  Color code: N in blue, C in grey, O in red, 
H in white.  All atoms are numbered the same as in table S8. 
 
Table S8 Atom type and charge for residue LIN. 
Atom # Atom type Charge (e) 
1 OL1 -0.34 
2 CL1 0.63 
3 OL1 -0.52 
4 CL1 -0.08 
5 HL1 0.09 
6 HL1 0.09 
7 CL1 -0.08 
8 HL1 0.09 
9 HL1 0.09 
10 OL1 -0.10 
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Figure S10.  Structure of residue AMY, the terminal monomer (surface 
group) of G2.5COO- PAMAM dendrimer.  Color code: N in blue, C in grey, 
O in red, H in white.  All atoms are numbered the same as in table 
S10. 
Table S10 Atom type and charge for residue AMY.   
Atom # Atom type Charge (e) 
1 CL1 -0.35 
2 HL1 0.25 
3 HL1 0.25 
4 CL1 -0.18 
5 HL1 0.09 
6 HL1 0.09 
7 CL2 0.34 
8 OL1 -0.67 
9 OL3 -0.67 
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Figure S9.  Structure of residue LYN, the linker between G2.5COO- PAMAM 
dendrimer and PEG chain.  Color code: N in blue, C in grey, O in red, 
H in white.  All atoms are numbered the same as in table S9. 
 
Table S9 Atom type and charge for residue LYN. 
Atom # Atom type Charge (e) 
1 CL1 -0.35 
2 HL1 0.25 
3 HL1 0.25 
4 CL1 -0.28 
5 HL1 0.09 
6 HL1 0.09 
7 CL2 0.51 
8 CL1 0.08 
9 HL1 0.09 
10 HL1 0.09 
11 CL1 -0.01 
12 HL1 0.09 
13 HL1 0.09 
14 OL1 -0.51 
15 NL1 -0.47 
16 HL2 0.31 
17 OL2 -0.17 
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Table S11. Force field parameters employed in this study. 
All potential energies below are based on kcal/mol 
𝑈𝐿𝐽 = −𝜀[(
𝑅𝑚𝑖𝑛
𝑟𝑖𝑗
)12 − 2(
𝑅𝑚𝑖𝑛
𝑟𝑖𝑗
)6] 
Atom    Ɛ       Rmin/2 (Å) 
Cl1 -0.06800 2.000 
Cl2 -0.11000 2.000 
Nl1 -0.35000 1.850     
Nl2 -0.20000 1.850 
Hl1 -0.02200 1.320 
Hl2 -0.03000 1.403 
Ol1 -0.24000 1.950 
Clp -0.05500 2.175 
Olp -0.10000 1.650 
Hlp -0.02200 1.320 
 
 
𝑈𝑏𝑜𝑛𝑑 = 𝑘(𝑟𝑖𝑗 − 𝑟0)
2 
Atom         k           r0 (Å) 
Cl1  Hl1     317.13      1.100  
Cl1  Cl1     222.00      1.530  
Cl1  Nl2     320.00      1.430  
Cl1  Cl2     365.00      1.502  
Cl2  Ol1     650.00      1.230  
Cl2  Cl1     365.00      1.502  
Nl1  Hl2     480.00      1.000  
Cl1  Nl1     320.00      1.430  
Nl1  Cl2     430.00      1.360  
Hl1  Nl2     480.00      1.000  
Clp  Olp     360.00      1.415  
Ol1  P       237.00      1.580  
Clp  Hlp     317.13      1.100  
Clp  Clp     222.50      1.530  
Cl1  Ol1     650.00      1.230  
Cl1  Olp     650.00      1.320  
Clp  Ol1     650.00      1.320  
 
𝑈𝑎𝑛𝑔𝑙𝑒 = 𝑘𝜃(𝜃 − 𝜃0)
2 
Atoms         kӨ              𝜃0  
Cl1 Cl1 Hl1   50.00       120.0  
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Hl1 Cl1 Hl1   35.50       109.0  
Hl1 Cl1 Cl2   50.00       120.0  
Hl1 Cl1 Nl1   51.50       109.5  
Hl1 Cl1 Nl2   51.50       109.5  
Ol1 Cl2 Nl1   80.00       122.5  
Ol1 Cl2 Cl1   80.00       121.0  
Nl1 Cl1 Cl1   80.00       116.5  
Nl1 Cl2 Cl1   80.00       116.5  
Nl2 Cl1 Cl1   80.00       116.5  
Cl1 Nl1 Hl2   34.00       123.0  
Cl1 Nl1 Cl2   50.00       120.0  
Cl1 Cl1 Cl2   40.00       120.0  
Cl2 Nl1 Hl2   50.00       111.0  
Hl1 Nl2 Cl1   34.00       123.0  
Hl1 Nl2 Hl1   23.00       120.0  
Cl1 Nl2 Cl1   50.00       120.0  
Cl1 Cl1 Ol1   80.00       121.0  
Cl1 Ol1 Cl1   40.00       109.0  
Hl1 Cl1 Ol1   50.00       122.0  
Ol1 Cl1 Ol1   50.00       123.0  
Nl2 Cl1 Ol1   80.00       122.5  
Hlp Clp Hlp   35.50       109.0  
CLp CLp HLp   34.50       110.0  
HLp CLp OLp   60.00       109.5  
CLp CLp OLp   45.00       111.5  
CL1 OLp CLp   95.00       109.7  
HLp CLp OL1   60.00       109.5  
CLp CLp OL1   45.00       110.0  
CL1 OL1 CLp   95.00       109.7  
HL1 CL1 OLp   60.00       109.5  
Olp Clp Olp   50.00       123.0  
Clp Olp Clp   95.00       123.0  
 
 
 
𝑈𝐷𝑖ℎ𝑒𝑑𝑟𝑎𝑙 = 𝑘(1 + cos (𝑛𝜑 + ∅)) 
Atoms                   k         n     ∅ 
Nl2 Cl1 Cl1 Nl2         0.6000    1     0     
Nl2 Cl1 Cl1 Hl1         0.0000    1     0     
Nl2 Cl1 Cl1 Cl2         0.0000    1     0     
Nl2 Cl1 Cl1 Nl1         0.6000    1     0     
Nl1 Cl2 Cl1 Cl1         0.0000    1     0     
Nl1 Cl2 Cl1 Hl1         0.0000    1     0     
Nl1 Cl1 Cl1 Hl1         0.0000    1     0     
Ol1 Cl2 Cl1 Cl1         1.4000    1     0     
Ol1 Cl2 Cl1 Hl1         0.0000    1     0     
Ol1 Cl2 Nl1 Hl2         2.5000    2     180   
Ol1 Cl2 Nl1 Cl1         2.5000    2     180   
Hl1 Cl1 Cl1 Hl1         1.4000    2     180   
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Hl1 Cl1 Cl1 Cl2         0.0500    3     180   
Hl1 Cl1 Nl1 Cl1         0.0000    1     0     
Hl1 Cl1 Nl1 Hl2         2.5000    2     180   
Hl2 Nl1 Cl1 Cl1         2.5000    2     180   
Cl1 Cl1 Nl1 Cl2         0.2000    2     180   
Cl1 Nl2 Cl1 Cl1         0.2000    1     180   
Hl1 Nl1 Cl1 Cl1         2.5000    2     180   
Hl1 Nl2 Cl1 Hl1         1.4000    2     180   
Cl1 Nl2 Cl1 Hl1         0.0000    1     0     
Cl1 Cl2 Nl1 Hl2         2.5000    2     180   
Cl1 Cl2 Nl1 Cl1         0.2000    1     180   
Cl2 Nl1 Cl1 Hl1         0.0000    1     0     
Cl1 Cl1 Nl2 Hl1         2.5000    2     180   
CL1 NL2 CL1 OL1         0.0000    2     180   
HL1 NL2 CL1 OL1         2.5000    2     180   
HLp CLp CLp HLp         1.2000    2     180   
HLp CLp CLp OLp         0.0000    1     0     
OLp CLp CLp OLp         0.5900    1     180   
OLp CLp CLp OLp         1.1600    2     0     
HLp CLp OLp CLp         0.2000    3     0     
CLp CLp OLp CLp         0.4000    1     0     
CLp CLp OLp CLp         0.4900    3     0     
CLp CLp OLp CL1         0.5700    1     0     
HLp CLp OLp CL1         0.2840    3     0     
CLp OLp CL1 HL1         0.2000    3     0     
OL1 CLp CLp HLp         0.0000    3     180   
OL1 CLp CLp OLp         0.0000    1     0     
OL1 CLp CLp OLp         0.0900    3     0     
HLp CLp OL1 CL1         0.2840    3     0     
CLp CLp OL1 CL1         0.4000    1     0     
CLp CLp OL1 CL1         0.4900    3     0     
NL2 CL1 OL1 CLp         0.0000    1     0     
OL1 CL1 OL1 CLp         0.0000    1     0     
Olp Clp Olp Clp         0.0000    1     0     
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ABSTRACT 
DESIGN OF FUNCTIONAL DENDRIMER NANOCARRIERS AND 
FORMULATIONS IN PROPELLANT-BASED INHALERS FOR 
PULMONARY DRUG DELIVERY 
by 
LIN YANG 
August 2014 
Advisor:  Sandro R.P. da Rocha 
Major: Materials Science and Engineering 
Degree: Doctor of Philosophy 
This Dissertation focuses on addressing two of the major challenges in developing 
pressurized metered dose inhalers for pulmonary drug / gene delivery to and through the lungs.  
First challenge is to design biocompatible moieties for the steric stabilization of suspension 
formulations in HFO-based propellants.  Using a combination of tools including ab initio 
calculation, molecular dynamics simulation and high pressure tensiometry, potential fluorocarbon-
philic moieties were systematically screened.  Surfactants with those chemistries as tail fragments 
were studied at the HFO|H2O interface for their ability to lower the interfacial tension at HFO|H2O 
interface.  Selected surfactants were further optimized for surfactant balance by altering the head 
to tail ratio.   
The second challenge is to design PAMAM functional dendrimer nanocarriers for the 
delivery of therapeutics to and through the lungs.  Using molecular dynamics simulations, we 
investigate the microstructures of PAMAM dendrimers as a function of generation, PEGylation 
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density, PEGylation PEG length, dendrimer terminal chemistry.  Our discussion is focused on how 
the differences in microstructures of PAMAM dendrimers will affect the function, efficacy and 
efficiency of PAMAM dendrimer as drug / gene nanocarriers. 
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